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SUMMARY 
 
Epileptic seizures arise from pathological synchronization of neuronal ensemble. Seizures 
originating from primary motor cortex are often pharmacoresistant, and many times 
unsuitable for respective surgery because of location of epileptic focus in eloquent area. Basal 
ganglia play important role in seizure propagation. Micro electrode recordings performed 
during previous studies indicated that input structures of basal ganglia such as GPe, Putamen 
and Subthalamic nucleus (STN) are strongly modified during seizures. For example the mean 
firing rate of neurons of the STN and Putamen increased and the percentage of oscillatory 
neurons synchronized with the ictal EEG was higher during seizures as compared to interictal 
periods. Pilot studies in humans have shown the possible beneficial effect of chronic DBS 
applied to STN in treatment of pharmacoresistant motor seizures. Our study was aimed at 
studying the therapeutic effect of electrical stimulation of input structures of basal ganglia.  
We first developed a stable, predictable primate model of focal motor epilepsy by intracortical 
injection of penicillin and we documented it’s pharmacoresistence. We then stereotactically 
implanted DBS electrodes in the STN and Putamen. The stimulator was embedded at the back 
of the animals. Subthreshold electrical stimulations at 130 Hz were applied to STN. 
Stimulator was turned ON when penicillin was injected. Sham stimulation at 0 volt was used 
as a control situation, each monkey being its own control. The time course, number and 
duration of seizures occurring in each epochs of 1 h were compared during ON and sham 
stimulation periods. Each experimental session lasted upto 6 hours, we also studied preventive 
high frequency stimulation of STN and subthershold low frequency stimulation of Putamen 
with 5 Hz and 20 Hz in the same model. Finally we studied combined effects of high 
frequency STN and low frequency Putamen stimulation in one monkey 
Results:  Data was analysed from 1572 seizures in 30 experiments in three monkeys for 
chronic STN stimulation, 454 seizures in 10 experiments in one monkey during preventive 
STN stimulation, 289 seizures from 14 experiments in two monkeys during LFS putamen 
stimulation and 477 seizures from 10 sessions during combined STN and Putamen stimulation 
in one monkey. 
The best results were observed during chronic STN stimulation. The occurrence of first 
seizure was significantly delayed as compared to sham situation. Total time spent in focal 
seizures was significantly reduced by ≥69% on an average (p ≤0.05) after STN stimulation, 
due to a significant decrease in the number of seizures especially so during the first 3 hours 
after stimulation. The duration of individual seizures reduced moderately. Bipolar and 
monopolar stimulation modes were equally effective Preventive HFS STN (in one specimen) 
was not found to be superior to acute stimulation. LFS Putamen alone was effective but 
mainly in first two hours of stimulation. In a combined HFS STN and LFS Putamen 
stimulation the effect of stimulation in terms of seizure control was modest and poor 
compared to HFS STN alone or LFS Putamen alone.  
 
This study provides original data in primates showing the potential therapeutic effect of 
chronic HFS-STN DBS to treat focal motor seizures. A discussion explaining these results 
and comparison with STN DBS in human motor seizures as well as future translational 
perspective in human therapeutics is provided.  
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RESUME 
Les crises d'épilepsie proviennent d'une synchronisation pathologique de réseaux neuronaux 
du cortex. Les crises motrices, générées à partir du cortex moteur primaire, sont souvent 
pharmaco-résistantes. La résection neurochirurgicale du foyer épileptique est rarement 
l'option thérapeutique de choix au regard des risques de deficits moteurs potentiellement 
induits par la résection. Les ganglions de la base ont un rôle important dans la propagation des 
crises. Des enregistrements par micro-électrode réalisés dans une précédente étude ont montré 
que les activités des structures d'entrée des ganglions de la base telles que le Putamen, le 
noyau caudé et le noyau sous-thalamique (NST) sont fortement modifiées pendant des crises 
motrices. 
Par exemple, le taux de décharge moyen des neurones du NST et du Putamen augmente et le 
pourcentage de neurones oscillants synchronisés avec l'EEG durant la période ictale est plus 
élevé durant les crises que pendant la période inter-ictale. Des études pilotes chez l'humain 
ont montré un effet bénéfique potentiel de la stimulation cérébrale profonde (SCP) chronique 
du NST pour traiter les crises motrices pharmaco-résistantes. Le but de notre étude est 
d'évaluer les effets thérapeutiques de la SCP des structures d'entrée des ganglions de la base. 
Nous avons dans un premier temps développé un modèle primate de crise d'épilepsie motrice 
focale stable et reproductible par injection intra-corticale de pénicilline. Nous avons ensuite 
caractérisé la pharmaco-résistance du modèle. Nous avons implanté stéréotactiquement des 
électrodes de SCP dans le NST et le Putamen. Le stimulateur a été placé sous la peau dans le 
dos de l'animal. Un protocole de stimulation à 130 Hz à un voltage inférieur à l'apparition 
d'effets secondaires a été réalisé dans le NST. Le stimulateur était mis en marche au moment 
de l'injection de la pénicilline. Un protocole de stimulation à 0 volt a été réalisé comme 
condition contrôle. Chaque primate étant son propre contrôle. L'apparition des crises, leur 
nombre et leur durée ont été comparés par période de 1 heure entre la condition stimulée et 
non stimulée. Chaque session expérimentale a été menée sur une durée de plus de six heures. 
Nous avons évalué l'effet préventif de la SCP à haute fréquence (130 Hz) du NST sur les 
crises motrices. Nous avons également étudié l'effet préventif de la SCP à basse fréquence (5-
20 Hz) du Putamen sur ce même modèle. Enfin, sur un autre primate, nous avons étudié l'effet 
combiné de la SCP du NST à haute fréquence et du Putamen à basse fréquence sur les crises 
motrices. 
Résultats : 
Les effets de la SCP chronique du NST à haute fréquence ont été analysés à partir de 1572 
crises apparues au cours de 30 sessions expérimentales chez 3 primates. Les effets de la SCP 
préventive du NST ont  été évalués sur 454 crises motrices durant 10 sessions expérimentales 
chez un primate. L'effet de la SCP du Putamen à basse fréquence a été analysé sur 289 crises 
durant 14 sessions chez 2 primates. Enfin l'effet combiné de la SCP du NST et du Putamen a 
été évalué sur 477 crises durant 10 sessions. Les meilleurs résultats ont été obtenus par SCP 
chronique du NST. L'apparition de la première crise était significativement retardée lorsque le 
primate était stimulé. Le temps total passé en situation de crise motrice était diminué en 
moyenne d'environ 69 % (p ≤0.05) par rapport à la condition non-stimulé au regard de la 
diminution significative du nombre de crises particulièrement durant les 3 heures après le 
début de la stimulation. La durée de chaque crise était modérément réduite. Les modes de 
stimulation mono-polaire ou bi-polaire avaient une efficacité similaire. La SCP préventive du 
NST n'a pas eu d'effet supérieur à la stimulation chronique du NST. La SCP chronique du 
Putamen à basse fréquence avait un effet positif mais principalement durant les deux 
premières heures de stimulation. L'effet combiné de la SCP du NST et du Putamen était 
inférieur à la SCP chronique du NST ou du Putamen. 
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Cette étude montre pour la première fois chez le primate des efets thérapeutiques de la SCP 
chronique du NST à haute fréquence pour traiter les crises focales motrices. Les résultats 
obtenus dans cette étude sont discutés au regard de la physiopathologie des ganglions de la 
base et des hypothèses concernant l'excitabilité et le métabolisme cortical durant les crises 
d'épilepsie. Finalement, nous discutons nos résultats au regard des résultats préliminaires 
obtenus chez l'humain. Nous envisageons enfin les perspectives apportées par cette étude pour 
le développement de stratégies thérapeutiques par SCP chez l'humain pour traiter les 
épilepsies motrices.  
 10 
 
 
GLOSSARY 
AED Anti epileptic drug  
ANT Anterior nucleus of thalamus  
AVM Arterio venous malformations  
BG Basal ganglia  
CCM Cavernous malformations  
CMT Centromedian nucleus of the thalamus  
DBS Deep brain stimulation  
DMAZ Dorsal midbrain anticonvulsant zone  
ECoG Electrocorticogram  
EEG Electroencephalogram   
EPC Epilepsia partialis continua  
fMRI Functional magnetic resonance imaging  
GABA Gamma-aminobutyric acid  
GAERS Genetic Absence Epilepsy Rat (from Strasbourg) 
GPe Globus pallidus externa  
GPi Globus pallidus interna  
IGE Idiopathic generalized epilepsy  
MCD Malformations of the cortical development   
MPTP 1 - méthyle 4 - phényl 1, 2, 3, 6-tétrahydro pyridine 
MRI Megnetic resonance imaging  
MST Multiple subpial transection  
MTLE Mesial temporal lobe epilepsy  
NMDA N-methyl-D-aspartate 
PET Positron emission tomogram  
PUT Putamen  
QQL Quality of life 
RE Rasmussen's encephalitis 
SN Substantia nigra  
SNrSubstantia nigra pars reticulata  
SNc Substantia nigra pars compacta  
SPECT Single-photon emission computed tomography  
STN Subthalamic nucleus  
SUDEP Sudden unexplained death in epilepsy 
SVD Spike and wave discharge  
TMS Repetitive transcranial magnetic stimulation 
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CHAPTER I  
EPILEPSY 
 
1.1 GENERAL INTRODUCTION 
 
A seizure (from the Latin sacire to take possession of) is the clinical manifestation of an 
abnormal, excessive, hypersynchronous discharge of a population of cortical neurons.  
 
Epilepsy is a disorder of the central nervous system characterized by recurrent seizures 
unprovoked by an acute systemic or neurologic insult.Epileptogenesis is the sequence of 
events that turns a normal neuronal network into a hyperexcitable network. 
 
Epilepsy represents an imbalance between excitatory and inhibitory membrane properties at 
synaptic level. 
 
The following figure schematically illustrates this: 
 
 
 
 
Figure 1: The balance between excitatory and Inhibitory events at synaptic level. 
 
 
A hyperexcitable state can result from increased excitatory synaptic neurotransmission, 
decreased inhibitory neurotransmission, an alteration in voltage-gated ion channels, or an 
alteration of intra or extra-cellular ion concentrations in favor of membrane depolarization. A 
hyperexcitable state can also result when several synchronous subthreshold excitatory stimuli 
occur, allowing their temporal summation in the post synaptic neurons. 
 
Epidemiology:  
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Epilepsy is the second most common neurological disease, the first being cerebrovascular 
accidents. Incidence of epilepsy is 5-7 per 10.000 persons per year. 
 
This varies with the age, 
 
 
 
Figure 2: The annual incidence of epilepsy and age related variation. (Hauser et al 1991) 
 
 
Two peaks are evident. The first at around 2 to 3 years of age, the second around 60 years of 
age. This is true about generalized epilepsy but focal epilepsy can manifest at any age 
(Hufnagel and Noachtar, 2003). The causes of epilepsy in infants include developmental 
malformations, genetic metabolic syndromes and perinatal cerebral injury. Febrile seizures 
and Temporal lobe epilepsies are major causes for epilepsy between the age of 5-15 years. 
While traumas, withdrawal of alcohol, infections and neoplasm emerge as leading causes of 
epilepsy in the adulthood. Stroke is the main etiology of new onset epilepsies after the 60 th 
year. 
 
The epileptic course can be divided in three phases. An ictal phase characterized by acute 
systemic changes in neuronal functions called ‘seizure‘. A post ictal state after the seizures 
where there is gradual return back to normal functions and an inter ictal phase between two 
seizure episodes. There are two major categories of seizures. The ones arising from a well 
circumscribed brain area are called ‘partial seizures ‘. These are propagated by recruitment of 
surrounding neurons and neuronal circuits related to these neurons .Partial seizures are often 
related to focal structural abnormality .The other type is primary generalized seizures. Here 
the seizures propagate because of rapid synchronization of abnormal rhythms in both 
hemispheres. 
1.2 SEIZURE AND EPILEPSY 
 
Following figure schematically represents the events that promote a chronic epilepsy from a 
single seizure e.g temporal lobe epileptic seizures.  
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Figure 3: Epileptogenesis. 
The process of evolution from a normal state to chronic epilepsy through epileptogenesis 
Box indicates the initial event that may lower a normal seizure threshold and produce a clinical seizure. Subsequent 
epileptogenesis characterized by cellular and synaptic changes represented by a circle. This makes person prone to more 
seizures and the cycle of cellular events may repeat at each seizure transforming the state to ‘Epilepsy’. The likely outcome 
after drug therapy are also represented 
 
Classification of epileptic disorders and seizures is described separately in annex.  
1.3 DRUG THERAPY 
 
Pharmaceutical therapy forms the mainstay of treatment for epilepsy. The cellular mechanism 
operating in seizure can be summarized as imbalance between excitation and inhibition of a 
synaptic transmission. Excess excitation and decreased inhibition both promote seizures. In an 
epileptic synapse the excitatory neurotransmitter Glutamate is released under influx of sodium 
and calcium ions in the presynaptic neuron. Post synaptic Glutamate receptors are of two 
types. Ionotropic (NMDA, and non NMDA) involved in fast synaptic transmission and 
Metabotropic receptors related to slow synaptic transmission. GABA is the main inhibitory 
neurotransmitter. The influx of chloride ions making the membrane hyperpolarised generates 
the inhibitory post synaptic potential (IPSP) under GABA influence. Anti Epileptic drugs act 
by one of the several mechanisms influencing one or several processes described above in 
generation of seizures. 
Commentaire [G1]:  
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Figure 4: Sites of action of Anti Epileptic Drugs (AED) 
Figure schematically represents a synapse. The possible sites of action of AED are numbered. The table below details 
commonly used AED corresponding to each site of action. 
 
The commonly used AED and their sites of action (ref figure) are summarized in the table 
below  
 
Table 1: Commonly used AED 
Site of Action Description Anti Epileptic Drug 
1 Sodium Channel 
Standard Phenytoin 
Carbamazepine Valproate 
Phenobarbital 
Newer Lamotrigine 
Oxcarbazepine Topiramate 
Zonisamide 
2 Calcium Channel Standard Ethosuximide Newer Zonisamide 
3 Glutamate  receptor (NMDA) Felbamate 
4 Glutamate  receptor (non NMDA) 
Standard Phenobarbital 
Newer Topiramate 
5 
GABA receptors potentiation 
Receptor function  
enhancement 
Description 
Benzodiazepines and 
barbiturates 
Topiramate 
Anti Epileptic Drug 
 
6 
GABA re uptake inhibition  Tiagabine 
GABA metabolism (GABA 
transaminase inhibition) Vigabatrin 
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In clinical management of epileptic patients certain drugs are preferred over others in specific 
types. Following tables summarizes these choices. 
 
Table 2 : Drug therapy for common Seizure types 
Seizure type Seizure pattern First Line Second Line 
Partial 
Simple 
Complex 
Partial with 
secondary 
generalization 
CBZ,VPA 
GVG, PHT, LTG 
CLB, GBP, AXCM 
FBM, PB 
Generalized Tonic –Clonic Tonic /Clonic VPA  CBZ 
PHT, LTG, CLB 
GVG, PB, AXM 
FBM 
Generalized Absence ESM,VPA LTG CZP AXM 
 
Atypical Absence 
Atonic (drop attacks) VPA 
LTG, CLB, CZP 
AXM, PB, FBM, 
CBZ,PHT, GBP 
Generalized Myoclonic VPA CZP, PCT, PB, AXM 
 Infantile Spasm ACTH GVG, NZP, CZP 
CBZ=carbamazepine, 
VPA=valproate, 
ESM=ethosuximide, 
GVG=vigabatrin, 
PHT=phenytoin, 
LTG=lamotrigine, 
CLB=clobazam,  
GBP=gabapentin,  
AXM=acetazolamide, 
FBM=febamate, 
PB=phenobarbitone,  
CZP=clonazepam,  
PCT=piracetam, 
NZP=nitrazepam 
 
 
 
 
Actazolamide (AXM) is an inhibitor of carbonic anhydrase enzyme and is used an adjuvant to 
main AED in specific cases. It appears to retard abnormal, paroxysmal, excessive discharge 
from central nervous system neurons. 
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1.4 MOTOR SEIZURES IN HUMANS 
 
1.4.1 INTRODUCTION 
 
Epileptic activity arising from frontal lobes frequently manifests clinically as motor epilepsy. 
Figure below shows the schematic relationships of different motor areas in the frontal lobe 
which are related to motor epilepsy. 
 
 
 
 
Figure 5 : The schematic representation of origin of motor seizures. 
 A lateral view of the brain, B medial view of brain 
from Kellinghaus C, Lüders HO 
 
The semiological classification of motor seizures  
 
1- Focal clonic seizures 
 
Seizures arising from primary motor cortex or when epileptic activity spreads into the primary 
motor cortex produce focal clonic motor activity in the contralateral body (Ikeda et al 1999). 
This manifest as a continuous increase in muscle tone associated with repetitive fast spiking 
over the precentral gyrus, followed by a regular pattern of synchronous, short contraction of 
agonistic and antagonistic muscles alternating with muscle relaxation. Consciousness is 
usually preserved in these types of seizures (Salanova et al 1995). 
 
2- Bilateral asymmetric tonic seizures 
 
Classically, these seizures are of short duration and arise from supplementary motor area. The 
semiological picture shows asymmetric tonic posturing of both arms but consciousness is 
preserved. In adition, sometimes patient experience somatosensory aura (Morris et al 1988). 
Sometimes though the symptomatic zone is SSMA the epileptic discharge might arise from 
additional frontal lobe areas like frontobasal or mesiofrontal area. 
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3- Complex motor seizures 
 
Hyper motor seizure: The complex motor seizures are seizures with repeated motor activity 
which appears as semi purposeful. These activities include motor activity like thrashing of the 
extremities, body rocking, bicycling leg movements, laughing and shouting (Salanova 1995, 
Bancaud et al 1992, Holthausen et al 2000, Manford M 1996). The majority (50-90 %) of the 
patients have auras, these seizures rarely last more than a minute. 
There are other seizure types with a motor manifestation for example the versive attacks, or 
rare forms of seizures where there is inability to initiate movement. But these are not 
exclusive due to an epileptic focus in motor area and can be observed in other seizure 
syndromes. Most of the motor seizures are pharmaco resistant. The more severe and 
progressive partial motor seizure is Epilepsia Partialis Continua (EPC). The features of EPC 
and its main etiologies i.e inflammatory (Rasmussen’s Encephelitis) and developmental 
(Malformations of cortical development and cerebral vascular malformations) are detailed 
below in relation to human focal motor seizures. 
 
 
1.4.2 EPILEPSIA PARTIALIS CONTINUA (EPC) 
Introduction 
 
In 1895, Kojewnikoff described a unique type of prolonged focal seizure, which he named 
epilepsia partialis continua (EPC). In 1927 Omorokow reported 52 cases during an outbreak 
of Russian spring-summer encephalitis. The clinical entity has been variously labeled as a 
variation of jacksonian epilepsy, as a jacksonian status epilepticus, as myoclonus epilepsy, or 
as continuous, localized myoclonia. 
 
In 1985 Obeso et al defined  EPC as ‘‘Spontaneous regular or irregular clonic twitching of 
cerebral cortical origin, sometimes aggravated by action or sensory stimuli, confined to one 
part of the body, and continuing for hours, days or weeks.’’ (Obeso et al 1985) A more 
generalized definition by Cockrell et al uses ‘‘Continuous muscle jerks of cortical origin to 
define EPC (Cockerell et al., 1996). 
 
Cockerell et al estimated the prevalence of EPC at less than 1 per million, based on 36 cases 
reported in the United Kingdom over a 1-year period, 10 of the cases being new.  
 
The features of EPC include:  
Focal motor clonic seizures without Jacksonian march, localized to a part of the lasting for at 
least 60 minutes and often for hours, days, weeks, or even longer. Consciousness usually is 
preserved, but postictal weakness is frequently evident. (Benacoud et al 1982, Gastaut 1968) 
Antiepileptic drugs, except few, do not seem to significantly alter the course of this condition 
(Schomer 1993).  
 
 
Definition 
 
Epilepsia partialis continua is currently defined as  a form of partial status epilepticus with 
simple motor manifestations that are maintained for over 1 hour, with clonic activity restricted 
to 1 body part and recurring at fairly regular intervals. This clinical presentation of EPC 
usually has following additional features:  
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• Motor activity often is modified by sensory stimuli 
• Frequency is usually 0.1-6 Hz 
• An occurrence of EPC can continue for long periods of time (sometimes years) 
without spreading, although spread can occur at times  
• EPC often is associated with postictal or interictal weakness 
 
Clonic activity in EPC can involve any muscle group but usually frequent in the upper 
extremities usually confined to a single muscle group in most patients. However in rare cases 
Jacksonian spread of the seizure or evolution into complex partial or secondarily generalized 
seizure can be noted. This syndrome also may be accompanied by other neurological and 
psychopathological symptoms.  
 
Classification  
 
Bancaud et al classified EPC into 2 groups. Both present with similar clinical seizures. 
 
 
Table 3 : Classification of EPC 
Type 1 
  Usually a fixed lesion 
 Neurologic deficit 
 Preceding partial motor 
seizures 
 Following myoclonic jerks 
 Focal abnormalities on 
electroencephalogram (EEG) 
 Nonprogressive course 
 Surgery usually effective 
Type 2   
stage 1 
Only simple partial motor or 
complex partial seizures,  EPC 
may occur 
 Normal development and 
history until seizure onset 
 Preceding partial motor 
seizures 
 Following myoclonic jerks 
 Abnormal 
electroencephalographic 
background, with focal and 
diffuse paroxysmal 
abnormalities 
 Progressive course 
Stage 2 
EPC with  progressive 
neurologic deficit and mental 
deterioration 
 Chronic encephalitis 
Stage 3 Arrest of deterioration and decrease in seizures. 
 Intractable  
 
The etiological factors of EPS include cerebral neoplastic lesions located in this cortical area, 
cortical developmental abnormalities, infections, inflamations, metabolic encephalopathies, 
vascular lesions like AVM and cavernous malformations and trauma. This wide spread 
etiological origin but unique clinical feature suggests that EPS is related to specific cortical 
anatomy rather than the physiology. 
 20 
 
Explanation of Specific invariable focal status presentation and pharmaco resistance of 
seizures in EPS: 
 
In case of seizures arising from limbic origin the seizures spread rapidly as limbic system 
processes functions like  memory and emotion, requiring wide  spread excitation across  many 
brain regions. In contrast the neocortex process very specific local information in sensory, 
motor, and cognitive domain and has strong lateral inhibition. This is the mechanism by 
which though seizures in EPS occur for a long duration their spread to other parts of body is 
rare. Since surround inhibition might limit seizure spread more effectively in motor neocortex 
than in any other area because of the tight afferent-efferent relationships, which support the 
activation of long-loop reflexes, EPC may be a unique expression of cortical organization. 
This was demonstrated in a monkey model. Injections of aluminum hydroxide in the monkey 
motor cortex (Chauvel et al., 1978) provided evidence of the long-loop reflexes for the 
generation of cortical myoclonus. In this study thermocoagulation of the posterior 
ventrolateralis nucleus of thalamus often cased myoclonic jerks thereby emphasizing that 
cortical myoclonus as seen in EPC might involve long loops.  
 
The synaptic mechanism of self-sustained status epilepticus has been studied. It is 
demonstrated that status epilepticus is initiated by failure of GABAergic inhibition but is 
maintained by widespread potentiation of excitatory (especially N -methyl-D-aspartate 
[NMDA]) synapses. Therefore, established self-sustaining status epilepticus becomes resistant 
to all agents except NMDA antagonists (Mazarati et al 1997). Same mechanism might operate 
in EPC where the epileptic structural focus would have desensitization of GABA receptors, 
while GABAergic inhibition would be preserved in the surround.  
 
The idiopathic causes of EPC are: 
 
• Rasmussen chronic encephalitis (Biraben et al 1998) 
• Autoimmune - Multiple sclerosis, (Spat et al 1995) anti-GluR3 or anti-NMDA-
GluR-Epsilon2 antibodies  
• Genetic causes like Alpers disease, Kufs disease (Gambardella et al 1998) 
Leigh syndrome and cytochrome C oxidase deficiency, (Elia et al 1996) 
nicotinamide adenine dinucleotide (NADH) coenzyme Q reductase deficiency 
and mitochondrial cytopathies, including mitochondrial encephalopathy with 
lactic acidosis and stroke (MELAS) (Veggiotti et al 1995).  
 
Diagnosis  
 
Diagnosis of EPS many times requires a multimodal approach. The EEG might not be 
successful in demonstrating focal cortical abnormal rhythms Evoked-potential techniques, 
especially somatosensory evoked potentials (SSEP), can be used to examine the physiologic 
mechanisms and anatomical locations of EPC. Giant SSEPs are seen often and point to 
cortical hyperexcitability, which may be an essential mechanism of EPC. MRI can point to 
the structural lesion of the cortex and/or white matter. PET and SPECT scans can be useful 
when computed tomography (CT) and magnetic resonance imaging (MRI) scans are normal. 
Combined imaging modalities might show epileptic foci not detected on structural MRI. For 
example SPECT-MRI fusion has been reported by Matthews to have successfully been used 
to identify epileptic focus in a patient with EPC (Matthews et al 2006).  
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Prognosis  
 
The long-term prognosis of EPC depends completely on its underlying cause. Anticonvulsant 
therapy is not effective for symptomatic control and most of these seizures are pharmaco 
resistant. In some cases steroids, immunoglobins, antiviral agents have been used depending 
upon the presumed inflammatory, autoimmune and viral mechanisms in etiology. 
 
Neurosurgical approaches, such as multiple subpial transections (Molyneux et al 1998), and 
hemispherectomy in refractory cases of Rasmussen encephalitis producing EPC, are also 
found useful. 
 
1.4.3 RASMUSSEN’S SYNDROME 
Introduction 
 
The first description of Rasmussen’s syndrome was provided by Rasmussen and co-workers 
in 1958 when they reported three patients with ‘focal seizures due to chronic localized 
encephalitis’ (Rasmussen et al., 1958). It is also called Rasmussen encephalitis (RE) or 
Rasmussen syndrome. Rasmussen proposed a viral etiology based on lymphocyte infiltration 
and microglial nodules found in affected brain. Similarity of presentation between Russian 
spring summer meningoencephalitis, caused by a flavivirus, and RE also supported the viral 
etiology. But so far no viral agent has been conclusively proved to be the infective agent 
(Rasmussen, 1978; Farrell et al., 1991; Jay et al., 1995). Hence the pathogenesis of 
Rasmussen’s Encephalitis is thought to be related to autoimmune reaction. Antibodies against 
subunit 3 of the ionotropic glutamate receptor (GluR3) were found in patients of RE (Rogers 
et al., 1994). But their specific role in RE is questionable as these are also found in other 
epilepsy forms in a comparable proportion (Mantegazza et al., 2002). Besides this the role of 
cytotoxic T lymphocyte (CTL) attack against neurons has been proposed as another immune 
mechanism since the affected brain tissue is found to contain these cells in large number (Li et 
al., 1997). 
 
Diagnostic criteria (Bien et al 2005) 
 
Part A: 
1. Clinical: Focal seizures (with or without Epilepsia Partialis Continua) and unilateral 
cortical deficit(s). 
2. EEG: Unihemispheric slowing with or without epileptiform activity and Unilateral seizure 
onset. 
3. MRI: Unihemispheric focal cortical atrophy and at least one of the following:  
• Grey or white matter T2/FLAIR hyperintense signal 
• Hyperintense signal or atrophy of the ipsilateral caudate head. 
 
Part B: 
1. Clinical: epilepsia partialis continua or Progressive* unilateral cortical deficit(s). 
2. MRI: Progressive* unihemispheric focal cortical atrophy. 
Histopathology; T cell dominated encephalitis with activated microglial cells (typically, 
but not necessarily forming nodules) and reactive astrogliosis. 
 
RE can be diagnosed if either all three criteria of Part A or two out of three criteria of Part B 
are present.  
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*‘Progressive’ means that at least two sequential clinical examinations or MRI studies are 
required to meet the respective criteria. To indicate clinical progression, each of these 
examinations must document a neurological deficit, and this must increase over time. To 
indicate progressive hemiatrophy, each of these MRIs must show hemiatrophy, and this must 
increase over time. 
 
Clinical features 
 
 The general presentation of RE is childhood epilepsies with progressive neurological 
deterioration. The disease is conceptualized to be progressive through three stages. Early  
‘prodromal stage’ with a relatively low seizure frequency and rare mild hemiparesis;  then the 
‘acute stage’ of the disease, characterized by frequent seizures, mostly simple partial motor 
seizures often as epilepsia partialis continua (EPC) with neurological deterioration  like 
progressive hemiparesis, hemianopia, cognitive deterioration and, if the language dominant 
hemisphere is affected, aphasia (Oguni et al., 1991). The last residual stage is characterized by 
permanent and stable neurological deficits and persistent seizures. 
 
Seizures in RE are often polymorphic depending upon the disease progression. In a study by 
Oguni and co-workers 77% of seizures were simple partial motor seizures involving one side 
of the body. Other seizure type included secondarily generalized tonic clonic seizures, 
complex partial, postural seizures and somatosensory seizures were also noted (21%) (Oguni 
et al., 1991).  EPC has been reported to occur in 56–92% of patients at some time during their 
disease course (Bien et al., 2002). But the major feature of these seizures is 
pharmacoresistance. Surgery appears to be the ideal choice of treatment for RE patients. 
Results of focal resections in RE patients have been reported as disappointing (Olivier, 1991; 
Honavar et al., 1992) But Hemisperectomy and its variants or the newer disconnective 
techniques produce seizure freedom rates between 62.5% and 85%. (Details of the 
hemispherectomy are described in Chapter 2). 
 
1.4.4 MALFORMATIONS OF THE CORTICAL DEVELOPMENT (MCD) 
Introduction  
 
Malformations of the cortical development are interruptions in the normal process of neuronal 
migration and establishment of connectivity in a developing brain. These are of interest to 
epilepsy as often children with MCD present with epilepsies that are pharmaco resistant. With 
the increased use of better imaging techniques like MRI in management of epilepsies these 
structural abnormalities are being detected more frequently and are found to be a major cause 
of partial seizures. 
 
The various types of MCD are described below: 
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Table 4 : Description of malformation of cortical development 
MCD Brief Description 
1 Agyria or Lissencephaly 
Absence of normal gyral formation 
Type 1 : Four layered cortex instead of 
normal 6 layered 
2 Pachygyria Broad and few number of gyri 
3 Polymicorgyria Narrow and thin gyri 
4 Schizencephaly Cleft of various depth from pial surface to 
ependymal 
5 Subependymal Ectopic grey matter tissue in the 
subependymal zone 
6 Subcortical Heterotopia Grey matter nodules below cortical mantle 
 
7 Micordysgenesis Small number of neurons in the white matter 
 
8 Dysembryogenic Nodules of pleomorphic cells including dysmorphic neurons 
 
9 Focal cortical Dysplasia 
Areas containing large number of 
dysmorphic neurons in otherwise       ‘normal 
‘ layered and convoluted cortex 
 
 
The incidence of MCD in patients with refractory epilepsies range from 7% to 12 % (Li et al., 
1995, Semah et al., 1998). Even high resolution MRI may not detect the cortical dysplasia at 
pre operative stage and the presence of cortical dysplasia would be obvious only at post 
operative histopathology studies. Thus the actual incidence of MCD in pharmaco resistant 
epilepsy might be higher (Li et al., 1995). The diagnosis of MCD is often made by clinical 
presentation and EEG abnormalities coupled with imaging studies like CT, MRI. 
 
Epileptic potential of MCD  
 
The epileptic potential of MCD arises from two things. The cortical area affected by 
maldevelopement is found to be hyperexcitable. The best studied examples of such 
epileptogenicity are related to focal cortical dysplasia (FCD). In the histological specimen 
cellular changes that support hyper excitability have been demonstrated previously (Ferrer et 
al., 1992, Mikuni et al., 1999). Epileptic discharges from human FCD have been reported 
(Rosenov et al 1998) and the surgically resected human epileptic tissue containing FCD 
maintained in vitro is shown to generate epileptic activity (Mattia et al., 1995). In case of 
Periventricular hetererotopia invasive recording from the nodules have demonstrated epileptic 
activity from the region (Debeau et al., 1995, Li et al., 1997). Similarly in a rat model of 
polymicrogyria the cortex near the vicinity of the lesion was shown to be epileptogenic 
(Jacobs et al., 1999). 
 
Based on these examples it can be presumed that cortical areas containing the malformations 
are potentially hyperexcitable. In addition the cellular altered morphology might affect the 
dendritic connectivity to other neurons. Both these factors (altered excitability and 
connectivity) might make the zone epileptogenic.  
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1.4.5 VASCULAR MALFORMATIONS 
 
Introduction 
 
Vascular malformations affect about 2 to 4% of the population. These are abnormal vascular 
structures. Two main types are found cavernous malformations (CCM) and arterio venous 
malformations (AVM). 
 
Cerebral cavernous malformations are clusters of dilated sinusoids filled with blood and lined 
with endothelium without intervening parenchyma. They sometime grow by formation of a 
vascular cavum due to repeated hemorrhages in them. The CCMs exhibit brittle vascular 
morphology devoid of mature vessel wall elements. 
 
Diagnosis 
 
Seizures are the main symptomatic manifestation of CCM. MRI are important in diagnosing  
CCM as  due to  their small size and often isodense appearance related to subacute 
hemorrhage or microcalcifications, CCMs are commonly missed or misdiagnosed on CT. 
Angiographically also these lesions are occult (Robinson et al., 1994). 
 
Epileptogenicity  
 
CCM essentially are malformed blood vessels and do not typically include functioning neural 
tissue. They are not intrinsically epileptogenic themselves. However they can induce seizures 
through their effect on the surrounding brain. These effects may include relative ischemia, 
venous hypertension, gliosis, deposits of blood breakdown products, and cellular and humoral 
inflammatory responses. These long standing changes in ‘occult‘non haemorrhagic CCM may 
make adjacent cortex epileptogenic. Distinct hemorrhage from CCMs may create 
encephalomalacia and cortical scars that may be additionally epileptogenic (Awad and 
Jabbour, 2006). 
 
Treatment  
 
The symptomatic drug treatment of seizures related to CCM by anticonvulsants might not be 
adequate and these seizures are often pharmaco resistant. Resection of structural lesions may 
be performed in two ways i.e lesionotomy that is resection limited to the lesion alone or 
lesionotomy and corticotomy where along with resection of the lesion the epileptogenic 
cortex is also excised. It is reported that the seizure control after lesionotomy alone is inferior 
to one achieved by lesionotomy and corticotomy. Other therapies like radiotherapy are also 
useful. 
 
Arterio Venous malformations (AVM) are complex, tangled web of abnormal arteries and 
veins connected by one or more fistulas. The AVM does not have capillary bed of its own. 
The AVM permits high-speed, high-flow shunting of blood from the arterial to the venous 
side of the circulation. This might produce relative ischemia in adjacent cortex and make it 
prone for epilepsy. AVM can clinically present as epilepsy but cerebral hemorrhage is more 
often the clinical presentation in this condition. For example arteriovenous malformations 
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account for approximately one third of primary intracerebral haemorrhage in young adults 
(Al-Shahi and Warlow, 2001) 
1.5 PHARMACO RESISTANT EPILEPSY  
 
Introduction 
 
People with epilepsy experience uncertainty, about getting a seizure and become vulnerable in 
social situations. Epilepsy patients have stated that uncertainty and fear of having a seizure are 
the worst things about having epilepsy (Fisher et al., 2000). But this problem assumes grave 
proportions in medically intractable i.e pharmaco resistant epilepsies. As apart from the 
uncertainty the patients face more events like falls, injury, neuropsychiatric problems and 
even SUDEP (sudden unexplained death in epilepsy). The following text describes the 
features of pharmaco resistant epilepsies. 
 
The steps followed in initiating drug therapy and arriving at a diagnosis of pharmaco resistant 
epilepsy are illustrated schematically below  
 
 
 
Figure 6 : Algorithm for determining a pharmaco resistant epilepsy 
   
Incidence of pharmaco resistant epilepsy  
 
The mainstay of epilepsy therapy is drugs and about 70 % of epilepsy patients are well 
controlled on the drug therapy. However 30 % are never controlled despite adequate 
treatment: and fall in the group of pharmaco resistant epilepsy. A seminal study by Kwan and 
Brodie illustrates this phenomenon. They studied the treatment and follow up of 523 epilepsy 
patients over 13 years. The age group ranged from 9 to 93 years and all epilepsy types 
(generalized, partial, symptomatic as well as idiopathic) were represented in patient 
population. It showed that 63 % of the patients were treatment responsive and had attained 
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seizure freedom for at least 1 year. About 50% achieved seizure freedom on first anti epileptic 
medication. Successive addition of antiepileptic produced minor improvement in this 
percentage but treatment with three or more anticonvulsant failed to improve this percentage 
further (Kwan, Brodie, 2000).  
 
  
 
 
Figure 7 : Response to Anti Epileptic therapy (reproduced from Kwan Brodie 2000) 
Nearly 50% of all patients with newly diagnosed epilepsy attained seizure freedom on their first drug. Those who failed their 
first drug were less and less likely to gain control with each successive drug trial. 
 
 
Semah and colleagues studied ease of seizure control and final treatment outcome in a sample 
of 2,200 adult outpatients with epilepsy. In this study it was found that patients with 
symptomatic or cryptogenic seizures were the least likely (around 26%) to be well controlled 
on drugs and become seizure free for 1 or more year (Semah et al., 1998). The availability of 
newer classes of anticonvulsant has not changed the picture of pharmaco resistant epilepsies 
.Studies show that for patients already considered as suffering from pharmaco resistant 
epilepsies the newer drugs improves seizure control only marginally. In these patients a 
further 50% control over seizures was seen in 15% patients with Gabapentine, 15% with 
lamotrigine 25% with Tigabine 35% with Topiramate, 35% with Oxcarbazine, 32% with 
Levitiracetam 20% with Zonisamide and 35% with Pregabalin (French, 2007). 
 
1.5.1 FACTORS ASSOCIATED WITH TREATMENT-RESISTANT EPILEPSY 
INCLUDE 
 
History of early onset of seizures and status epilepticus, long history of poor seizure control, 
history of multiple seizures high seizure density, (French, 2007) are indicators of pharmaco 
resistant epilepsy. Symptomatic epilepsies like in patients with a history of brain infection or 
head trauma are often pharmaco resistant. Certain structural abnormalities like cortical 
dysplasia, hippocampal sclerosis are associated with pharmaco resistant epilepsy. In a study it 
was found that for patients with a single identified lesion, TLE with hippocampal sclerosis 
(HS) had a particularly bad prognosis (11% seizure free) compared with other etiologies (24% 
with cortical dysplasia seizure free). Patients with Hippocampal sclerosis and another 
identified pathology (dual pathology) had the worst prognosis (3% seizure free) (Semah, 
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1998). Developmental delays and other cognitive disability are associated with poor seizure 
remission rates (Okuma, Kumashiro, 1981). 
 
 
False pharmaco resitant Epilepsy: 
 
Pharmaco resistant epilepsy means failure to achieve optimum control over seizures by use of 
anti epileptic medications. Besides the true pharmaco resistance many factors produce 
suboptimal performance of antiepileptic drugs resulting into false pharmaco resistance. Few 
of the causes are mentioned below. 
Misdiagnosis and misclassification into epileptic syndrome means possible: inappropriate 
class of anticonvulsant as first choice and poor response. 
 
Drug interactions with other AED and a poor compliance from patient might lead to a false 
impression of pharmaco resistant epilepsy. 
 
True pharmaco resistant Epilepsy: 
 
What constitutes a definition of pharmaco resistant epilepsy is difficult to decide because 
various factors like seizure frequency, seizure severity, patient’s subjective perception of 
handicap can influence the meaning of pharmaco resistant epilepsy.  
 
Most epilepsy centers define intractability as failure of at least 2 or 3 first-line antiepileptic 
medications. However, many physicians define medical intractability differently. They might 
try numerous antiepileptic drugs (AEDs) before referral for a presurgical evaluation is even 
considered, (Berg, Kelly, 2006). If the two drug criteria is used then 24% of focal seizures, 
9.3% of idiopathic seizures and 66.7% of catastrophic seizures are found to be pharmaco 
resistant. 
 
The stringent criteria for pharmaco resistant epilepsy as defined by Berg (Berg, 2006) are  
a) failure of two appropriate anticonvulsants  
b) occurrence of an average of one seizure per month for 18 months  
c) no more than 3 months of seizure free interval between these 18 months.  
 
Using these criteria 13.3% of focal epilepsy 3.9% of idiopathic epilepsy and 52.2% of 
catastrophic epilepsy are found to be pharmaco resistant. 
 
However, this definition is more suitable for epidemiological and research studies in epilepsy. 
The medical intractability in a particular patient depends upon the natural course of the 
specific epilepsy and individual’s response to anticonvulsant. 
 
Hence a consensus proposal by the Task Force of the International League Against Epilepsy 
(ILAE) Commission created an operational definition of drug-resistant epilepsy, noting that 
this definition may change as more empirical evidence becomes available (Kwan et al., 2010). 
The ILAE defines drug-resistant epilepsy as “a failure of adequate trials of two tolerated and 
appropriately chosen and used AED schedules (whether as monotherapies or in combination) 
to achieve sustained seizure freedom”. 
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Seizure freedom is defined as freedom from seizures for a minimum of 3 times the longest 
preintervention interseizure interval (determined from seizures occurring within the preceding 
12 months) or 12 months, whichever is longer (Kwan et al., 2011).  
 
1.5.2 MOLECULAR HYPOTHESIS OF PHARMACO RESISTANT EPILEPSY  
 
The graphic below schematically illustrates two important hypothesis that explain why a 
perticular epilepsy becomes pharmaco resistant  
  
  
 
Figure 8 : Molecular hypothesis of pharmaco resistance (Remy S. and Beck H. Brain 2006) 
Part A illustrates how a target might be altered.  
Part B shows the upregulation of multidrug transporters in epilepsy and subsequent removal of drug in the vascular space. 
 
Target hypothesis (part A): 
 
The Anticonvulsant drug targets are of three types viz. voltage gated ion channels, proteins 
involved in synaptic inhibition (enhancing GABA neurotransmission) and proteins involved 
in synaptic excitation (acting on glutamate transmission). These targets can be altered due to 
altered gene encoding ultimately affecting the pharmacodynamics of AED. Alternatively 
these targets can have altered sensitivity to AED during the course of epilepsy. Their 
distribution and density can also become altered. All these mechanisms may contribute to the 
less seizure control despite adequate therapy. 
 
Multidrug transporter hypothesis (part B): 
 
Inadequate transport to the target neurons may be a cause of pharmaco resistant epilepsy. The 
drug transport molecules are found upregulated in many types of epilepsy. This could be 
genetic or ‘acquired ‘as a consequences of repeated seizures. These transporter molecules act 
as a drug efflux pump proteins and export drug molecules to vascular space at blood brain 
barrier level. This results in less drug molecules reaching the target neurons. 
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1.5.3 CONSEQUENCES OF PHARMACO RESISTANT EPILEPSIES  
 
Quality of life  
 
Quality of life (QOL) is a measure of how a person’s sense of own wellbeing and degree of 
functional integration in the society. Health related quality of life is often found affected in 
chronic diseases like diabetes, hypertension and epilepsy. Recurrent seizures, poor seizure 
control, multi drug therapy, prolonged treatment period are features of pharmaco resistant 
epilepsy which augment the negative effects. 
 
The epileptic patients perceive ‘loss of control over their lives .and develop anxiety and 
depression (Ettinger et al 2004, Gilliam et al 2006, Jacoby et al. 1996) studied the impact of 
epilepsy related variables in an unselected population of people with epilepsy in the UK. 
Increased seizure activity was significantly related to anxiety and depression. Longer duration 
of epilepsy and older age of onset were also significantly correlated with depression.  In fact, 
in patients with pharmaco resistant epilepsy, depression was found to be 1 of the 2 
independent predictors of poor quality of life. Furthermore, these patients have significantly 
greater risk of suicidal ideation and suicidal behavior, compared with that in the general 
population (Jones et al., 2003). 
 
The negative effect on quality of life is more pronounced in intractable epilepsy. Baker and 
colleagues showed that compared with patients whose seizures were in remission, patients 
with intractable seizures scored significantly worse across all domains of the Nottingham 
Health Profile, as well as in relation to sense of mastery and self-esteem (Baker et al 1997). 
Similarly  in a study by Vickrey et al. 340 adults with refractory partial seizures were 
evaluated presurgically, QOLIE-89 domain scores were considerably lower than those that 
has been reported for patients with well controlled seizures, (Vickrey et al 2000). 
 
Specific epilepsy syndromes produce cognitive problems in patients with epilepsy and these 
problems also influence quality of life. MTLE is the most common focal epilepsy syndrome, 
and is characterized by focal seizures that cause epileptogenic mesial temporal lesions 
(usually hippocampal sclerosis) which are often resistant to AED therapy. The range of 
cognitive functions that can be compromised in people with repeated MTLE seizures include 
intelligence, learning, visuo-spatial functions, problem solving, memory function and 
academic attainment (Hermann et al., 1997; Hermann and Seidenberg, 2002). Frontal lobe 
seizures are the second most prevalent type of seizure that are subject to surgical intervention 
and 15% of refractory epilepsy cases are due to FLE (Helmstaedter, 2001). In such patients 
improvement in IQ is found after epilepsy surgery (Milner, 1975). 
 
Lastly even employability is found affected in patients experiencing poor control of seizures. 
In a study (Leidy et al., 1999) studied QOL in 139 adults with active epilepsy, defined as a 
diagnosis of 1 year minimum and prescribed AEDs, recruited from three U.S. epilepsy 
centers. It appeared that people with active epilepsy was a disabled group with only 35% 
reporting being in full-time employment despite a mean age of 38.5 years. 
 
SUDEP  
 
It is known that patients with epilepsy have a mortality rate significantly higher than that of 
the general population.  
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The underlying causes of high mortality are summarized below  
 
• Death due to the underlying neurologic disorder in symptomatic epilepsy 
• Accidents during epileptic attack (ie, trauma, drowning, burning, choking) 
• Status epilepticus 
• Suicide 
• Treatment-related  death 
• Sudden unexpected death in epilepsy (SUDEP) 
Incidence of SUDEP is considerably higher in patients with chronic epilepsy, 1-2/1,000 
person-years, and highest with severe, refractory seizures, 3-9/1,000 (Tomson et al 2005). 
SUDEP accounts for 8-17% of deaths in people with epilepsy. Sudden unexplained death in 
epilepsy patients (SUDEP) is 40 times more likely among patients who continue to have 
seizures than in those who are seizure free (Tomson, 2000). 
 
SUDEP is defined as sudden, unexpected, nontraumatic, nondrowning death in an individual 
with epilepsy, witnessed or unwitnessed, in which postmortem examination does not reveal an 
anatomic or toxicological cause for the death. 
 
The possible mechanisms operating in SUDEP are graphically represented below. 
 
 
Figure 9 : The factors operating behind SUDEP 
 
Economic burden 
 
In 2000 the annual cost for patients with epilepsy in the United States was estimated to be 
approximately 12.5 billion dollars (based on a 1995 survey); with pharmaco resistant epilepsy 
contributing a substantive proportion (Begley et al., 2000, Kwan et al 2011). Another study 
found that costs correlate with severity of illness and that, those patients who have intractable 
seizures incur a cost eight times greater than in those whose epilepsy is controlled (Jacoby et 
al., 1998).  
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CHAPTER II  
TREATMENT OF PHARMACO 
RESISTANT EPILEPSIES 
 
 
Treatment of pharmaco resistant epilepsies can be divided into surgical and nonsurgical 
therapies. Epilepsy surgeries are classified as curative or palliative, depending on the goal. 
Curative procedures include lobectomy, lesionectomy, and hemispherectomy.Palliative 
procedures include corpus callosotomy and multiple subpial resections. In addition 
neuromodulation in terms of vagus nerve stimulation, deep brain stimulation, TMS and 
radioneurosurgery are non resective-surgical approaches for control of intractable epilepsy. A 
review of all these therapies except the Deep Brain Stimulation (DBS) is presented in this 
chapter.  
 
2.1 SURGICAL THERAPIES  
 
 
Not all patients of refractory epilepsy are good surgical candidates. The decision to offer 
surgery is based on strict criteria. 
 
2.1.1 SELECTION CRITERIA FOR RESECTIVE SURGERY (NOACHTAR ET AL 2003) 
 
• Confirmed diagnosis of epilepsy. 
• Medical intractability. 
• Disabling seizures. 
• Resectable focus  
• Motivated patient. 
• No progressive underlying cause (except Rasmussen’s encephalitis). 
• High probability that better seizure control will improve quality of life. 
 
2.1.2 PRE SURGICAL EVALUATION 
 
When the candidate satisfies the selection criteria, a presurgical evaluation for planning the 
type and extent of surgery is done. The table describes the evaluation. 
 
These steps are interchangeable and many evaluations are undertaken simultaneously. 
Not all evaluations are necessary in each patient and the selection of tests depends upon 
nature of epilepsy and surgery planned. Intra carotid amobartbital is less and less used these 
days, replaced by functional MRI. 
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Figure 10 : The steps followed during pre surgical evaluation of a candidate for epilepsy surgery 
 
2.1.3 CURATIVE PROCEDURES: 
 
(Lesionectomy, lobectomy, topectomy,) 
Surgical excision of a lesion: gyrectomy (usually performed including a lesion) is rewarding if 
the ictal onset zone determined by pre surgical evaluation matches the location of a specific 
lesion (like tumor, dysplasia, sca,r granuloma etc…). Often just excision of the lesion is not 
sufficient to control seizures and more extensive procedure of lobectomy is necessary as in 
case of seizures arising from temporal lobes. In addition to lesionectomy, focal excision of the 
epileptic cortex is also undertaken in specific cases. This procedure is called topectomy. 
 
Neocortical focal resection (topectomy) or gyrectomy 
 
First described by Heath and Poole in 1948(Heath and Poole, 1948) as a treatment for 
psychoses the technique of topectomy is useful for epilepsy. The technique is more suitable if 
the cortical epileptic focus is well defined. 
 
Rationale: Resection of the diseased cortex controls possibly the generation of abnormal 
electric activity. 
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Technique  
 
The pial surface over the gyrus to be resected is coagulated in the crown of the gyrus roughly 
in the midline in entire length. Pia is elevated and reflected to expose the grey matter. A 
gentle subpial aspiration of the cortical matter is performed, avoiding injury to blood vessels 
running over the gyrus. The depth of aspiration is limited to depth of the gyrus and white 
matter beyond this level is not breached.  
 
Outcome of gyrectomies 
 
Frontal resections: When unilateral resections are carried out the postoperative cognitive 
deficits are minimal so that they are not noticeable during routine daily activity of the patient. 
Resection of the pars opercularis of the inferior frontal gyrus requires careful consideration 
because of location of language area (Brocas area) in it. Temporal topectomies for epilepsy as 
such are controversial because standard anterior lobectomy or amygdalohippcampectomy are 
considered better options. In the central cortex topectomies of face in non dominant side 
produce temporary deficits. Interference with throat facial muscle functions may produce 
dysarthria. Care should be taken for preserving hand and limb functions. Mapping of cortex as 
well as stimulating white matter in the depth of resection is undertaken. It highlights white 
matter tracts associated with movement and injury to them could be avoided. The parietal lobe 
topectomies generally are safe with just 0.5% risk of hemiparesis. Visual field deficits in the 
contra lateral eye are major side effects of some parietal lobe topectomies. Occipital 
resections are rare and carry the same risks of damaging visual tracts. 
 
Hemispherectomy  
 
Introduction: Hemispherectomy is a surgical removal of one cerebral hemisphere keeping 
most of the basal ganglionic structures intact. The technique is employed when the pathology 
is located unilaterally. From large resections of entire hemisphere called as anatomical 
hemisherecotmy in the past, more sophisticated disconnection techniques called ‘functional 
hemishectomy’ and ‘hemisphirotomy’ have emerged recently.  
 
Hemisoherotomy was initially described by Dandy in 1928 (Dandy, 1928). He performed it 
for a malignant glioma. The surgery showed that the survival of patient after such extensive 
surgery is possible. This led the foundation of using this technique for intractable epilepsy. 
Kenneth Mckenzie (Mckenzie, 1938) first used it for intractable partial epilepsy. It became 
popular till 1970 then the use of anatomical hemisphrectomy declined due to awareness of 
late onset complications related to surgery. 
 
Rationale: Isolating the epileptic focus from other parts of brain by a resection  or effectively 
arresting spread of abnormal  electric discharge by disconnection of focus  are the  basis by 
which epilepsy can be controlled. There are various methods of achieving this aim. But 
common to all is interruption of the corpus callosum, the internal capsule and corona radiata, 
mesial temporal structures and the frontal horizontal fibers. 
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Techniques 
 
Classical anatomical hemispherectomy:  
 
The classical technique involved ligating the major vessels after the perforant branches then 
proceeding with the resection of the lobes. This technique left a large vacant space in the skull 
after the surgery. CSF leakage, hydrocephalus, infections are immediate complications. But 
more important is ‘superficial hemosiderosis. Due to recurrent hemorrhages in the cavity, a 
thin film of coagulated blood and its end products form over the brain. This eventually leads 
to recurrence of seizures and decline in the cognitive performance. Such late complications 
have made the classical technique less popular. However attempts to minimize these 
complications were made. The subdural space was reduced by suturing dura to falx tentorium 
and skull base at the floor of the anterior and middle cranial fossae Plugging of the  ipsilateral 
foramen of Monro with a piece of  muscle was  also undertaken  to avoid communication 
between ventricle and empty subdural space. 
 
The classical anatomical hemispherectomy is now seldom practiced. There are newer surgical 
techniques like Functional hemispherectomy (Rasmussen, 1983), Hemidecortication (Carson 
et al., 1996) and techniques involving extensive disconnection rather than excision called 
Hemispherotomy (Delalande et al., 2007, Villemure et al., 1995), Hemispherical 
deafferentation (Schramm et al., 1995). 
 
Regardless of the surgical approach and technique certain connections need to be sacrificed in 
order to achieve a good seizure control.  
 
The table below describes these. 
 
Table 5 : The white matter zones sacrificed hemispherectomy 
White mater fibres Description Significance  of connection 
Corpus callosal fibres 
Rostrum and Genu 
Rostral fibers of the trunk 
 
Middle trunk 
Frontal lobe 
Premotor and supplementary 
motor 
Precentral fibers 
Faciculi 
Superior longitudinal bundle 
 
Anterior limb 
 
Posterior limb 
Connects frontal parietal 
occipital and temporal lobes 
Connects speech area to 
frontal eye field 
Connects secondary visual 
area to frontal eye field 
Uncinate fibers  Temporal lobe and amygdala 
Occipito frontal fibers  Association areas 
 
Outcome: seizures  
 
Following table illustrates outcome on seizure control. 
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Table 6 : Seizure outcome in hemispherectomy (De Ribaupierre, Delalande, 2008) 
 
 
 
Other outcome measures 
 
Hemispherectomy and all its variants are known to improve other functions of brain. Since 
there is freedom from seizures the cognitive performance is improved as reflected in 
improved IQ. Other behavioral aspects also improve. The motor deficits that are anticipated 
after such extensive disruption of the motor tracts may not always be serious. Children who 
walked before the surgery still are able to walk. Sometimes the paraplegia on the contra 
lateral side is spastic especially in Rasmussen’s encephalitis, and after surgery transmission of 
weight in spastic limb allows a walk. 
 
2.1.4 PALLIATIVE PROCEDURES.  
 
Corpus callosotomy  
 
There are six midline commissural structures connecting the cerebral hemispheres, including 
the corpus callosum, anterior commissure, posterior commissure, hippocampal commissures, 
massa intermedia, and fornix. Of these, the most significant is the corpus callosum. It contains 
most of the myelinated fibers which are topographically arranged. The rostrum transfers 
higher cognitive information; the genu and anterior midbody transfer motor information by  
fibers arising from the premotor, motor, anterior insular, and anterior cingulate  areas. The 
posterior midbody transfers somatosensory information; the isthmus transfers auditory 
signals; and the splenium transfers visual information (Wong et al., 2006; Funnell et al., 
2000).  
 
The first description of corpus callosotomy was by Dandy when the structure was excised 
during a surgery for pineal tumor. The use of this technique for epilepsy was promoted by 
Van Wagenen and Herren (Van & Herren, 1940). They observed that tumors of corpus 
callosum presented clinically as seizures but these seizures decreased as the tumor grew and 
destroyed more of the corpus callosum. The neurophysiological outcomes were defined by 
Bogen and Vogel (Bogen & Vogel, 1963). Callosotomy as a replacement for more radical 
hemispherectomy was advocated in the 1960s. 
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Rationale 
 
It was noted during experimental epilepsy that epileptic activity in one hemisphere could 
produce similar activity in other (Crowell & Ajmone, 1972). Thus the interhemispheric 
connectivity was implicated in bilateral synchrony of abnormal cortical activity and 
generalized seizures. Since anterior parts of corpus callosum carry motor information 
sectioning these was considered a palliative measure of controlling tonic clonic seizures and 
drop attacks.   
 
Outcome 
 
The goal of a callosotomy procedure is to reduce the frequency and severity of seizures by 
interrupting common seizure spread pathways. Traditionally anterior two third corpus 
callosotomy has been performed with great success. Different series have reported 50% or 
more reduction in seizure frequency in 55–100% of patients following this procedure (Wong 
et al., 2006; Maehara & Shimizu, 2001). 
 
  
Table 7 : Long term outcome after Callosotomy (Tanriverdi et al., 2009). 
 
 
 
Side effects  
 
A specific syndrome is often described after callosotomy essentially due to disconnection 
between dominant and non dominant lobes. For example the visual information presented to 
non language dominant lobe might not be processed by language dominant lobe and patient 
would not be able to name objects even if he is able to see them. Similarly the non dominant 
hand might not perform motor acts rapidly if verbal commands are given. This syndrome is 
more noticed in total callosotomy than the anterior callosotomy. Most of the patients are 
unaware of the deficits and the severity declines gradually over the postoperative period. 
 
Multiple subpial transection (MST) 
 
Resective procedures in the eloquent cortex leave major postoperative functional deficits. 
MST was introduced as a surgical tool for addressing medically intractable epilepsy in 1989 
by Morrel (Morrel et al 1989). However the concept of MST was formulated in 1960s during 
animal experiments. Asanuma first concluded that ascending thalamocortical information and 
descending information to pyramidal cells have an orientation perpendicular to the cortical 
surface and cutting of horizontal connections does not produce major deficits (Asanuma, 
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1975). Morrel described in animal model that spread of epileptic discharge could be halted by 
MST, later it was applied to human patients. 
 
Rationale 
 
As determined by Morrel in his experiments a ‘functional cortical unit’ is a column of 5mm 
width. The most important information processing occurs in vertically oriented manner in 
these columns. The intracoritcal penetrating vessels also follow a vertical approach. Hence it 
is possible to control epilepsy if horizontal connections are sacrificed subpially at a distance 
of about 5 mm. This would not produce damage to a ‘functional cortical column’.  
 
Procedure 
 
The pia is opened at the edge of a gyrus by needle or knife blade. A special knife is used for 
MST. This consists of a stainless still hook with a flattened tip angled at 105° to shaft and a 
length of 4 mm. This tip is introduced in the pial opening. It is then advanced through 
arachnoid forwards into the width of the gyrus, keeping the shaft perpendicular to gyral 
surface directed upwards and sharply brought back. The process is repeated at an interval of 
5mm in the entire length of the gyrus. The resultant small red lines of petechial markings are 
visible through the pia. A MST is considered complete when the intra operative 
electorcorticography indicates disappearance of epileptiform discharges seen before the 
procedure. Direct cortical stimulation in awake patients or SEEG in anesthetized patients 
helps in determining the area of cortex that is to be transected. 
 
Outcome 
 
Morel reported findings in 22 patients who had follow up ranging from 5 to 22 years. 55% 
were seizure free. Others had progressive disorder like Rasmussen’s encephalitis. 18 out of 22 
patients had immediate cession of epileptiform activity after the procedure. 
 
Blount and colleagues described outcome in 20 pediatric patients in which MST with or 
without limited cortical resection was performed for intractable epilepsy. Majority of them 
had invasive subdural grid placement and monitoring prior to surgery 12 (46%) were seizure 
free (Engel Class I) following surgery. Eleven patients (42%) (Engel Classes II and III) 
continued to suffer seizures but improvement in seizure control was adequate following 
surgery (Blount et al., 2004). 
 
A metanalysis of results from six epilepsy centers was performed by Spencer and his group. 
Fifty-three patients underwent MST without resection. In patients with MST plus resection, 
excellent outcome (95% reduction in seizure frequency) was obtained in 87% of patients for 
generalized seizures, 68% for complex partial seizures, and 68% for simple partial seizures. 
For the patients who underwent MST without resection, the rate of excellent outcome was 
only slightly lower, at 71% for generalized, 62% for complex partial, and 63% for simple 
partial seizures (Spencer et al., 2002). 
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Controversy and current place in therapy  
 
The Morel’s hypothesis was based on normal cortex. The variation in the thickness of cortex 
especially in diseased conditions should be taken into consideration. In an atrophic cortex the 
technique might transect more white matter and in a thick cortex (example pre central cortex 
with a thickness of 4 mm) it might not reach the adequate depth. Similarly the rapid spread of 
epileptic discharges in pathological conditions indicate that the circuits involved are complex 
and larger than originally hypothesized. 
 
MST was advocated in the period when MRI were not widely available .Intra operative 
monitoring, that is ‘physiology’ took precedence over detection of structural abnormality that 
is ‘anatomy‘in deciding epilepsy surgery. With advent of MR imaging (both structural and 
functional MR imaging) resection of epileptic focus is favored over MST as it gives 
equivalent and even better results. This has led to a decline in the popularity of MST. 
 
However new indications for MST have evolved. MST has been used in temporal lobe 
epilepsy in dominant temporal area in which pre op MRI shows no atrophy. In such situations 
resections usually produce major memory deficits. This problem can be addressed by 
adopting MST to this region (Shimizu, 2008) 
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2.2 NEUROSTIMULATION PROCEDURES  
 
2.2.1 VAGUS NERVE STIMULATION  
 
Vagus nerve is composed of mainly afferent fibers (upto 80%) coming from gastro intestinal 
and respiratory tract to the brain. Its extensive connections in the brain and relatively easy 
accessibility in the neck are attractive features as a target for brain stimulation for control of 
epilepsy. 
 
Zabara (Zabara, 1992) first demonstrated that experimental epilepsy in dogs could be 
controlled by Vagus nerve stimulation. Penry (Penry and Dean, 1990) first implanted 
commercial Vagus stimulator in humans. The European approval for this therapy was 
provided in 1994 and US FDA approved the Vagus nerve stimulation in 1998. Since then this 
is an established therapy for control of partial seizures which are medically intractable and not 
suitable for resective surgeries. 
 
Rationale  
 
The Vagus nerve contains motor, sensory, and preganglionic parasympathetic fibers at the 
area (mid cervical portion) where clinical nerve stimulation is carried out. The sensory 
information is conveyed by afferent fibers that terminate on nucleus tractus solitaries, cuneate 
nucleus and spinal nucleus of trigeminal nerve. From these second order and third order 
neurons connect to reticular formation, rephe nucleus, thalamus. These structures connect 
extensively to hippocampus, amygdala, septum and eventually cortex. In chronic partial 
pharmaco resistant epilepsy it is proposed that seizures recur because of lowered seizure 
threshold as a dysfunction of Benzodiazpine receptors in hippocampus granule and pyramidal 
cells. Structures like amygdala, orbitofrontal cortex might be modulated by Vagus nerve 
stimulation and raise the seizure threshold. (Hernando, Pedro, 1993)  
 
 
 
A                       B 
 
Figure 11 : Vagus Nerve Stimulation 
Part A illustrates the position and incisions for vagus nerve stimulation procedure. 
Part B schematically shows the electrodes and stimulator and their placement. 
 
 40 
 
Procedure 
 
An incision parallel to anterior border of Sternomastoid or a collar incision parallel to clavicle 
is taken. After cutting the platysma along the direction of its fibers the carotid sheath is 
opened. The jugular vein is retracted laterally to expose the Vagus trunk in the depth between 
carotid artery and the jugular vein. 
 
The helical coil shaped electrodes have three segments (Figure 11 part B). The most proximal 
is a neutral one used as an anchor, the most distal is anode and the middle is cathode. These 
electrodes are wound over Vagus nerve by using a sting attached to each coil. The remaining 
portion is secured deep to carotid sheath so as to prevent migration of electrode due to neck 
movements. 
 
A tunneling instrument is used to create a subcutaneous tunnel from neck to axilla above 
clavicle .An incision over anterior border of axilla is made to create a subcutaneous pocket to 
house the stimulator. Impedance of the electrodes and the battery is tested before skin closure. 
 
Stimulation parameters 
 
Stimulation parameters are variable but most beneficial effects are noted with a stimulation 
frequency of 30 Hz and 30 seconds on and 5 min off cycle. 
 
Side effects 
 
Coughing and hoarseness of voice are side effects of stimulation. These are often transient 
and settle down with adjustment of the parameters. Like any other implant infection, breakage 
are also documented with VNS. 
 
Right sided stimulation 
 
Initially VNS was performed exclusively on the left side. There was a concern about the 
cardiac side effects of right sided Vagus nerve stimulation. However right sided stimulation 
can also be performed safely and is often undertaken if left sided Vagus nerve stimulation is 
not possible or fails because of infection, lead migration or local pathology in the neck.  
 
Efficacy 
 
The Vagus nerve stimulation is found useful in both adult and pediatric patients (Elliot et al., 
2011). About 40% of patients seem to have a 50% reduction in the seizures (Handforth et al 
1998). This effect increases with the time. The number of anticonvulsants needed to control 
seizures seems to decrease with the time. 
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Table 8 : Efficacy of vagus nerve stimulation for control of seizures (Connor et al., 2012) 
 
 
 
2.2.2 DEEP BRAIN STIMULATION  
 
Deep brain stimulation is an emerging technique for controlling pharmaco resistant epilepsies. 
An extensive account of its place in epilepsy therapy is provided in a separate chapter. 
2.3 NEWER EXPERIMENTAL TECHNIQUES  
 
2.3.1 TMS: REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION 
 
The TMS technique is a noninvasive method of stimulating brain. It was developed around 
1985 by Anthony Barker to stimulate motor cortex. Since then the technique has evolved into 
many areas of diagnosis, and even therapeutics. It is an attractive method because of its easy 
to use nature and relative inexpensiveness as well as large safety margin. rTMS (repetitive 
transcranial magnetic stimulation) reflects neuronal excitability. Different parameters used in 
TMS represent different events in neuronal functioning and are summarized below:  
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Table 9 : Parameters of TMS and effect (Theodore, 2003) 
 
  
 
 
Rationale 
 
Though there is very little information about how rTMS may influence human epilepsy the 
evidence is extrapolated from animal experiments. The application of rTMS as a therapeutic 
measure stems from its lasting effects even after stopping ongoing stimulation. The low 
frequency stimulation below 1Hz increases the cortical silent period and decreases excitability 
while high frequency stimulation promots cortical excitability.  
 
These effects are similar to long-term depression (LTD) and long term potentiation, two 
forms of synaptic plasticity elicited in animal models of cortical circuitry by low- and high-
frequency electrical stimulation, respectively. So it has been suggested that low-frequency 
rTMS may exert antiepileptic effects whereas high-frequency stimulation may act as a 
proconvulsant. 
 
TMS is a relatively new therapy for pharmaco resistant epilepsies. Though it is found useful 
in human condition as exemplified from the table below many issues need to be addressed. 
Coil design, best location of coil, best stimulation parameters are few such issues. With 
advancement in technology and better understanding of its mechanism TMS could become an 
important tool for treating pharmaco resistant epilepsies in future.  
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Table 10 : Efficacy of TMS for control of seizure (Kimiskidis, 2010) 
 
 
2.3.2 RADIONEUROSURGERY  
 
Radiosurgery is application of ionizing radiation as a surgical tool. Focused radiation has been 
used to treat difficult deep seated lesions in brain like tumors, cavernous malformations.  
Same therapy can be applied to target a non lesional epileptic focus. 
 
Radiation beams are of two types a proton beam and a photon beam. Protons have mass and 
proton beams scatter less. However the proton accelerators are costly. In contrast photons 
have no mass but scatter easily. This limitation is overcome by focusing multiple beams to a 
target. Currently used radiosurgical therapy units use multiple beams focused on a target. 
 
The use of radiosurgery in non lesional epilepsy 
 
The first use of ionizing radiation to treat a non lesional epilepsy was by Talairach and 
colleagues in mesial temporal epilepsy. They treated 44 epileptic patients with stereotactic 
implantation of yttrium-90 into the amygdala and the hippocampus. Of the treated patients 
88% showed disappearance of epilepsy (Talairach et al., 1974). 
 
First use of current linear accelerators for treatment of epilepsy was done in 1993 in 
Marseilles. A gamma knife at a low dose of 25Gy was used on 3 patients with medically 
refractory to perform an entorhinoamygdalohippocampectomy (Régis, 2000b). 
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The use of radiosurgery in lesional epilepsy 
 
The ameliorating effect on seizures was noted in treatment of cerebral lesions like tumors and 
cavernous malformations. Initially it was thought that the destruction of lesion leads to control 
of seizures because the abnormal epileptic activity associated with the lesion gets abolished. 
However it was noted that seizures associated with AVM treated by radiation ceased even 
before the AVM was closed and in few cases despite failure of closure. That led to foundation 
of thought that radiation itself could work as anti epileptic. 
 
Rationale 
 
 Ionizing radiation acts by damaging the DNA and generating free radicals. The developed 
neurons are as such resistant to these effects. Hence the improved control over epilepsy seen 
after radiosurgery might be not related to destruction of the lesion alone. Perhaps neural 
plasticity and neurogenesis might be affected by radiation providing a neuromodulatory 
effect. However MR and MR spectroscopy indicates several changes occurring in the 
irradiated cerebral tissue. So a combination of structural and functional mechanisms might act 
together to produce control over the epilepsy. 
 
Outcome 
 
Radiotherapy for epilepsy associated with hypothalamic hamartoma has been explored. 
Hypothalamic hamartoma are deep seated non malignant lesions difficult to excise surgically 
because of location and important functions related to the hypothalamus -pituitary complex. 
About 30% patients were found to be seizure free after radiosurgery (Regis et al., 2000b). 
However other surgical technique like transcallosal excision has documented better (about 
55%) remission rates. No multicentric trial is reported as yet. 
 
Seizure remission rates in RS of arteriovenous malformation range from 55–80%. Although 
the usefulness of RS in the treatment of cavernous malformation is controversial (mainly from 
high rates of hemorrhage in some series (Steiner et al.,2010), RS causes remission of seizures 
in 25–64% of patients with cavernous malformation (Regis et al., 2000b, Kim et al., 2011). In 
mesial temporal epilepsy the European trial demonstrated a 2-year postoperative seizure 
remission rate of 62% (Barbaro et al., 2009) An American trial showed a remission rate of 
77% in the high-dose group and 59% in the low-dose group. An open lable trial radiosurgery 
versus conventional respective surgery in MSL is ongoing in USA (Quigg et al., 2012). 
 
Safety issues 
 
Radiosurgery for control of lesional and non lesional epilepsy requires that all safety issues 
with the radiation are addressed. Radiation induced necrosis edema can produced transient 
symptoms of headache and partial dysfunction of the edematous zone. The control over 
seizures evolve along the time and patient needs to know this .Some complications like post 
procedure hemorrhages in the treated area especially cavernous malformations are reported. 
The dose, treatment protocols are yet to be standardized for epilepsy. 
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CHAPTER III  
DEEP BRAIN STIMULATION AND 
EPILEPSY 
3.1 INTRODUCTION 
 
Stimulating specific brain structures to treat pharmaco resistant epilepsy is a concept gaining 
ground. Epilepsy occurs due to synchronization of abnormal neuronal activity across regions 
of the brain. These abnormal circuits could be interrupted by stimulation. The stimulation 
could be at three sites, ie either at the cortical area where the abnormal rhythm is generated, at 
the ‘nodes’- the subcortical structures that are involved in seizure propagation and 
maintenance or  at ‘modulatory ‘regions  which influence the ‘ nodes ‘. 
 
Introduced in 1986, vagus nerve stimulation (VNS) has now become a well established 
cranial nerve stimulation procedure for treating pharmaco resistant epilepsy. It offers a mean 
seizure reduction of 28% for patients in whom it is employed with 23% of patients having a 
greater than 50% reduction in seizure frequency (Class 1 evidence) (DeGiorgio et al., 2000). 
Rather than stimulating a nerve accessible peripherally and influencing indirectly the brain, 
direct stimulation of more central structures (deep brain stimulation DBS) appears rational. 
DBS has advantages like titrability, reversibility, and excellent safety profile, its remarkable 
success in treating movement disorders like Parkinson's disease (Benabid et al., 2009) has 
paved the way for exploring its potential application in epilepsy. 
 
Figure 12 : Brain connectivity 
A schematic representation of connectivity in the brain .For reasons of simplicity few of the connections (like recurrent 
thalamo- cortical relay, hyperdirect cortico STN path are not shown. Any of these structures could be potential targets for 
DBS in epilepsy. 
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Circuits implicated in Epilepsy 
 
The classical circuit of Papez links the hippocampus to the thalamus, the cingulate gyrus and 
entorhinal cortex/parahippocampal gyrus. Fibers from the hippocampus travel via the fornix 
to the mamillary bodies, which in turn link to the hypothalamus and then the anterior nucleus 
of the thalamus via the mamillothalamic tract. The anterior thalamic nucleus communicates 
with the cingulate gyrus, which connects via cingulum to parahippocampal gyrus then to 
entorhinal cortex. The other circuit is basal ganglia- cortical circuit described in details in next 
chapter. The third one consists of thalamo cortical loops which allows, forward and back 
information flow between cortex and thalamus. Though these three circuits appear separate 
they are interconnected and integrated functionally. Hence different parts in these circuits 
(nodes) activated by electrical stimulation can modulate and control epilepsy. 
 
3.2 RATIONALE IN CHOOSING TARGETS FOR DBS  
 
Cerebellum  
 
The discovery of the importance of cerebellar Purkinje cells in the generation of widespread 
inhibitory discharges led the foundation of using this as a target for stimulation in epilepsy. 
Also it is found that cerebellar input to the ventral lateral thalamic nucleus results in 
diminished excitatory output to the cortex. 
 
Subthalamic nucleus  
 
The STN is functionally divided into three parts (ref figure below): Medial most portion is 
related to anteriror cingulate cortex and ventral pallidum. The dorsolateral motor portion is 
connected to motor cortex while ventral portion is related to associative areas with connection 
to the substantia nigra.Thus STN is connected to limbic areas, motor areas and associative 
areas of cortex. It is connected to output structure Snr and can perform modulation of the 
substantia nigra. A nigral control of epilepsy in animals has been well described (Depaulis et 
al 1994). The substantia nigra receives projections from the subthalamic nucleus (STN), and 
stimulation of STN is believed to enhance the antiepileptic effect of the substantia nigra pars 
reticulata (Lim et al., 2007). Moreover, STN has already been well- established as a target for 
Parkinson’s disease (Benabid et al., 2009).  
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Figure 13 : Functional anatomy of STN (Benarroch, 2008) 
 
Amygdala and Hippocampus 
 
It is known for quite some time that electrographic localization occurs in these areas in cases 
of Mesial temporal lobe epilepsy. Similarly surgical excision of these structures provides 
excellent control over seizures. These observations were used to stimulate the hippocampus 
and amygdala as the areas involved in generation of epilepsy (Velasco et al., 2007). 
 
Thalamic nuclei 
 
1. Anterior nucleus of thalamus (ANT) is a preferred target because it is highly connected 
with the hippocampus through Papez circuit. Hippocampus is one of the most epilepsy-
susceptible areas involved in origin of temporal lobe epilepsy. Moreover the ANT projects 
largely to the cingulate gyrus, then it further projects to limbic structures and wide regions 
of neocortex acting as a relay station amplifying and synchronizing seizure activities in 
these circuits (Takebayashi et al., 2007). ANT is involved in central thalamus and 
posterior thalamus to amplify and synchronize seizure afterdischarges as noted in 
metabolic studies .Thus it is important station in intra thalamic pathways (Jones and 
Leavitt, 1974).  
 
2. The centromedian nucleus of the thalamus (CMT) is an important structure in the reticulo-
cortical system, and is thought to mediate cortical excitability (Jasper, 1991). 
 
Striatum (Caudate and Putamen) 
 
The primary motor cortex and the primary somatosensory cortex project mainly to the 
putamen, but the premotor cortex and supplementary motor areas project to the caudate head. 
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Frontal lobe projects predominantly to the caudate head and the putamen; the parietal and 
occipital lobes project to the caudate body; and the temporal lobe projects to the caudate tail. 
The low-frequency stimulation of caudate is hypothesized to induce cortical hyperpolarization 
and resultant control over seizures. 
3.3 DBS IN EPILEPSY ANIMAL STUDIES  
 
In the following tables experimental evidence in animal models about DBS and epilepsy is 
summarized. 
 
STN 
 
Table 11 : Animal studies of STN stimulation for epilepsy 
Studies (First Authors) Model /animal Stimulation parameters Summary of results 
Vercueil 1998 Absence seizures GAERS rats 
130 Hz, up to 300µA, 
60µS 
 
Bilateral stimulation 
effective in suppressing 
spike wave discharge 
Lado 2003 
Generalized clonic and 
tonic-clonic flurothyl 
seizures. Adult rats 
130, 260, 800 Hz, upto 
500µA, 60µS 
 
Bilateral stimulation of  
at 130 Hz increased the 
seizure threshold 800Hz 
was proconvulsive 
Usui  2005 Limbic seizures, Kainic 
acid. Adult rats 130 HZ, 60µS 
Unilateral stimulation 
decreased secondary 
generalization of 
seizures but time spent 
in focal seizure 
unaffected 
Shehab 2006 
Tonic Brain stem 
seizures. Electroshock 
model; rats 
130 260 Hz,upto 300µA 
30 min before inducing 
seizures 
Tonic hind limb 
extension (seizure) not 
affected 
 
 
  
 49 
 
Table 12 : Animal studies of SNr stimulation for epilepsy 
Studies (First Authors) Model /animal Stimulation parameters Summary of results 
Morimo to 1987 Amygdala and pyriform kindled rats 
100Hz  upto 1.2 µA 
14 days before inducing 
kindling 
After discharges 
duration decreased, 
Bilateral prestimulation 
blocked seizure 
generalization in some  
animals, prolonged the 
latency to bilateral 
forelimb clonus in others 
Velsek 2002 
Generalized clonic and 
tonic-clonic flurothyl 
seizures. Adult and 
Young rats 
130 Hz, up to 690 µA 
for young and 952 µA 
for adult rats, 60µS 
Bilateral stim effective 
in clonic seizures in 
adults, effective in both 
clonic and tonic clonic 
seizures in young rats 
 
Usui 2005 
 
Limbic seizures, Kainic 
acid; Adult rats 
 
130 HZ, 60µS 
 
No effect 
Shi 2006 Amygdala kindling ; rats 130 Hz upto 200 UA, 60µS 
43.5% rats showed 
complete blockage of 
stage six seizures 
Induced by kindling. 
There was a protective  
after effect 
Subsequent Kindling 
failed in 60% of rats 
belonging to this group. 
Feddersen 2007 Absence seizures; GAERS rats 
5 to 500 Hz ,10 to 100 
µS 
60 Hz frequency and th 
60µS optimal for 
controlling SWD.But 
repeated stimulation 
ineffective and might 
increase seizure number. 
Shehab 2011 
Tonic Brain stem 
seizures. Electroshock 
model; rats 
30 or 260 Hz fails to suppress tonic 
seizures 
Saillet 2012        
Absence seizures;         
GAERS rats 
responsive SNr 
stimulation               
and Auditory 
 
Snr bilat stim effective 
in 97% seizures 
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Caudate nucleus  
 
Table 13 : Animal studies of caudate stimulation for epilepsy 
Studies (First Authors) Model /animal Stimulation parameters Summary of results 
Costin (1963) 
Hippocampal 
Stimulation; 
Rabits 
15, 200, 300 Hz; 2-8 V; 
1 ms 
 
Prolongation of after 
discharge when caudate 
nucleus was stimulated 
immediately after the 
hippocampal stimulation 
Mutani (1969) 
Cobalt induced 
rhinencephalic  epileptic 
focus 
100 Hz; 5-30 V; 
0.6 ms 
 
Decreased excitability of 
the focus after caudate 
stimulation 
Grutta (1971) Amygdala stimulation ; Cats 
30 Hz; 0.2-1.5 mA; 
Pulse width 1.5 ms 
 
Preventive stimulation of 
caudate useful in 
blocking after discharges 
Wagner (1975) Penicillin induced focal 
seizures ;cats 
400 Hz; 0.3-0.9 mA; 
Pulse width 0.5 ms 
 
Very active foci driven 
by stimulation but low 
activity foci suppressed 
Amato (1982) 
 
Amygdala stimulation; 
rats 
 
30-80 Hz; 4-12 V; 
0.1-1 ms 
 
Caudate nucleus 
stimulation less effective 
than SNr, 
Endopeduncular nucleus 
Oakley (1982) 
Aluminium injection 
(focal) 
 
10 and 100 Hz; 1-6 mA; 
Pulse width 1 ms 10 
min on/off or continuos 
 
 
Low frequency 
stimulation controlled 
seizure frequency, high 
frequency increased  
seizure frequency 
 
 
 
Psatta (1983) 
 
 
 
 
 
Cobalt induced focal 
seizures ; cats 
 
 
S5 Hz; 1-5 V; 1 s 
feedback stimulation by 
automatic detection of 
interictal spike 
pulse width 0.3 ms 
30 Hz; 0.2-1 mA; 10-60 
s 
Pulse width 0.5-1 ms 
 
 
 
Number of interictal 
spikes decreased  by 
stimulation 
Grutta (1988) 
Penicillin induced focal 
hippocampal  seizures; 
cats 
10 or 25 Hz; 0.1-0.5 
mA; 
Pulse width 1 ms 
Caudate stimulation 
decreases number and 
amplitude if 
hippocampal spikes 
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Reticular nucleus  
 
Table 14 : Animal studies of Reticular nucleus stimulation for epilepsy 
Studies (First 
Authors) Model /animal 
Stimulation 
parameters Summary of results 
Nanobashvili 
(2003) 
 
Hippocampal 
Kindling limbic seizures; 
rats 
 
60 Hz; 150 μA; pulse 
width 0.5 ms 
 
Costimulation of caudate 
during kindling reduced 
seizure duration and 
number of  seizures 
Anterior nucleus of thalamus  
 
Table 15 : Animal studies of Reticular nucleus stimulation for epilepsy 
Studies (First Authors) Model /animal Stimulation parameters Summary of results 
Mirski (1997) PTZ; rats 
100 Hz and 8 Hz; 350- 
1000 μA 
Pulse width 0.1 ms 
 
high frequency  
stimulation  raised the 
clonic seizure threshold 
Low frequency 
stimulation (8 Hz) was in 
contrast, proconvulsant 
Hamani (2004) Pilocarpine; adult  rats 
100 Hz; 800 μA 
Pulse width 100 μs; uni 
and bilateral 
 
Bilateral thalamic 
stimulation did not 
prevent SE (observed in 
56% of the animals), but 
it significantly prolonged 
the latency to its 
development 
 
 
 
Ziai (2005) 
 
 
 
 
PTZ ;Sprague-Dawley 
male rats 
100 Hz; 150 μA; Pulse 
width 0.1 ms; 
40 min before and 
continued during PTZ 
infusion. bilateral 
 
 
Bilateral AN stimulation 
delayed the onset of EEG 
seizures 
Lado (2006) 
 
Systemic  Kainic acid 
producing status and 
chronic epilepsy; rats 
 
100 Hz; 100-550 μA; 
Pulse width 100 μs; 
cont./intermitt 
bilateral 
 
Seizure frequency during  
stimulation was 2.5 times 
the baseline,In some cases 
stimulation triggered 
seizures 
Zhang (2012) 
 
amygdala-kindled 
seizures ; Wistar rats 
15min train of 100μs 
pulses at 150Hz and 450-
800μA 
Bilateral HFS reduced the 
number, severity of 
seizures and reduced 
duration of afterdischarge 
Preventive stimulation 
also protected but weaker 
effect. 
Takebayashi 
(2007) 
 
Kainic Acid in amygdala 
focal limbic seizure; rats 
 
130 Hz; 140-500 μA 
 
significantly decreased 
mean seizure frequency 
and secondary generalized 
seizure frequency 
Hamani (2008) 
 
Pilocarpine; rats 1000, 500, 200 µA and 20 Hz or 130 Hz. 
stimulation at 500 µA 
significantly increased the 
latency for seizures  
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Table 16 : Animal studies of Cerebellar stimulation for epilepsy 
Studies (First 
Authors) Model /animal Stimulation parameters Summary of results 
Hutton (1972) 
 
 
 
 
Mutani (1969) 
 
Penicillin focal; cats 
 
 
 
 
Cobalt focal; cats 
 
 
 
 
 
100 Hz,7V Pulse width 0.6 
ms 
Lobus anterior 
Cerebellar stimulation 
inhibits seizure foci 
 
 
Decrease or interruption of 
AD 
After seizure activity; 
inhibition 
? 
Maiti (1975) 
 
 
Hippocampal electrical 
Stimulation; 
cats and monkeys 
Cerebellar middle cortex 
vermis stimulation 
After discharges reduced 
cerebellar cortex can exert 
inhibitory influence on 
amygdala and hippocampus 
 
Hablitz (1975) 
Aluminium 
hydroxide gel 
focal motor seziures ; 
primate 
 
5-15 Hz and 100 Hz; 
1-10 V; 1-30 s 
Pulse width 1 ms 
LFS ineffective HFS 
proconvulsive 
Bantli (1978) 
 
Penicillin focal sensory 
motor seizures ; cats 
10 Hz; 26 mA/cm2 
Pulse width 0.1 ms 
 
Duration of seizures 
significantly reduced 
Ebner (1980) 
 
Aluminium 
hydroxide gel 
focal motor seizure 
;primate 
 
10 Hz; 
10 min on/off 
Pulse width 0.1 ms 
Vermis 
stimulation did not produce 
any statistically significant 
effect on excitability at 
focus 
Godlevskii 
(2004) 
 
 
Systemic Penicillin 
Induced seizures ;rats 
10-12 Hz and 100-300 Hz; 
20% of behavioural 
threshold 
Pulse width 0.25-0.5 ms 
 
LFS proconvulsive HFS 
decreased the frequency and 
amplitude of spike potentials 
and decreased total duration 
of epileptic foci. 
 
Rubio (2004) 
 
 
Amygdala kindling 
Rats 
 
100 Hz; 20 μA Superior 
pedunculus 
 
facilitate the limbic seizures 
and impede the secondary 
generalized seizures. 
Wang 2008 Amygdala kindling; rats 
1 Hz (15-min train of 0.1-ms 
pulses, 100 µA)immediately 
after kindling 
Ipsilateral Nucleus fastigeus  
stim significantly 
inhibitedthe seizure stage 
and afterdischarge 
 
 
 
 
 
Hippocampus 
Table 17 : Animal studies of Hippocampus - Amygdala stimulation for epilepsy 
Studies (First Authors) Model /animal Stimulation parameters Summary of results 
Gaito (1980) Amygdala kindling; Rats 
3 Hz; 100-196 μA; 30 s 
at kindling focus 
 
Suppression of 
behavioral seizures 
Shao (1982) Amygdala kindling 
 
60 Hz; until 54 μA; 1s 
at kindling focus 
 
Inhibition 
 53 
 
Studies (First Authors) Model /animal Stimulation parameters Summary of results 
Ullal (1989) Amygdala kindling; Rats 
Single episode of LFS 4 
Hz; 1/2 of AD threshold 
pulse width 125 ms 
After diszcharge 
thereshold increased 
Weiss (1998) Amygdala kindling; Rats 
1 Hz; 5-15 μA; 15 min 
Direct Current (DC) 
 
DC produced attenuation 
of kindling development 
and an increase in the 
afterdischarge threshold. 
This effect persisted in 
some animals for 1 
month after 
discontinuation  
Bragin (2002 
Kainic Acid  
spontaneous recurrent 
seizures 
 
1, 50 and 200 Hz; 10 
min 
 
Daily 2-h LFS and HFS 
did not have a long-term 
effect on the rate of 
interictal events and 
spontaneous seizures. 
Velsek (2002b) Amygdala kindling; Immature rats 
1 Hz; 280 μA; 15 min 
pulse width 
200 μs 
 
LFS suppressed 
afterdischarge duration 
and seizure stage 
Lopez- Meraz 
(2004) 
 
Amygdala kindling; rats 
 
1 Hz; 100-400 μA; 15 
min 
immediately  after 
kindling 
 
The LFS suppressed 
attainment of stage V 
kindling) but not the 
presence of partial 
seizures in 85.7% of the 
rats. 
Goodman 
(2005) 
 
Amygdala kindling ; rats 
 
1 Hz; 50 μA; 30 s 
 
LFS produced  
significant decrease in 
AD duration and stage 5 
seizures 
Wyckhuys 
(2007) 
 
Alternate Day 
Rapid Kindling model 
of temporal lobe 
epilepsy; rats 
 
130 Hz; 329 ± 52 μA; 
 
After discharge 
threshold 
increased,duration 
shortened by high 
frequency stimulation 
Mohammad-Zadeh 
(2007) 
 
Rapid kindling of  
Perforant path;rat 
1 Hz; 50-150 μA 
Pulse width 0,1 ms 
At Perforant path 
LFS of perforant path 
has a significant 
antiepileptogenic effec 
Urino 2010 Kainic acid in amygdala 10 or 30 Hz, 0.1-0.3 
mA.1 msec duration 
Seizure frequency was 
significantly reduced by 
10 Hz stimulation of the 
amygdala thalamus. 
Sun 2010 
amygdala- kindled 
seizures ;Sprague-
Dawley rats. 
LFS (15 min train of 0.1 
ms pulses at 1 Hz and 
100 µA)at CA3 region 
LFS reduced severity of 
and susceptibility to 
evoked seizures,effect 
weak in Preventive 
stimulation 
 
 54 
 
 
 
 
 
Locus coereleus   
Table 18 : Animal studies of stimulation of other targets for epilepsy 
Studies (First 
Authors) Model /animal 
Stimulation 
parameters Summary of results 
Jimenez-Rivera 
(1987) Amygdala kindling 
Twenty to thirty 
minutes of Locus 
coereleus  
stimulation  delivered 
prior to each 
amygdala kindling 
session 
Stimulated animals 
spent longer time in 
stage 1 (inhibitory ) 
Libet (1977) Subconvulsive dose pentylenetetrazol; rats 
50-200 Hz; 40-100 
μA; 20- 40 min 
Pulse width 20-200 μs 
A unilateral stimulus 
suppressed bursts 
bilaterally. 
 
 
 Nucleus of tractus solitarius (NTS) 
 
Table 19 : Animal studies of nucleus of tractus solitarius stimulation 
Studies (First Authors) Model /animal Stimulation parameters Summary of results 
Magdaleno- 
Madrigal (2010) 
 
Amygdala kindling; 
Cats 
1 min on/5 min off, 1 h 
total /6 days prior to 
kindling 
preemptive NTS 
electrical stimulation 
interferes with 
epileptogenesis 
Magdaleno- 
Madrigal (2002) 
 
Amygdala kindling; cats 
 
30 Hz; 150-300 μA; 1 
min 
Pulse width 0.5 ms 
 
NTS Significant slower 
progression towards 
fully 
kindled animals 
3.4 DBS IN EPILEPSY HUMAN STUDIES  
 
Table 20 : Human studies of STN stimulation for epilepsy 
Studies (First 
Author) 
Number of 
patients / Trail 
design 
Seizure / Epilepsy Stimulation Parameters Results 
Benabid (2002) 1 cortical dysplasia Refractory partial 
seizures  
80% reduction in number 
and severity of seizures. 
improvement in both motor 
and cognitive functions 
Chabardes (2002) 5 
Medically 
refractory epilepsy  
one patient of 
severe myoclonic 
epilepsy (Dravet 
HFS STN 
67% to 80% reduction in 
seizure frequency was 
observed in three patients. 
Dravets syndrome 
responded weekly and no 
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syndrome)and one 
had  an autosomal 
dominant frontal 
lobe epilepsy 
effect on patient with 
autosomal dominant frontal 
lobe epilepsy 
Shon (2005) 
2 already 
underwent 
respective surgery 
on frontal cortex 
Bilateral 
asymmetric tonic 
seizures (left > 
right) with rare 
drop attacks 
Chronic HFS 
Seizure frequency reduced 
by 86.7%  in patient 1and 
by  88.6% in patient 2 
 
Handsforth (2006) 2 Partial onset 
refractory seizures HFS 
One patient had about  50% 
reduction in seizures other 
had 33% reduction in 
frequency but more benefit 
in seizure severity 
Lee (2006) 
 
3   49.1% reduction 
Table 21 : Human studies of STN stimulation for epilepsy 
 
Studies (First 
Author) 
Number of 
patients / Trail 
design 
Seizure / Epilepsy Stimulation Parameters Results 
Wille (2011) 5-Progressive myoclonic epilepsy 
syndrome 
HFS STN/ SNr 
+ HFS ventral 
intermediate nucleus 
(VIM) 4 patients 
 
 
HFS STN/ SNr 
Produced 30% to 100% 
reduction in seizure 
frequency 
improved capabilities like  
free standing, walking ; 
improved fine motor skills 
VIM stimulation 
found ineffective, 
sometimes triggered 
myoclonia 
Cappeci (2012) 
2 patients already 
undergone 
anteriror 
collosotomy but no 
benefit 
First patient had 
Partial motor and 
tonic clonic 
seizures 
Second patient had 
atonic drops and 
absence seizures 
Bilateral HFS 
First patient- had 65% 
decrease of partial motor 
seizures and 100%control 
over tonic- clonic 
generalized attacks. 
Second patient -no 
reduction of fits and an 
increase atypical absence 
seizures. 
 
 
 
Table 22 : Human studies of Anterior Nucleus stimulation for epilepsy 
Studies (First 
Author) 
Number of 
patients /Trail 
design 
Seizure /Epilepsy Stimulation Parameters Results 
Upton (1987) 6 open label Partial onset 
60–70 Hz, 
300ms 
pulses, 3.5–3.8V 
66% 
improvement 
Hodaie (2002) 
5 open label  
follow up for 15 
months 
Refractory 
Secondarily GTC, 
GTC, CPS, 
partial motor, 
atonic drop 
attack 
100 Hz, 10V 
mean reduction of 
54% In two  
patients seizure 
reduction of > or 
=75%. 
 56 
 
Kerrigan (2004) 
5 open label 
follow up from 6 
to 15 months 
Intractable partial 
epilepsy. Four of 
the patients also 
had secondarily 
generalized 
seizures. 
100 Hz, pulse 
width, 90 ms;  
voltages 1.0 -
10.0 V. 
20% reduction 
Table 23 : Human studies of Anterior Nucleus stimulation for epilepsy 
Studies (First 
Author) 
Number of 
patients /Trail 
design 
Seizure /Epilepsy Stimulation Parameters Results 
Lee (2006) 3 
Chronic 
refractory 
epilepsy  
 
75.4% reduction 
in seizure number 
from stimulation  
Osorio (2007) 
4  
 36 months of 
treatment period 
Mesial temporal 
lobe epilepsy 
75 Hz; 4.1 V; 90 
ùs; 1 min ON, 5 
min OFF) 
reduction in 
seizure frequency 
was 75.6% 
Lim (2007) 4 follow up for 48 
months 
Generalized 
seizures, partial 
seizures and 
secondary 
generalization 
4-5 V, 90-110 
Hz, and 60-90 
micros. 
35% to 76% 
seizure reduction. 
 
Fisher (2010) 
SANTE trial 
 
110 patients 
Randomised 
blinded, in first 3 
month phase  into 
control and 
stimulation group 
 
Partial seizures 
and partial with 
secondary 
generalization 
 
By end of 
blinding phase 
Stimulated group 
had a 29% greater 
reduction in 
seizures .By end 
of two years 
overall reduction 
was 56% 
Oh (2012) 9 follow upto 1 year 
Refractory 
epilepsy  
Mean seizure 
reduction 57.9% 
(35.6-90.4%). 
improvements in  
verbal recall and 
oral information 
processing 
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Centro median nucleus thalamus  
 
Table 24 : Human studies of Centro median Nucleus stimulation for epilepsy 
Studies (First 
Author) 
Number of 
patients /Trail 
design 
Seizure /Epilepsy Stimulation Parameters Results 
Fisher et al. 
(1992) 
 
7 double blind  
cross over blocks 
of 3 months on / 
off 3 months  
washout period 
Generalized onset 
seizures 
 
65 Hz 90-
microseconds 
pulses, 1 min of 
each 5 min for 2 
h/day, with 
voltage set to half 
the sensory 
threshold 
tonic- clonic 
seizure frequency 
reduced by  30% 
during 
stimulation. No 
effect on number 
of generalized 
seizures 
 
Chkhenkeli 
(2004) 15 open label 
Mesio temporal 
foci 20–130 Hz 
desynchronized 
the EEG and 
suppressed partial 
motor seizures 
Andrade (2006) 2 open label 
GTC, multifocal 
partial 
epilepsy with 
secondarily 
GTC 
100–185 Hz, 1–
10V No benefit 
Velasco (2007) 
 
13 open label Lennox-Gastaut 
syndrome (LGS) 
130 Hz, 0.4–
0.6mA 
Overall seizure 
reduction was 
80%. Improved 
quality of life 
 
 
Table 25 : Human studies of Cerebellar stimulation for epilepsy 
 
Studies (First 
Author) 
 
Number of 
patients /Trail 
design 
Seizure 
/Epilepsy 
Stimulation 
Parameters Results 
 
Copper (1976) 
 
15 patients open 
lable 
Psychomotor, 
Gen tonic cloinc 
myoclonic 
10 HZ, 
66%reduction 
Apparently no 
adverse effect 
Sramka (1976) 10 Types not described 
10–100 Hz, 1 ms, 
10 V at bilateral 
dentate nucleus 
100% initial 
benefit but 
development of 
kindling 
phenomenon 
 
Gillman (1979) 
 
6 Types not described 1 ms 10 HZ 
83% had 
decreased 
seizures 
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Table 26 : Human studies of Cerebellar stimulation for epilepsy 
 
 
Studies (First 
Author) 
 
Number of 
patients /Trail 
design 
Seizure/Epilepsy Stimulation Parameters Results 
Davis (1992) 
32 seizures 
patient 
implanted 26 
followed up for 
17 years 
Two ‘spastic 
seizures’ others 
seizure types 
variable  
Charge densities 
were 0.9-2.5 
microC/ cm2/ phase 
delivered at 10-180 
pulses/ s to bilateral 
electrode pads on the 
superomedial 
cerebellar cortex. 
150 pulses/ s, 1–1.4 
mA 
5 (31%) continue 
to be seizure-
free, 7 (44%) 
have a reduction 
and 4 (25%) have 
no change or a 
slight increase 
Wright (1984) 
12 patients 
double blind 
follow up for 6 
months 
Severe 
intractable 
epilepsy 
 
No significant 
benefit 
statistically 
however 11 
patients 
subjectively felt 
better 
Velasco (2005) 
Double blind 
randomized 5 
patients 
Generalized tonic 
clonic;  motor 
epilepsy 
Post operatively first 
3-month double-
blind phase- 
reduction of seizures 
up to 33% of pre 
operative phase. Six 
month follow up 
reduction to 41% of 
pre op frequency. 
Effect persistent for 
2 years 
 
Krauss (2007) 
(review of 
many studies) 
36 (from 
different small 
series of clinical 
studies) 
Various 
33.3% seizures free; 
91.6% w/ 
significantly 
decreased seizures 
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Table 27 : Human studies of Hippocampus - Amygdala stimulation for epilepsy 
Studies (First 
Author) 
Number of 
patients / Trail 
design 
Seizure / 
Epilepsy 
Stimulation 
Parameters Results 
Vonck (2002) 
 
3 follow up 5 
months 
Complex partial 
seizures  
50% reduction in 
seizures in all 
patients 
Tellez-Zenteno 
(2006) 
4double blind, 
multiple cross-
over, randomized 
controlled 
Mesial temporal 
lobe epilepsy 
90 microsec, 190 
Hz 
Overall reduction 
in seizure 
frequency 15% 
not statistically 
significant 
Boon (2007) 10 follow up 12 to 52 months 
Refractory 
temporal lobe 
epilepsy  
 
1 patient had 100 
% reduction of 
seizure frequency 
1 did not respond  
5 patients had 
50% reduction 
Velasco (2007) 9 follow up 18 
months to 7 years 
partial complex 
seizures, some 
with secondary 
generalizations 
 
Five non lesional 
MTl had seizure 
reduction of 
>95%, four with 
hippocampal 
sclerosis had 50-
70% reduction. 
McLachlan 
(2010) 
2double blind, 
cross-over, 
randomized 
controlled 
Bilateral mesial 
temporal epilepsy  
Seizure frequency 
decreased by 33% 
patients during 
stimulation and 
remained lower 
by 25% for the 3 
months after  
stimulation  
turned off then e 
returned to 
baseline 
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Table 28 : Human studies of Hippocampus - Amygdala stimulation for epilepsy 
Studies (First 
Author) 
Number of 
patients / Trail 
design 
Seizure / 
Epilepsy 
Stimulation 
Parameters Results 
Tyrand (2012) 
6  temporal lobe 
epilepsy with  
hippocampal 
sclerosis (HS)  
6 non lesional 
temporal epilepsy 
Temporal lobe 
epilepsy 
130 HZ  
amygdala-
hippocampus area 
Interictal epileptic 
discharge rates 
significantly 
reduced in all 
patients with 
hippocampal 
sclerosis but only 
2 patients showed 
this improvement 
in non lesional 
group 
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Other targets  
Hypothalamus /Zona inserta  
 
Table 29 : Human studies of stimulation of other targets for epilepsy 
Studies (First 
Author) 
Number of 
patients / Trail 
design 
Seizure / Epilepsy Stimulation Parameters Results 
Franzini (2008) 
4 patients 
refractory 
epilepsy 
patient 1-  
multifocal 
epilepsy, 
patient 2-  
refractory partial 
motor and 
secondary 
generalized 
seizures. 
Patients 3- focal 
motor status 
seizure 
Patient 4-
behavioral 
multifocalseizure 
Patient 1,4-
posterior 
hypothalamus 
patient 2,3 -
caudal zona 
incerta 
 
All patients 
showed 
significant 
decrease in 
seizure 
frequency patient 
3 -motor focal 
reduced by  70% 
Khan (2009) 
2 hypothalamic 
hamartoma cases 
Mamillo thalamic 
tract 
 High frequency 
one patient  
seizure free for   
10 months post 
operative period 
.Other also 
benefitted  
Marras (2011) 1 report follow up 18 months 
Left temporal 
seizures 130 HZ 
Number of 
complex partial  
seizures 
decreased but no 
significant effect 
overall 
 
Which Target for which epilepsy? 
 
Making a selective recommendation of a particular target for particular form of epilepsy is 
difficult based on the results of published human data. This is so because except the SANTE 
trial of Anteriror Nucleus of thalamus Stimulation which involved 110 patients, all other 
reports are based on few case studies or clinical trials on small number of patients. However 
pooling the robust data of animal studies and considering the circuits mentioned at the 
beginning of the chapter, some conclusions can be drawn about optimal targets for stimulation 
based on the seizure onset zone These are described below.   
 
It has been reported, that DBS of the STN acts on afferent neurons from layer V of the 
primary motor cortex, in an animal model of PD (Gradinaru et al., 2009). The STN receives a 
strong input from cortex via hyperdirect pathway as described in details in chapter 4. The 
substantial benefits of STN stimulation in a case of refractory seizures, due to cortical 
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dysplasia in motor cortex (Benabid et al., 2002) supports this. Capecci (Capecci et al., 2012) 
reported two patients who had already undergone anterior callosotomy without benefit in 
which HFS of STN was performed. The best responder had 65% decrease over seizures had 
tonic clonic motor seizures. Other good responders to STN stimulation appear to be patient 
suffering from Progressive Myoclonic Epilepsy Syndrome (PME) (ref table 20 above). These 
patients have often trigger-dependent myoclonic jerks and generalized tonic–clonic seizures 
with  frequent association with additional ataxia and fine motor skills impairment  possibly 
resulting from abnormal sensorimotor integration and hyperexcitability of the sensory and 
motor cortex (Manganotti et al., 2001). So it can be assumed that pharmaco resistant partial 
epilepsies and partial with secondary generalization epilepsies arising from frontal lobe would 
be good candidates for STN stimulation. 
 
The mechanism that generates absence seizures is now believed to involve an alteration in the 
circuitry between the thalamus and the cerebral cortex (Futatsugi and Riviello, 1998, 
Kostopoulos, 2001) The animal data (ref table 12 above)suggests that stimulation of  Snr 
would be possibly effective in such cases through the connection of Snr with DMAZ (dorsal 
midbrain anti epileptic zone). 
 
As mentioned earlier the anterior nucleus of thalamus (ANT) is a component of Papez circuit 
and is closely associated with hippocampus, limbic structures as well as thalamic nuclei. 
Hence seizures arising from all these different structures should respond to anterior nucleus 
stimulation. 92.7 % patients recruited in SANTE trial had complex partial seizures. The best 
responders with median seizure reduction of 44.2% from baseline had seizure onset in one or 
both temporal regions. Subjects with multifocal or diffuse seizure origin showed a 35.0% 
reduction compared to a 14.1% but only in 2 out of 10 such patients. This substantiates the 
wide spread connectivity of ANT and its possible role in complex partial seizure control.  
 
Direct stimulation of the epileptic focus appears a logical thought as it’s the shortest way of 
action to interrupt ongoing seizure activity. In mesial temporal lobe epilepsy, the most 
common pathological finding in surgically resected specimens is hippocampal sclerosis 
(Blumcke et al., 1999, Liu et al 1995). Stimulation of the amygdala, hippocampus seems 
beneficial in such patients. The strongest evidence is from Vellaso (Vellaso 2007) where non 
lesional epilepsy patients had a >95% seizure reduction while those of hippocampal sclerosis 
responded with a 50 to 70% reduction. However double blind cross over trial reported by 
McLachlan and Tellez-Zenteno (ref table 24 above) seem less spectacular in terms of seizure 
control. Direct stimulation of an epileptic focus from eloquent cortex (example motor cortex) 
would produce many stimulation related side effects and it seems possible but not practical. 
Direct stimulation of malformations like hypothalamic hamartoma is successful but whether a 
surgical resection of this focus yields better results is a question. Stimulation of the 
hypothalamic hamartoma would possibly be only therapy when the resection is not possible. 
Cerebellar outflow is inhibitory and stimulation of cerebellum appeared productive from early 
studies in 1980s (ref table 23 above) however controlled trials have failed to replicate results 
of uncontrolled studies (Krauss, Fisher,.1993). Hence recommendation of cerebellum as a 
target for stimulation for control of seizures is difficult to make. 
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CHAPTER IV  
BASAL GANGLIA AND EPILEPSY 
 
The description of basal ganglia in this chapter is a synthesis of information from articles 
published earlier. The authors are mentioned at appropriate places. 
4.1 BASAL GANGLIA ANATOMY AND PHYSIOLOGY  
 
Basal ganglia are subcortical structures that are connected extensively to the cortex and form 
a network with other brain structures. They play an important role in integrative functions of 
the brain. They are involved in processing information related to motor, cognitive and sensory 
domain arising from the cerebral cortex, thalamus, hippocampus and amygdala. Because of 
their wide spread connectivity the basal ganglia also control the excitability of brainstem 
areas, thalamic motor circuits, premotor, prefrontal and limbic circuits of the cerebral cortex. 
The basal ganglia dysfunction is implicated in many disorders like Parkinson’s disease, 
Dystonias that involve the motor circuits and psychiatric disorders like OCD involving limbic 
circuits. Treatment options like DBS are found useful for these disorders when specific basal 
ganglia structures are targeted during electrical stimulation. Their role in patho physiology of 
seizures essentially a disorder of abnormal synchronization appears interesting. The anatomy, 
physiology of basal ganglia presented below is a synthesis of various studies on rats, cats and 
primates. 
 
 
Basal ganglia comprise the caudate nucleus and putamen (striatum), globus pallidus, 
subthalamic nucleus and substantia nigra (see figure 14). 
 
 
Figure 14 : Schematic coronal section of human brain. 
Schema showing the basal ganglia. Inset shows the relationship of caudate and putamen. 
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Striatum (Caudate and Putamen) 
 
The striatum is by far the largest structure of the basal ganglia. Early neuroanatomists 
considered the striatum to be a uniform and homogeneous structure. But now we understand 
that striatum is a complex structure with heterogeneous composition. It has a varied and 
clustered cytology, and different cytochemistry as evident from its rich neurotransmitter 
distribution (Graybiel & Ragsdale, 1983). 
 
 It is divided into two portions, the caudate nucleus and putamen, separated by fibers of the 
internal capsule. Despite this division, these nuclei form a single anatomical and functional 
entity. The head of the caudate nucleus lies rostral to the thalamus and bulges into the anterior 
horn of the lateral ventricle. Its body extends in a long slender fashion dorsolateral to the 
thalamus. The putamen lies between the internal capsule and the lateral medullary lamina of 
the globus pallidus. Rostrally and ventrally, the putamen and the head of the caudate nucleus 
are continuous, as the internal capsule is absent in this medial region. 
Cellular features  
 
Spiny I or medium spiny 
The medium spiny neuron has an ovoid cell body of medium size (20-14 µm) giving rise to 
seven or eight primary dendrites. These dendrites are profusely covered in spines (Groves, 
1983). They radiate approximately in a spherical manner and are dense in number so there is a 
considerable overlap in the dendritic field of each neuron. But very few dendrodendritic 
synapses exists. The axons of the spiny neurons give many collaterals before the primary 
branch extends beyond the striatum. These collaterals form axo dendritic synapces .The main 
neurotransmitter is Gamma Amino Butyric Acid (GABA) (Kita & Kitai, 1988). 
 
Spiny II 
These constitute roughly 1% of striatal neurons and are found distributed evenly in striatum. 
The axon of the spiny II, like the medium spiny, extends beyond the striatum to the major 
striatal output structures (DiFligia et al., 1976). A number of collaterals have been observed to 
branch orthogonally near the cell body of origin (Groves, 1983). Together the two types of 
spiny neurons generate the entire output pathways of the striatum. They fire very infrequently 
and, are silent for much of the period in normal state. 
 
A number of non spiny types of neurons have also been found in the striatum. They are 
considered to be interneurons, as their axons (if any) are not traced beyond the structure. But 
there is evidence that some of these neurons receive afferents from the cortex, thalamus, and 
globus pallidus). 
 
Neurotransmitter found in these neurons is actyl choline. However in the cat and primate 
striatum interneurons alsowere found to contain neuropeptide somatostatin (Chesselet & 
Graybiel, 1986).  
Activity pattern 
 
Extracellular electrophysiological recordings indicate two striatal populations: Phasically 
activated striato-pallidal neurons (PAN) also called low firing frequency neurons (LFNs), 
have with a broad-shaped action potential and a base firing rate of 0.5–1 spikes/s. The other 
tonically active neurons (TANs), with a base firing rate of 5–15 spikes/s (Kimura et al., 1990, 
1996; Apicella et al., 1992). These have since been identified as cholinergic interneurons 
(Aosaki et al., 1995). 
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PANs and TANs both respond to movement. It has been shown that that 60% of PANs are 
correlated to one or more movement parameters and 8% to motor preparation, whereas no 
TANs respond to sensory stimulus (Kimura et al., 1996). Multi-channel studies allowing 
cross-correlation analysis have shown that about 60% of TANs fire in a synchronized pattern 
without oscillation (Raz et al., 2001). 
Globus Pallidus 
 
In primates, the globus pallidus is divided into two anatomical segments: internal (GPi) and 
external (GPe). Although these segments are separated by the medial medullary lamina, the 
pallidal neurons from each segment are extremely similar, and for the most part 
morphologically indistinguishable. In non primates the anatomical structures referred to as the 
pallidum and entopeduncular nucleus corresponds to the external and internal medial 
segments respectively. In humans the external segment constitutes 70% of the total volume of 
the globus pallidus. However the mean volume of neurons is higher in the internal segment 
(Carpenter, 1981). There is a topographical organization of afferents of Globus pallidus with 
striatum and in between GP externa and interna (Smith et al., 1994).  
 
Cellular features  
 
Two types of pallidal neurons are noted. The majority are large with four to five thick 
dendrites radiating outwards. The dendrites can extend up to 1000 µm in length. It seems that 
the dendritic field is so arranged that it’s axis lies perpendicular to the incoming striatal 
afferents. This positions the dendritic fields to intercept maximal numbers of striatal afferents 
(Park et al., 1982). The large pallidal neurons have thin axons that extend beyond the 
pallidum. Almost all pallidal output neurons are GABAergic (Parent & Hazrati, 1993). There 
is also some evidence that neurons in the external segment may coexpress substance P 
(Parent, 1986). 
 
There are other small interneurons (12-21 µm in diameter) that are observed less frequently. 
These have few dendrites that extend only up to around 150µm (Parent, 1986). Occasionally 
these are identified with short sparsely branching axons. In the macaque monkey medium 
sized neurons (23–34µm) have also been found, and may be associated with the pallidal 
projections to the lateral habenular nucleus.  
 
In monkeys, four types of neurons have been characterized in, and around, the pallidal 
segments (DeLong, 1971; Bergman et al., 1994; Boraud et al., 1998): (1) GPi neurons that 
show high frequency firing and respond to passive joint movements (2) GPe neurons wit high 
frequency firing  but predominant burst activity and long period if silence  responding to 
passive joint movements (3) Gpe neurons showing a low firing rate with bursts, and (4) 
“border cells”, because of their location at the periphery of the pallidal segments and in the 
internal medullary lamina between the GPe and the GPi. 
Activity pattern 
 
GPe neurons present a tonic firing rate with pauses and a frequency of approximately 50–70 
spikes/ s (DeLong, 1971, DeLong et al., 1984; Miller and DeLong, 1987). 11% of recorded 
cells display an oscillatory autocorrelogram in the 5–20 Hz range and fewer than 5% of 
recorded pairs are correlated (Raz et al., 2000). Ninety-one percent of GPe neurons have been 
shown to respond to the passive movement of only one joint. GPe neurons respond to 
movement either by an increase in firing rate for 30% of neurons or a decrease for 70% 
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(Georgopoulos et al., 1983; Turner and Anderson, 1997). The average onset of response is 
around 10-15 ms after the onset of movement (Georgopoulos et al., 1983). 
 
A majority of GPi neurons modify their activity not only later than motor cortex neurons 
(DeLong et al., 1984) but also about 80-100 ms after the onset of muscle activity (Boraud et 
al., 2000) and even around 10 ms after the onset of movement (Georgopoulos et al., 1983).  
 
The subthalamic nucleus (STN)  
 
It is a major component of the basal ganglia. It is a small lens–shaped nucleus lying on the 
dorsomedial surface of the internal capsule. STN is a midbrain structure that is included in the 
basal ganglia because of its close ties with other basal ganglia components. The diversity of 
STN cytology is still under question.  
 
Cellular features  
 
Early studies revealed a homogeneous structure (Yelnik & Percheron, 1979). Currently, it is 
considered that there may be up to three principal varieties of neurons in the subthalamic 
nucleus. Two of these constitute projection neurons, one type is described as having an 
elongated triangular soma with four to nine dendrites radiating outwards (Afsharpour, 1985; 
Hammond & Yelnik, 1983). These dendrites are sparsely covered in spines and give rise to 
tapering branches. The second type of projection neurons are a similar size, yet with polar 
dendrites. Axons of both of these neuron types are found to emerge from the proximal 
dendrites or somas and branch into two fibers either inside the STN. A small interneuron has 
also been observed (Carpenter, 1981). It has only a few long dendrites, with as yet, no clearly 
identified axon. The neurotransmitter expressed by STN is Glutamergic. 
 
Activity pattern 
 
It has been documented that STN neurons display a tonic activity with a frequency range of 
15–25 spikes/s (Georgopoulos et al., 1983; Wichmann et al., 1994) and that more than 50% of 
STN neurons present bursts (Miller and DeLong, 1987; Wichmann et al., 1994). Very little 
oscillatory activity has been detected in the normal monkey. In STN from 60 to 90% of STN 
neurons increase their discharge rate during eye or limb movement (Georgopoulos et al., 
1983; DeLong et al., 1984, Wichmann et al., 1994b). For voluntary movement the responding 
ratio has been reported to range from 20% to 5% (Georgopoulos et al., 1983; Wichmann et 
al., 1994). A linear correlation has been shown between the timing of STN activity in relation 
to the onset of movement. 
 
The substantia nigra (SNr) 
 
Substantia nigra is also a midbrain structure, but considered together with basal ganglia as it 
has extensive relation with the striatum.  Classically it has been divided into two components: 
the pars compacta (SNc), and the pars reticulata (SNr). The pars compacta is a cell-rich region 
that in humans is composed of large pigmented neurons. The pars reticulata is less rich in 
cells, and contains morphologically similar neurons deeply entangled in the striatonigral 
projections. In monkeys the pars compacta contains 85% of the total nigral neuron population. 
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Cellular features  
 
Cells in both the pars compacta and pars reticulata exhibit a triangular (fusiform) shapeand 
are devided in two types. Small neurons (10-12 µm in diameter) with short axons are 
considered to the major nigral interneurons (Parent, 1986). The second type of neuron is 
larger (15-20 µm in diameter) and constitute the nigral output neurons. The projection 
neurons are closely grouped in the SNc, yet separated by astrocytic sheaths (Juraska et al., 
1977). They display three to five long smooth dendrites orientated in two main directions and 
with few branches (Juraska et al., 1977). A close similarity has been drawn with the GPi 
output neurons and STN neurons (Tokuno & Takada, 1993).  
 
It appears that DA neurons are not related to movement itself (DeLong et al.,1983; Schultz et 
al., 1983), contrary to the other BG projecting neurons, but are sensitive to relevant behavioral 
stimuli such as reward, the anticipation of a reward and prediction error (Schultz, 1992). 
These neurons present a typical triphasic action potential of a duration ranging from 2-5 ms 
(Schultz et al., 1983). Their firing frequency has been reported to be slow (0.5-10 spikes/ s; 
Schultz et al., 1983). 
 
4.2 CONNECTIVITY AND THE CIRCUITS IN THE BASAL GANGLIA  
 
 
Figure 15 : Connectivity and circuits in basal ganglia. 
The ‘Box and arrow‘ type of schematic representation of basal ganglia connectivity. Few of the connections are not shown 
for simplicity. (Obeso 2011 used with permission) 
 
The individual parts of basal ganglia are connected to each other extensively. These structures 
can be visualized as two functional entities. The ‘input‘structures that gather cortical 
information and also receive information from thalamus the amygdala and the hippocampus. 
The output structures that relay information to thalamus and CM parafacicular complex, PPN 
indirectly providing feedback to cortex again. 
 
Circuit level connectivity 
 
The cortical information is transmitted from the input to the output structures via three 
different pathways: 
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1. A trans- striatal “direct” pathway, which connects the striatum directly with the 
output structures. When activated, this direct pathway results in a strong 
disinhibiton of the thalamus and brainstem structures. Cortical glutamatergic 
excitatory inputs activate the striatal neurons which have inhibitory (GABAergic) 
projection to the SNr. They suppress the tonic inhibition of the thalamus and 
brainstem neurons, producing a strong disinhibition of thalamus and brainstem 
structures. 
 
2. A trans- striatal “indirect” pathway connecting the striatum with the output 
structures via the GPe and STN. In this pathway, the neurons from the cortex 
activate the striatum. The striatal output is inhibitory (GABAergic) to the GPe. The 
GABAergic neurons from the GPe influence the activity of the STN which leads to 
a dishinhibition of the glutamatergic neurons of the STN resulting in an activation 
of SNr neurons (Bevan et al., 1998; Maurice et al., 1998). 
 
 
3. A “hyperdirect” pathway connecting the cortex directly with the STN and the 
output structures (SNr and GPi). The excitatory corticosubthalamic neurons are at 
the origin of a direct activation of the STN. That leads to an activation of the SNr 
via its excitatory glutamateric neurons (Albin et al., 1989, Nambu et al., 2002). 
 
The models of information processing in basal ganglia  
 
After reviewing the anatomy and connectivity within the basal ganglia the models of 
information processing in the system are described below. These models provide a clue to 
basal ganglia functions as well as provide substrate for explaining the dysfunctions. 
 
 
Figure 16 : Schematic representation of information processing in basal ganglia 
The different colors represent different sub circuits. For the sake of simplicity only one sub circuit is shown in part C. 
 
A) Segregated loop (Fig.16 part A) 
The classical model described by Alexander et al (Alexander, Delong, 1986) describes the 
basal ganglia thalamocortical circuits to be arranged in five different parallel loops with both 
structural and functional separation from each other. Of these two are motor (motor and 
occulomotor) two associative (dorsolateral prefrontal and lateral orbitofrontal) and one limbic 
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loop. These loops are conceptualized to arise from separate cortical areas and provide 
feedback to the same cortical areas. They have a very little interaction between each other 
during normal physiology.  
 
B) Convergent loops (Fig.16part B) 
Parent and Hazarati (1993) proposed that the cortico strial, striato palidal and striatonigral 
pathways structurally show convergence and thus the loops are not ‘parallel ‘. However  
Parent et al found that the though there is a  high degree of convergence, the motor, 
associative and limbic areas of cortex project to segregated specific three areas of striatum 
and same tripartite arrangement is seen in the pallidum. 
 
C) Split Circuit Theory (Fig.16Part C) 
Joel and Weiner (1997) proposed the ‘split circuit’ theory. In this concept the cortico striatal 
pathway is one but the striato thalamo cortical circuit has two components. One renters and 
provides feedback to the same cortical area from which it arose and forms a closed loop while 
other enters different cortical area creating an open loop of information processing. 
 
The strict segregation and parallel circuits as proposed earlier by Alexander et al are not 
considered valid anymore. Modifications to these connections have been proposed in view of 
further research. For example the ‘direct’ pathway from the striatum to the output nuclei has 
been shown to have branching collateral fibers terminating sparsely in GPe (Wu et al., 2000 
Matamales and al., 2008). The exclusive feed forward nature of the ‘indirect projection’ from 
the striatum is also doubtful. Because the STN is now recognized as a major input station of 
the basal ganglia with external afferents from both cortical and subcortical structures 
(Lanciego et al., 2004; Hartmann-von Monakow et al 1978, Nambu et al 2002, Fger et al., 
1994, Coizet et al., 2009). Similarly it is shown that the GPe projects not only to the STN but 
displays a network of branched collaterals that reaches the GPi, SNr, and to nigrostriatal 
dopamine neurons (Smith et al., 1998). Reciprocating connectivity between STN and GPe and 
between the GPe and the striatum has also been documented (Miwa et al., 2001, Shink et al., 
1996). Thus though the feed forward nature of information processing in the basal ganglia is 
still considered relevant, accommodating newer information about connectivity in the model 
is essential. 
 
These new findings actually support the ‘split circuit theory‘of information processing in 
basal ganglia. 
 
Motor activity and basal ganglia pathways 
 
Output from GABAergic GPi and SNr neurons keep targeted structures in the thalamus and 
brainstem under tonic inhibitory control. The phasic inhibitory signals from direct pathway, as 
explained above suppresses the thalamic inhibition that is ‘disinhibits’ thalamocortical 
neurons and facilitates a movement. The indirect pathway modulates the actions of the direct 
pathway. Along with the GABAgeric system, Dopaminergic input from the substantia nigra 
pars compacta (SNc) modulates corticostriatal transmission. Dopa has duel effect. Neurons 
that co-express dopamine D1 receptors, substance P and dynorphin and give rise to the ‘direct 
pathway’ are excited by Dopamine. Neurons that co-express D2 receptors and encephalin, and 
that give rise to the ‘indirect pathway’, are inhibited (Gerfen et al., 1996). According to this 
model, in the normal state, activation of the ‘indirect circuits’ at the level of the striatum 
would promote movement inhibition or arrest, whereas activation of the ‘direct circuit’ would 
facilitate movement (Delong et al., 1990). 
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The subthalamic nucleus neurons that project to the internal globus pallidus and substantia 
nigra pars reticulata are excitatory. Normally, when the indirect pathway is activated by 
signals from the cortex, the medium spiny neurons discharge and inhibit the tonically active 
GABAergic neurons of the external globus pallidus. As a result, the subthalamic neurons 
become more active and, by virtue of their excitatory synapses with cells of the internal 
globus pallidus and reticulata, they increase the inhibitory outflow of the basal ganglia.  
 
Dysfunction and basal ganglia models 
 
The functioning of the intricate balance between different structures of basal ganglia can also 
be interfered from the diseases of the basal ganglia. 
 
Hemiballism is a disorder that is characterized by sudden violent involuntary movements of 
the limbs. The pathology in this disease is dysfunction of the STN. STN is an important 
‘node‘in indirect pathway. The excitatory influence of STN over the output nodes GPi and 
SNr becomes less in this disorder. This in turn decreases the inhibitory outflow of basal 
ganglia affecting the modulation of a motor program.  
 
In patients with Huntington's disease, undesired ballistic and choreoform movements are seen. 
The pathology is degeneration of the medium spiny neurons of striatum that project to GPe. 
The reduced inhibitory flow from striatum to GPe makes it more active .The Gpe is inhibitory 
to STN. Thus increased inhibition of STN in this disease leads to decreased excitation of the 
GPi and SNr. The net result is the inhibitory outflow of the basal ganglia is reduced. Without 
the restraining influence of the basal ganglia, upper motor neurons can be activated by 
inappropriate signals, resulting in the hyperkinetic movements like chorea observed in 
Huntington's disease. 
 
The hypokinetic features of Parkinson’s disease can also be interpreted using this paradigm. 
Parkinsonian features include diminished facial expressions and lack “associated movements” 
such as arm swinging during walking. Movements are difficult to initiate and, once initiated, 
they are often difficult to terminate. The pathology in Parkinson’s disease is loss of 
nigrostriatal dopaminergic neurons. As mentioned above, these neurons produce two different 
effects. The one terminating on the D1 receptors of Striatal spiny cells are excitatory to the 
cells. These spiny cells project to GPi forming the direct pathway. The nigro strial neurons are 
inhibitory to the D2 receptors in striatal cells which in turn project to GPe forming the indirect 
pathway. Both of these dopaminergic effects serve to decrease the inhibitory outflow of the 
basal ganglia and thus to increase the excitability of the upper motor neurons. In contrast in 
Parkinson's disease, the inhibitory outflow of the basal ganglia is abnormally high, and 
thalamic activation of upper motor neurons in the motor cortex is suppressed. This explains 
the hypokinetic features of Parkinson’s disease. 
 
Limitations to old model 
The conceptual model of basal ganglia pathophysiology mainly arose from the dysfunctions 
noted in Parkinson’s disease. In animal models of MPTP induced Parkinson’s disease it was 
noted that the GPi neurons fire at a higher rate than the control. The GPi rate theory thus 
explained the imbalance between direct and indirect pathway as a function of Dopamine 
depletion, to be the cause of features of Parkinson’s disease. This simple feed forward schema 
of the basal ganglia functioning was proposed earlier. But this model fails to explain other 
features of Parkinson’s disease like cognitive and emotional deficits, language problems. 
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Many studies have failed to show increased GPi discharge rates at rest in Parkinson’s disease 
as compared to normal controls in patients and animals. Similarly the recent findings of 
therapeutic DBS of GPi drives the output have also negated the theory. 
 
The ‘system oscillator theory‘: a more generalized model suitable for explaining basal ganglia 
in epilepsy: 
 
Many of the physiological and pathological processes are mediated by neuronal synchrony 
and oscillations. Basal ganglia also exhibit oscillatory discharges. The single spike mode of 
neuronal activity represents information transfer or processing .But basal ganglia neurons also 
fire in burst mode. These bursts indicate functional changes in the system. (Ivry, 1996, 
Steriade, 1997) Such oscillatory discharges  have been recorded  in corticostriatal neurons, 
(Plenz & Kitai, 1996) tonically active striatal interneurons (Aosaki et al., 1995, Raz et al., 
1996), the substantia nigra pars compacta (SNc) (Li et al., 1996), both pallidal segments and 
the STN (Beurrier  et al., 1999).   
 
The system oscillatory theory (Montgomery 2007) 
 
Earlier models explaining the basal ganglia functions were based on a unidirectional flow of 
information from input to output. The circuit level models explained basal ganglia functioning 
in terms of parallel or converging circuits. Extrapolating the circuits to a system level, the 
system oscillatory theory was developed. It maintains that basal ganglia and connections of 
thalamus to cortex comprises of dynamically coupled, nonlinear, reentrant, polysynaptic 
oscillators representing a wide range frequencies. And the main oscillator is the very high 
frequency (140Hz) Ventro lateral nucleus of thalamus. Activity of the system is 
conceptualized to be modulated by lower frequency oscillators comprising the BG nuclei. Just 
as the system oscillators participate in the normal functioning of the basal ganglia, their 
dysfunction can be explained as the pathological basis of diseases. In fact pathological 
oscillatory synchrony has been used to explain features of Parkinson’s disease (Hutchison et 
al., 2004), epilepsy (Timofeev, Steriade 2004, Traub, 2003) schizophrenia (Stelt et al., 2004), 
dementia (Jeong, 2004).  
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4.3 EVIDENCE OF INVOLVEMENT OF THE BASAL GANGLIA IN 
EPILEPTIC SEIZURES 
 
 
Figure 17 : Basal ganglia circuits showing possible locations implicated in epilepsy 
1-Dopaminergic modulation 2-Excitatory influence over STN 3-Excitation of output structure 4-Inhibition of thalamic nuclei 
indirectly influencing the thalamo cortical connections 5- Influence of SNr over DMAZ (Dorsal Midbrain Antiepileptic 
Zone).  
 
In the earlier text the intricate networking among the basal ganglia structures and models of 
information processing in them were mentioned. These circuits might influence the epileptic 
seizure by various mechanisms (see fig 17). A review of evidences of involvement of basal 
ganglia is presented below. 
  
4.3.1 PHARMACOLOGICAL STUDIES IN ANIMALS 
 
Striatum 
 
Dopamine acts differently on two receptors D1 and D2. Acting on D1 receptors, it activates 
the direct inhibitory GABAergic striato- nigral pathway. Acting on D2 receptors it reduces the 
activity in the indirect pathway by an inhibition of the subthalamo- nigral excitatory 
projection. The net effect of both mechanisms is suppression of the SNr. Injections of D2 
agonists into the dorsal striatum have been shown to block seizures in pilpcarpine induced 
seizures in rats (Al tazir et al., 1991, Wahnschaffe, 1991). Apomorphine, a Dopamine agonist, 
has been shown to be anticonvulsant when applied in striatum (caudate-putamen, nucleus 
accumbens) in pilocarpine induced seizures in rats. Halopridol, a Dopamine antagonist used 
systematically or applied into caudate, putamen bilaterally has been shown to lower the 
seizure threshold in the same model (Turski et al., 1988) but intrastriatal injection of a D1 
agonist failed to suppress clonic seizures in the pilocarpine model. NMDA (N-methyl-D-
aspartate) is an excitatory amino acid and is a proconvulsant if injected intracortically. But 
bilateral microinjections of NMDA into the caudate-putamen, however, protected against 
limbic seizures induced by pilocarpine. Further lesioning the caudate- putamen by bilateral 
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microinjection of the excitotoxin ibotenate converted subconvulsant doses of pilocarpine into 
convulsant ones (Turski et al., 1987). Similarly the application of NMDA intrastriately was 
shown to be protective in amygdala kindled rats (Cavalheiro et al., 1986). 
 
In a genetic model of absence seizures GAERS, it was observed that activation of striatal 
neurons by NMDA or by a D1 receptor agonist, significantly suppressed absence- seizures 
especially so when injection sites were located in the core of the nucleus accumbens. 
Conversely, blockade of the D1 receptors in the nucleus accumbens or of the GABA receptors 
in the SNR increased the occurrence of absence-seizures in GAERS (Deransart, Depaulis, 
2002). 
 
Pallidum  
 
Involvement of pallidum in epilepsy has been studied in few species using pharmacological 
manipulation. In GAERS, disinhibition of the globus pallidus or the ventral pallidum by 
injection of a GABA antagonist has been shown to suppress absence seizures. This effect was 
found correlated with a decrease in glutamate levels in the SNR as measured by microdialysis, 
indicating a possible involvement of STN: that is indirect path (Derensart et al., 1999). The 
preferential involvement of the ventral aspects of the pallidum was also documented in 
amygdala kindling. In this model, disinhibition of the ventral pallidum by local injection of a 
GABA antagonist reduced both the behavioral expression of seizures and the duration of the 
after discharge’ (Derensart, Depaulis, 2002). In a pentylenetetrazol (PTZ) induced tonic 
seizures pretreatment with bilateral intrapallidal microinjection of tiagabine a GABA uptake 
blocker suppressed the incidence of tonic seizures by 67.7 % and reduced the mortality rate to 
16.7 %. GABA-B receptor agonist (baclofen) completely suppressed PTZ- induced tonic 
seizures but this effect was largely abolished by co-injection of the GABA-B receptor 
antagonist CGP55845 (Chen et al., 2004). 
In rats, behavioural and electrographic signs of limbic seizures following pilocarpine (380 
mg/kg) were suppressed by the focal microinjection into the entopeduncular nucleus of the 
NMDA antagonist, 2-amino-7-phosphonoheptanoate or the kainate antagonist, gamma-D-
glutamylamino-methylsulphonate (40 nmol) (Patel et al., 1988). 
 
STN  
 
The STN sends glutaminergic output to the substantia nigra. Inhibition of the subthalamic 
projection by bilateral injections of a GABAergic agonist in the STN was found to suppress 
absence seizures in the GAERS (Deransart et al., 1996), flurothyl seizures (Velskov et al., 
1996) and amygdala-kindled seizures (Deransart et al., 1998). Injection of muscimol into STN 
protected against limbic motor seizures evoked either by intravenous bicuculline or by focal 
application of bicuculline into the anterior piriform cortex (Dybdal and Gale, 2000). 
 
SNr 
 
Substntia nigra (SN) is the output structure of basal ganlia. Because of its connection to 
various nuclei of thalamus; the substantia nigra modulates thalamo cortical rhythms. Similarly 
a dorsal midbrain anticonvulsant zone (DMAZ) has been proposed in rats. (Shehab et al., 
1995, Redgrave et al., 1992) SN connections to superior colliculus and nearby structures seem 
interesting in this regard. Hence its role in dynamics of seizure has been investigated in the 
past. Iadarola and Gale showed that elevation of GABA in the ventral midbrain tegmentum 
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would lead to blockade of tonic hind limb extension in the maximal electroshock model. It 
also produced blockade of tonic and clonic seizures produced by pentylenetetrazole and 
bicuculline. Thus they concluded that substantia nigra to be the site of anticonvulsant activity 
(Iadarola, Gale, 1982). In a maximal electroshock seizure model introduction of gamma-vinyl 
GABA, an inhibitor of GABA transaminase, within the SN suppressed seizures (Miller et al., 
1987; Platt et al., 1987) and in Flurothyl seizure model (Xu et al., 1991). Bilateral intranigral 
injection of muscimol was shown to suppress EEG recorded spike and wave discharge in 
wistar rats that show spontaneous 0 Hz SVD (Depaulis, 1988). In amygdala kindled model of 
motor and limbic seizures bilateral micorinjections of muscimol in SN was shown to suppress 
seizures (McNamarra, 1984). However such suppression of seizures by inhibition of the SNr 
was not found to be universal. In a model of audiogenic seizures Lesions of the SC markedly 
attenuated audiogenic seizure (AGS) severity by abolishing all behavioral components 
(Merril, 2003) but these seizures were not suppressed by bilateral activation of GABAergic 
transmission within the SNr (Depaulis et al., 1990). This suggests that the so-called “nigral 
control of epilepsy” may be dependent on the different circuits involved in seizures. 
 
4.3.2 ELECTROPHYSIOLOGICAL STUDIES IN ANIMALS 
 
Striatum 
 
In a GAERS model it was shown that corticostriatal neurons display suprathreshold rhythmic 
depolarizations in-phase with local EEG spikes. Consistent with this synchronized firing in 
their excitatory cortical afferents, striatal output neurons also exhibited, during SWDs, large-
amplitude rhythmic synaptic depolarizations. During spike and wave discharge (Slaght, 
2004). Similarly in amygdala kindled rats the ictal discharges in amygda were found 
synchronized with cortex, STN and SNr during the course of the seizure .But the temporal 
evolution of ictal discharges from amygdala arrived first at cortex teen SNr and then STN (Shi 
et al., 2006). 
 
Subthalamic nucleus 
 
Electrical stimulation of the motor cortex (Kitai and Deniau, 1981) has been used to document 
bursting patterns in STN. Paz et al have shown in GAERS that cortical paroxysms generate 
bursting patterns in the STN which in turn may produce phasic synaptic excitation of the 
basal ganglia output nuclei (Paz et al., 2005).  
 
In a primate model of focal motor seizures, our group at Grenoble showed dynamic changes 
that occur in basal ganglia structures during a seizure (Devergnas et al., 2012). These findings 
are described in details in chapter 6. 
 
Substantia nigra 
 
It was shown that the SNr controls the thalamus and superior colliculus neuronal activity 
especially during the motor activity (Chevalier and Deniau, 1990). These connections can be 
postulated to participate in the epileptic process. In a study by Bonhouise et al in  amygdala  
kindled seizures in rats the  relationship of amygdala,  cortex and subcortical structures (STN, 
SNr) was documented  by  using the EEG  and behavioral (clonic motor) expression  in  both 
immobilized and unrestrained animals. The principal finding was that in both immobilized 
 75 
 
and unrestrained animals the SNR neurons of kindled, but not control, animals were recruited 
(Bonhouise et al., 1991). Kaniff et al demonstrated involvement of substantia nigra in focal 
cortical epilepsy .In this study single unit activity was recorded in the substantia nigra during 
focal cortical epileptiform discharges induced by topical application of penicillin to the 
cortical surface in urethane anesthetized rats. Eighty percent of SN units responded during the 
cortical interictal spike discharge (Kaniff et al., 1983). In a genetic model of absence epilepsy 
(GAERS), It was shown that pharmacological blockade of glutamatergic transmission in the 
SNr increased the rate of discharge in VM thalamic cells and produced an irregular tonic 
firing pattern matched with an interruption of cortical SWDs. Thus the disinhibition of VM 
nucleus by SNr could be conceptualized to produce cortical desynchronization leading to 
control over spike wave discharges (Paz et al., 2007). 
 
Other techniques: Few representative studies using other techniques implicating basal ganglia 
in epilepsy are presented below. 
 
4.3.3 METABOLIC STUDIES IN ANIMALS   
 
Measurement of glucose uptake is a reflection of brain metabolism. An increase in glucose 
uptake as sign of increased activation was seen in different models of epilepsy. In amygdala 
kindled rats, 14C-2-deoxyglucose (DG) autoradiographic technique showed increased uptake 
increased in the substantia nigra, specific and nonspecific thalamic nuclei, globus pallidus, 
and neocortex. After the appearance of generalized motor seizures (Engel et al., 1978).Using 
same technique Fernandes et al showed that in status epilepticus, evoked by pilocarpine 
injection in rats; a rise of glucose metabolism was noted in the caudate (Fernandes et al., 
1999). 
 
4.3.4 EXPERIMENTAL CELL TRANSPLANTATIONS  
 
In an amygdala kindled model of temporal lobe epilepsy, transplant of GABA producing 
immortalized embryonic rat cells were shown to be anticonvulsant (Nolte et al., 2008) 
Similarly in a kainic acid induced seizures in rats, it was shown that does of kainic acid 
required to induce seizures increased and the severity of motor seizure decreased in the group 
that received intranigral GABAergic cells (Castillo et al., 2008). 
 
4.4 EVIDENCE IN HUMAN IMAGING STUDIES 
 
The evidence of basal ganglia involvement in various types of epilepsies in humans has been 
documented by different imaging techniques. These include volumetric measurements on 
structural MRI, SPECT and PET studies, and fMRI and EEG coregistered with fMRI. Few 
studies representing each technique are mentioned below. 
 
Structural MRI  
 
Pulsipher (2007) and colleagues studied 48 patients with unilateral temporal lobe epilepsy and 
compared the volumes of subcortical structures with 29 healthy controls. The greatest volume 
loss was noted in ipsilateral hippocampus, corpus callosum, thalami bilaterally. The putamen 
also showed the next highest volume reduction. Du et al., (2011) made MRI comparison of 
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volumes of subcortical structures in 14 male patients of IGE with 28 age and sex matched 
controls. It showed significant regional atrophy in the left thalamus, left putamen and bilateral 
globus pallidus in patients with IGE than control fourteen male patients with IGE. While MRI 
morphometric analysis of patients with temporal lobe epilepsy showed smaller thalamic and 
striatal volume in both hemisphere (Dreifuss et al., 2001) In another volumetric MRI study, 
patients, with tonic clonic seizures, exhibited reduced fraction of gray matter in the frontal, 
parietal, temporal cortex, thalamus, and cerebellum. The thalamus and cerebellum also 
showed reduced volumes, as did the caudate and putamen (Ciumas and Savic, 2006). 
 
Functional MRI 
 
In patients with partial seizures getting secondarily generalized Group analysis during 
generalization revealed that the cerebral blood flow (CBF) increased in the superior medial 
cerebellum, thalamus and basal ganglia. Post-ictally, there was also marked progressive CBF 
increase in the midbrain and basal ganglia. (Blumenfeld et al., 2009) 
 
The altered connectivity of subcortical structures including the basal ganglia has been 
demonstrated. In fMRI study of resting state network in patients of idiopathic generalized 
epilepsy characterized by tonic–clonic seizures MRI imaging signal correlations and diffusion 
tensor image tractography showed altered nodal characteristics and functional connectivity 
was altered in patients with epilepsy than healthy controls (Zhang et al., 2011). 
 
Functional connectivity of basal ganglia at resting state was studied in IGE patients. It 
demonstrated there was significantly more integration within the basal ganglia structures in 
IGE patients than control groups. Furthermore the increased functional connectivity was 
found in bilateral caudate nucleus and the putamen in patients of IGE with interitctal 
discharges than patient without evidence of interitctal discharges (Luo et al., 2012). 
 
EEG coregistred with fMRI  
 
In typical absence seizures in children a simultaneous registration of EEG and fMRI showed 
that six out of eight patients had decrease BOLD signals in basal ganglia during the typical 
spike wave discharge (Berman et al., 2010). A similar study of EEG and f MRI in absence 
seizures showed deactivation of the caudate nuclei in 59% of the patients during the seizures 
(Moeller et al., 2010). 
 
PET and SPECT studies  
 
In Ring chromosome 20 syndrome epilepsy is a major clinical symptom. Seizures are often 
complex partial and reported as episodes of altered consciousness with staring, oral 
automatisms, unspecified automatic behavior, focal motor symptoms and/or head turning. 
These seizures are often pharmaco resistant. An [18F] fluoro-L-dihydroxyphenylalanine 
([18F] fluoro- L-DOPA) PET study showed that uptake was significantly decreased 
bilaterally in putamen and caudate nucleus of patients with ring chromosome 20 epilepsy, 
compared with controls (Biraben et al., 2004) The authors suggested that  dysfunction of 
striatal dopaminergic neurotransmission might impair mechanisms that interrupt seizures.  
 
SPECT study with (99m) Tc-hexamethyl-propylene-amine-oxime (HMPAO) was performed 
in tonic seizures with different semiology presentation like versive, bilateral symmetric and 
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hypermotor seizures. It was found that in versive seizures prominent hyperperfusion was 
present in the frontal eye field opposite to the direction of head version along with caudate .In 
bilateral asymmetric seizure group hyperperfusion in ipsilateral supplementary sensorimotor 
area alongwiht bilateral basal ganglia was noted. The hypermotor seizure subgroup also 
demonstrated hyperperfusion in caudate and basal ganglia (Wong et al., 2010). 
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CHAPTER V  
MODEL 
5.1 CHARACTERIZATION OF PENICILLIN-INDUCED FOCAL MOTOR 
CORTICAL SEIZURES IN PRIMATES 
 
5.1.1. INTRODUCTION 
 
The pre-clinical testing of the effectiveness of novel therapeutic modalities requires well-
characterized animal models mimicking various epilepsy types (Chabardes, et al., 2008, 
Pallud et al., 2008). In rodents, acute and chronic models of generalized, multifocal, or limbic 
epilepsy have been previously described (Chevassus-Au-Louis et al., 1999, De Deyn 1999, 
Fisher, 1989). Previous studies also reported focal neocortical seizures in rats produced by 
local injection of kainic acid (Hashizume and Tanaka, 1998, Yamamoto et al., 1995), 4 amino 
pyridine (Yamamoto et al., 1995, Yang et al., 2003), iron (Willmore et al., 1978) or 
bicuculline (Eder et al., 1997,). However, few models are available in big mammals and in 
particular, models of focal neocortical epilepsy in non human primate are uncommon and 
have not been well characterized. 
 
5.1.2 MECHANISM OF ACTION OF PENICILLIN 
 
The proconvulsant effect of penicillin topically applied to cerebral cortex is known since 1946 
(Johnson and Walker, 1946). Penicillin acts as a gamma amino butyric acid (GABA) blocker. 
PNC is a blocker of the cortical gamma- aminobutyric acid (GABA)-dependent interneurons 
(Elger and Speckmann, 1983; Gloor, 1969; Gloor, et al., 1977). 
 
Penicillin leads to suppression of lateral inhibition and the facilitation of the horizontal 
cortical activation. The neurons in the area where penicillin is injected show paroxysmal 
depolarizing shift (Matsumato and Ajmonemarsan, 1964) mimicking epileptic neurons in an 
epileptic focus. Previous studies suggested that intra-cortical injection of penicillin creates a 
suppression of the activity of the surrounding inhibitory interneurons that limit the spread of 
spikes at seizure onset (Gloor, 1969; Gloor et al., 1977; Meyer and Prince, 1973; Noebels, and 
Prince, 1977). Intracellular recording studies (Elger and Speckmann, 1983) showed that 
penicillin induces epileptic activities in the superficial layer of the cortex and there is a 
vertical inhibition of the spread of spikes due to hyperpolarization of neurons in deeper layers 
of cortex. 
 
5.1.3 PENICILLIN AMONG OTHER EPILEPTIC AGENTS  
 
In rats, acute focal neocortical epilepsy using kayanic acid, (Hashizume and Tanaka, 1998; 
Yamamoto et al., 1995), using intracortical 4-amino-pyridine (4-AP) 37 are documented. Use 
of local epidural bicuculline, another proconvulsant drug that also acts as a GABA- blocker 
has been described in the past (Anschel et al., 2004), Campbell and Holmes (1984), Eder et 
al., 1997). Focal seizures in rats can also be induced by focal electrical stimulation (Ajmone-
Marsan, 1972; Hiroshi et al., 2002). 
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All these models have limitations that make them difficult to be used in primates. For 
example, the 4-AP model requires repeated injections to maintain status epilepticus. 
Bicuculline can lead to extremely violent seizures and high mortality. Such difficulty in 
administrating proconvulsant and high mortality precludes use of these agents in primates. 
The seizures induced by electric stimulation often get generalized, are acute and do not 
generate themselves spontaneously. 
 
 
Considering the mechanism of seizure induction by Penicillin and limitations of use of other 
proconvulsants, we choose intracortical injection of Penicillin to generate focal motor status 
epileticus. We also tested effect of Diazepam on the seizures in this model. Diazepam was 
specifically selected as anti epileptic drug in our experiments because of its allosteric 
modulation of GABA receptors. In this study we present electrophysiologic and clinical 
characteristics of seizures induced by acute focal intracortical injection of PNC in the motor 
cortex of NHP. 
 
5.2 MATERIALS AND METHODS   
 
5.2.1 ANIMALS 
 
Study was performed on two Macaca fascicularis (CRP, Port Louis, Mauritius), one 7 years 
old weighing 6.9 kg (Monkey A) and the other 7.5 yrs old weighing 7.8 kg (Monkey B). 
These 2 monkeys were included in two distinct experimental protocols that are not described 
in the present study, but in those protocols spontaneous seizures were recorded under similar 
conditions.  
 
5.2.2 SURGERY 
 
The animals were kept fasting 10 hours before surgery. The surgery was performed under 
general anesthesia with intra muscular injection of Ketamine (Imalgene, Merial laboratory, 
France). 0.4 mg at induction followed by 0.2 mg per hour) and Xylasine (Rompun, Bayer 
Healthcare AG, Germany) 2%, 0.2 ml at induction followed by 0.1 ml per hour. Additional 
local scalp anesthesia was provided with subcutaneous injection of Lidocaine with 1% 
Adrenalin. Prophylactic antibiotics, analgesics and anti-inflammatory drugs were delivered 
during peri operative period. 
 
Surgery was performed with a stereotactic frame (David Kopf Instruments, Tujunga 
California USA) under intraoperative tele- radiographic control. The motor strip was first 
localized using bi-commissural landmarks obtained by a ventriculography performed by 
injecting 2 ml water soluble iodine contrast medium (Bracco Imaging, France). Motor 
responses were induced by epidural cortical stimulation delivered by an external stimulator 
(Grass Technologies Astromed Inc USA) and were used to confirm the location of the motor 
strip through a small craniotomy. Two canulae were screwed in the skull above the hand area 
of the right motor cortex to enable further injections of penicillin. Four stainless steel screws 
(radius of the head 2.25 mm length 20 mm, Safix, Echirolles, France) were implanted 
bilaterally over the cranium and one additional screw was implanted close to the canulae. The 
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screws were secured with their heads in contact with the dura (see Figure 18). Finally, a head 
holder (Crist Instrument Company, Hagerstown, USA) was positioned and secured with 
dental cement. Antero-posterior and lateral tele Xray were used whenever necessary to check 
the position of the screws.  
 
Animals were allowed to recover and monitored in the post operative period. Food and water 
was provided ad libitum. Experimental induction of seizures was performed after 10 days of 
recovery period. 
 
 
 
Figure 18 : Schematic Representation of location of electrodes for ECoG and canulae for injection 
Four experiments in each monkey were completed for the characterization of model. 
 
5.2.3 INDUCTION OF SEIZURE 
 
Monkey was positioned on a primate chair (Crist Instruments, USA), with the head fixed to a 
head holder. This allowed free movements of limbs and permitted oral feeding of animals 
during the course of the experiments. Electrocortigcogram (ECoG) was recorded for 10 
minutes prior to seizure induction. Electromyogram (EMG) of the controlateral left forelimb 
and hindlimb was systematically monitored. PNC (PNC-G, Panpharma, Fougères, France) 
was diluted with sterile saline  to achieve a strength of 500 IU/l. Using sterile technique, a 
total 2500 IU of PNC was injected at a rate of 1µl/min with Hamilton syringe and pump 
through the canula at a depth of 3+/-1 mm intracortically in the right motor cortex. After the 
end of injection of PNC, the injecting needle was kept in situ for 5 min before withdrawal. 
The dose rate and site of intracortical injection was not modified in the series of experiments 
in order to allow comparison. The injections were performed twice a week. A total of 11 
purpose comparison. In a monkey, 3 additional experiments were performed to test resistance 
to antiepileptic drug (AED). In each experiment, seizures were recorded for an average of 5 
hours continuously, paying attention to containment and comfort of animal in a restrained 
position. 
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5.2.4 VIDEO- ECOG- EMG RECORDINGS 
 
Video- ECoG -EMG recording was performed using a commercial amplifier and software 
system synchronized with a video camera that can be used for standard clinical monitoring in 
human patients (System Plus, Micromed,Treviso Italy). ECoG and EMG signals were 
obtained with an analog acquisition band-pass filter between 0.05 Hz and 90 Hz and 
digitalized with a sampling rate of 250Hz. A 4 channel bipolar montage between ECoG 
electrodes was used for analyses. ECoG/ EMG synchronization with an analog video system 
permitted behavioral analysis of recorded seizures. 
 
5.2.5 EFFECT OF DIAZEPAM 
 
We studied the effect of Diazepam (Valium, Roche, Neuilly Sur Seine, France) on seizures in 
Monkey B. A dose of 0.5 mg/kg was injected intramuscularly one hour after the intracortical 
injection of PNC, after the first typical seizure manifested. A total of 3 experiments were 
completed. The results were compared with the 4 experiments in the same monkey when 
Diazepam was not administered. 
 
5.2.6 STATISTICAL ANALYSIS 
 
The seizures were analyzed for ictal onset, evolution patterns of ECoG abnormalities and 
temporal resolution of the events. Two examiners analyzed the data independently and post-
hoc statistical analysis found no significant inter observer bias. 
 
The variability in number of seizures, average duration of each seizure and total time spent 
during seizure in each hour were estimated for each monkey (intra subject) and between the 
two monkeys (intersubject). Statistical tests were performed using software GraphPad InStat3 
(GraphPad Software Inc., California, USA). Intersubject variability in number of seizures, 
average duration of each seizure and total duration of seizure was assessed using a two tailed 
non parametric Wilcoxon–Mann–Whitney two-sample rank-sum test. The difference between 
datasets was quantified using the Hodges–Lehmann (HL) estimator. A nonparametric 
ANOVA was used for data obtained in each experiment (n=4) in each experimental animal 
(n=2). A difference was considered statistically significant for a p-value <0.05. 
 
To study the effect of Diazepam, average duration of each seizure and total time spent in 
seizures in each hour was compared. Four control experiments and three experiments with 
intra muscular Diazepam were compared using a two tailed non parametric Wilcoxon–Mann–
Whitney two-sample rank-sum test. 
 
5.2.7 SPECTRAL ANALYSIS 
 
Time-frequency analysis of 17 seizures recorded in Monkey B was performed. They were 
selected so that they contained no artifact throughout their duration, which was comprised 
between 23 s and 88 s (average duration: 48 s). ECoG signal was chosen as the monopolar 
derivation covering the primary motor cortex that received PNC-G (see figure 18). The 
amplitude (square-root of power) of oscillatory activity between 1 and 100 Hz was obtained 
using standard time-frequency analysis based on the Morlet wavelet transform (Le Van 
Quyen, 2001). The first and last spikes of each discharge were used to define its onset and 
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termination, respectively. Time window of analysis of each discharge was defined to contain 
at least ten seconds before seizure onset and after seizure termination. For each frequency, the 
amplitude was computed on 40 periods length sliding time-window, providing an effective 
frequency specific time resolution. Time-frequency sampling of the time frequency plane was 
49 ms / 1Hz. Time-frequency data were normalized using the standard procedure: for each 
frequency, the mean of the baseline (periods of at least 10 seconds without interictal spikes 
chosen prior to each seizure) was subtracted to the data and then demeaned data were divided 
by the standard deviation of the baseline. Baseline was defined for every seizure as a period of 
at least 10 seconds without interictal spikes chosen just before seizure onset.  
 
Finally, the typical time-frequency pattern of recorded seizure was defined as the median 
value over seizures of the normalized time-frequency charts computed as such. Before median 
averaging, time-frequency charts were resampled linearly on a time scale to normalize seizure 
duration to the observed average (48 s). 
 
5.2.8 HISTOPATHOLOGY  
 
Both animals were euthanized as per standard protocol after the end of experiments and brain 
histopathology was studied to document changes, if any, after repeated intracortical injections 
of penicillin.  
 
 
Figure 19 : Coronal sections of brains of monkey 
Monkey A and monkey B, showing the site of intracortical injection of Penicilin marked by a black arrow. (Cresyl Violet 
Stain) 
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5.3 RESULTS  
 
Clinical and electrical focal motor status was obtained after each single injection of PNC. 
 
5.3.1 BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS FOLLOWING A 
SINGLE INTRACORTICAL PENICILLIN INJECTION  
 
We observed three distinct electrocorticographic patterns and matching behavioral 
presentations.  
 
 
Figure 20 : Interictal spikes and beginning of a seizure 
 
 
Pattern 1: Interictal spikes associated with controlateral myoclonic jerks  
These interictal spikes involved single ECoG spiking with higher amplitude than baseline 
with brisk contraction of flexors of contralateral hind limb, sometimes associated with flexion 
of forelimb. The typical spike lasted 0.2 seconds, had anaverage amplitude in the range of 200 
μV to 400 µV with a mean frequency of 0.3 Hz. 
 
Pattern2: Consisted of a train of interictal polyspikes with myoclonic contractions of contra 
lateral hind limb occurring at an average of 3 to 6 in succession. Polyspikes lasted for less 
than 3 seconds, had average amplitude in the range of 200-400 μV. 
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Figure 21 : Focal motor seizure 
 
Pattern 3: Motor seizure (Figure 21) 
This pattern followed pre ictal myoclonus that evolved into a sustained seizure lasting 
between 5 seconds and 120 seconds (mean 49+/-8 s.). The beginning of seizure was marked 
by  ECoG spikes, similar to interictal ones, with amplitude in the range of in the range of 200 
μV to 800 μV, at a frequency of 0.5 to 1 Hz and lasting less than 5 s. This was followed by 
ictal discharge on ECoG with a frequency in the range of 20 to 25 Hz. The amplitude 
increased to a range 1500 μV to 2500 μV (mean 1850+/-372.5 μV) during the seizure .The 
end of seizure (figure 22) was marked by abrupt return of ECoG to baseline. 
                   
 
Figure 22 : The end of a seizure.  
Marked by abrupt cessation of spiking. A period of about 3 to 5 seconds is noted after which the interictal spikes begin to 
appear again. 
 
Time-frequency chart of the normalized amplitude of primary motor cortex activity during 
motor seizures (Figure 23) confirmed the primary role of beta oscillations (12-25 Hz) that 
started 3 s after seizure onset and remained steady until seizure termination. Seizure onset was 
characterized by a brief vertical column of activity between 1 and 70 Hz that corresponds to 
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first large spike. During the three seconds following the first spike, a fast drift of low-gamma 
activity, from 40 Hz to 25 Hz, could be observed. Low-gamma activity became broadly 
distributed in the second part of the seizure, and kept increasing until seizure termination, 
particularly between 25-40Hz. 
 
This was accompanied by appearance of 4 Hz activity. These two features actually translate in 
the time frequency domain the bursty ECoG patterns (4 Hz beta-gamma bursts) that could be 
observed at the end of seizures. 
 
 
Figure 23: Time frequency analysis of Focal Motor Seizure 
 
The clinical picture of a typical seizure demonstrated initial tonic contraction of contralateral 
hind limb often associated with involvement of contralateral fore limb. This was followed by 
clonic movements of contralateral limbs. It ended by abrupt cessation of motor activity with 
concurrent return to baseline of ECoG signal. 
 
5.3.2 TEMPORAL EVOLUTION OF INTERICTAL SPIKES AND SEIZURES  
 
In all experiments, a consistent succession of ECoG patterns in relation to seizure activity 
could be observed. 
 
Occurrence of interictal spikes  
 
Typically, interictal spikes were apparent within the 2 to 5 min following intracortical 
injection of penicillin. Interictal spikes and myoclonic jerks were most numerous during the 
first hour (figure 24) and were partially replaced by seizures afterwards. The number of 
interictal spikes gradually decreased in following hours, but they could still be clinically 
detected at the 8th hour post injection. 
 86 
 
  
 
Figure 24 : Evolution of interictal spikes  
Graph indicates average number of interictal spikes in one specimen during experiments. The number was maximum in the 
first hour after intra cortical injection of Penicillin. Thereafter it reached a plateau that lasted for several hours. 
X axis: Hours after intracortical injection. 
 
Evolution of seizures 
 
The first typical seizure appeared from 30 min to 54 min after the injection. The seizure 
duration and severity (in terms of involvement of muscle groups of the limbs in observed 
tonic clonic activity) increased gradually during subsequent hours, reaching a peak during the 
third hour before tapering off in the fifth hour of the post injection period. Even after removal 
of animal from the restrain chair, the behavioral seizures could be observed till seventh hour. 
In every experiment, no behavioral or ECOG abnormality could be detected the next day. 
 
5.3.3 SEIZURE CHARACTERIZATION 
 
Monkey A 
 
The total time spent in seizures and average duration of seizure in each hour in four 
experiments is graphically described below (Figure 25). 
 
The average number of seizures was 8.5 (±4) in the first hour, and gradually increased in the 
second and third hour before decreasing to 10.5 (±9.8) in the fourth hour. The average time 
spent in seizures was around 2020% of total duration for the first hour, around 30% in second 
and third hour and 40% of total duration in the fourth hour. The average duration of each 
seizure was 61.55 (±38.84) in the first hour and was 73.07 s (±23.4s) in last hour.  
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Figure 25 : Duration of motor seizure in monkey A 
Part A of figure shows total time spent in seizures and part B shows average duration of seizure during each hour in each 
experiment (total 4)  
X axis: Hours after intracortical injection  
Y axis: Total time in spent in seizures in seconds  
(Inj: injection of intracortical Penicillin) 
 
 
Monkey B 
 
The total time spent in seizures and average duration of seizure in each hour in four 
experiments is graphically described below (Figure 26) 
 
The average number of seizures was 11 (+/-1.7) in first hour, increased in second and third 
hours before decreasing to 21.5(+/-8.6) in the 4th hour. The average  time spent in seizures 
was  around 15% of total duration for the first hour,around 28.30%  and  29.70%  in the 
second and  third hour respectively  and  around 27% of total duration) in the fourth hour..The 
average duration of each seizure was 31.48 (+/-10.1) in the first hour and 48.35 s (+/-15) in 
the fourth hour.   
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Figure 26 : Duration of motor seizure in monkey B 
Part A of figure shows total time spent in seizures and part B shows average duration of seizure during each hour in each 
experiment (total 4)  
X axis: Hours after intracortical injection  
Y axis: Total time in spent in seizures in seconds  
(Inj: injection of intracortical Penicillin) 
 
 
5.3.4 INTERSUBJECT VARIABILITY 
 
The pattern of seizure evolution was same in both specimens. The comparison between the 
two monkeys showed that average duration of seizures (p ≥0.05) (figure 27a), number of 
seizures (p≥0.05) (figure 27b), and total time spent during seizure (p≥0.05) did not differ 
significantly. 
  
 
Figure 27: Intersubject variability between monkey A and B 
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Part A of figure shows comparison of average duration of seizure between two monkeys  
Part B of figure shows comparison of number of seizures between two monkeys  
 X axis: Hours after intracortical injection  
Y axis: Total time in spent in seizures in seconds  
Monkey A (grey bars) Monkey B (black bars) 
5.3.5 EFFECT OF DIAZEPAM ON SEIZURES 
 
In Monkey B, compared to control experiments, administration of Diazepam decreased the 
total time spent in seizures (Figure 28A). However it remained steady (at around 200 seconds 
in each hour) throughout. The difference between average duration of seizure in each hour 
between control and experiments that included diazepam administration was not statistically 
significant (p≥0.05) (Figure 28B). The average number of seizures in each hour did decrease 
after administration of Diazepam. 
  
 
Figure 28: Effect of Diazepam on motor seizures 
Part A of figure shows effect of Diazepam on total duration of Seizures   
Part B of figure shows effect of Diazepam on average duration of seizure in each hour   
X axis: Hours after intracortical injection  
Y axis: Total time spent in seizures in seconds  
Control experiments (Black bars) Diazepam (Grey bars) 
 
The number of interictal spikes (myoclonic jerks) remained same even after the 
administration of Diazepam. The frequency of myoclonus remained in the range of 60 to 210 
in each hour in three experiments (figure 29). It did not decrease significantly after 
administration of Diazepam. 
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Figure 29 : Effect of Diazepam on interictal spikes 
Number of interictal spikes recorded in each hour during three experiments when Diazepam was administered 1 hour after 
the intracortical injection of Penicillin  
X axis: Hours after intracortical injection  
Y axis: Number of interictal spikes  
Inj: injection of Penicillin intracortically 
 
5.4 DISCUSSION 
 
In this study, we describe electrophysiological and clinical properties of a primate model of 
acute focal motor status epilepticus following intracortical injection of penicillin, which acts 
as a GABA blocker. The main results of our study are the following:  
 
1) We could obtain on demand, a stable and reproducible motor status 
2) The electro-clinical features of the seizures mimicked those seen in Kojelnikow 
syndrome 
3) The seizures were resistant to benzodiazepine although their number was 
significantly decreased.  
4) No major histopathological lesions were seen on brain specimen. 
 
Models of focal neocortical epilepsy secondary to topically applied penicillin has previously 
been described in large animal models like cats (Yamamoto et al., 1995) rabbit (Pockberger et 
al., 1984), sheep (Opdam et al., 2002) and monkey (Kato et al., 1980), there is a paucity of 
studies aimed at characterizing and quantifying semi-acute focal motor status epilepticus in 
primates. The development of such a model in primate is important because seizure 
progression might differ from species to species (Gale, 2004). Critically, a primate model 
might be the most suited for preclinical testing of innovative therapies such as deep brain 
stimulation, local drug delivery, cooling of the epilepogenic zone or gene therapy, this was an 
important motivation in initiating this work. 
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5.4.1 CLINICAL SEMIOLOGY AND RESISTANCE TO AED 
 
We found that focal intracortical injection of penicillin systematically led to a series of 
stereotypical and reproducible controlateral clinical signs that were strongly correlated with 
the ECoG spiking. These seizures closely mimicked those encountered in humans suffering 
from epilepsia partialis continua (EPC) and from Kojevnikov’s syndrome.  
 
Indeed, epilepsia partialis continua is described as a spontaneous regular or irregular clonic 
muscle twitching of cerebral cortical origin, confined to one part of the body and continuing 
for a period of hours, days, or even weeks24. In most of the cases of EPC, the seizures are of 
focal cortical origin and motor activity remains localized. Motor activity (myoclonus) is often 
persistent, lasting for at least 60 minutes and sometimes extending for hours, days even 
weeks. Consciousness usually is preserved but postictal weakness is frequently evident 
(Bencaud, 1982). In Kojevnikov’s syndrome, besides intericatl spikes correlated with 
controlateral jerks, controlateral tonic seizures can occur. The clinical course seems to be not 
modified by use of anti epileptic drugs (Schomer, 1993). Failure of GABAergic inhibition and 
potentiation of excitatory (NMDA) synapses are considered as mechanisms for self-sustaining 
status epilepticus. This is also the reason for resistant to all AED (including benzodiazepine) 
except NMDA antagonists in such conditions (Mazarati and Wasterlain, 1997). 
 
The intracortical injection of penicillin pointing to a cortical origin of seizures, strictly 
regional clinical manifestation in contralateral limbs, relatively stable number of myoclonic 
jerks observed in the inter ictal period, controlateral and regional tonic seizure, resistance to 
Diazepam are features of our model which closely resemble the description of epilepsia 
partialis continua and Kojevnikov’s syndrome.  
 
However, there is a need to test response to other classes of AED and document focal changes 
at the injection site by histopathology in order to characterize this model as a representative of 
human motor epilepsy. Our model has the distinct advantage of being in the non human 
primate thus incorporating anatomical pathways that may distinguish the primate (e.g. human) 
from rodent pathways and models. The semiology of the seizure bears strong resemblance to 
the human even if it does not replicate the pathology precisely nor the spontaneous aspects of 
human seizures. Furthermore, there is not underlying gross lesion (dysplasia, tumor, ischemic 
lesion) in the present model. However, our model is not a model of epilepsy syndrom but 
rather mimicks symptoms observed during motor seizures;  
 
5.4.2 COMPARISON WITH OTHER MODELS  
 
In a sheep model of focal epilepsy induced by intra cortical injection of PNC, Opdam and 
colleagues found that up to one third of the animals exhibited electroencephalographic 
seizures without any behavioral correlation. 
 
 This lack of motor response in association with the rhythmic ictal spiking may be due to 
methodological differences as Opdam et al injected the penicillin in the premotor cortex, in 
contrast to direct motor cortex injection in our protocol.  
 
Penicillin injection models in newborn monkeys have been described in the past (Kato, 1980). 
However our model was characterized in adult monkeys and is suitable for pre clinical testing 
of therapies. Our model also differs from the more classical primate model of neocortical 
focal seizure obtained by intracortical application of alumina gel studied previously (Ribak, et 
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al., 2009). Indeed, in this model, the appearance of symptomatic epilepsy takes 4-8 weeks and 
behavioral characteristics are unpredictable with seizure frequency ranging from 1 per month 
to 10 per day (personal observation, unpublished data). Recently, focal seizures induced by 
electric cortical stimulation in primates have been studied (Spellman et al., 2009) to define 
optimal stimulation parameters for electroconvulsive therapy. Though the seizures induced 
were focal as recorded on EEG, it was not possible to observe clinical response in this model 
because anesthetics and muscle relaxants were used. Interestingly, our model of focal motor 
seizure in monkeys share electrical and clinical resemblances with those observed in rats 
Chabardes, et al., 2008). This might suggest that the protocol used in the present study can be 
replicated in others species in rodents or big mammalian. 
 
5.4.3 REPRODUCIBILITY  
 
In our study, there was no secondary generalization of the seizures. The electrophysiological 
and behavioral abnormalities were usually absent after 24 hours after the injection. These are 
very attractive features of the model as they allow a rapid recovery of animal to a non 
epileptic state and improves safety in repeated experiments.  
 
The various ECoG ictal patterns that were identified were reproducible even after several 
penicillin injections. The electrophysiological characteristics of this model are useful in 
evaluating treatment outcomes. Besides the usual duration and frequency of seizure, the 
number of interictal spikes and polyspikes are tangible abnormalities that can be assessed as 
parameters for testing effectiveness. This is possible because the inter ictal spikes are 
observed both as an electric and a clinical event in the form of contraction of contralateral 
limb.  
 
The time frequency analysis representative of the 17 seizures indicated predominant beta 
rhythm activity throughout the course of a seizure. This beta rhythm, a marker of motor cortex 
activity, confirmed indirectly the site of intracortical injection of Penicillin.  
 
5.4.4 CONCLUSION 
 
The PC injection in motor cortex in primate leads to the induction of a reproducible acute 
focal motor status epilepticus. An animal model of epilepsy is considered suitable when it 
satisfies certain requisites. The model should be safe for the animal, simple to generate, easy 
to document and reproducible. Data obtained from ECoG recordings should be easy to use in 
automated analysis like automatic spike detection. Also for translational therapeutics of 
human diseases, the most important step is to validate novel therapies in closer species like 
primates. Our model described above satisfies these conditions. 
 
5.5 GENERATION OF EPILEPSY BY TETANUS TOXIN IN PRIMATES: 
TECHNICAL NOTE 
 
Between a good stable reproducible semi acute model of seizures by Penicillin injection at 
one end and a highly unpredictable chronic model of epilepsy induced by alumina application 
at the other end, a need was felt for characterizing an additional animal model of Epilepsy in 
primates, which could be chronic but stable and seizures generated in the model could be 
 93 
 
predictable. As Epilepsy is an episodic disorder of cerebral dysfunction with multiple areas of 
brain developing abnormal oscillations and abnormal synchronization. A model generating 
epilepsy in chronic mode resembles better to actual pathology in Humans. With this aim we 
tried to establish a model of Tetanus toxin injection in primate motor cortex. 
 
Tetanus Toxin as a pro-convulsant has been used for creating animal models of epilepsy for 
past several years. However most of these studies are related to non primate mammals. Below 
are few examples of different non primate models of epilepsy created using Tetanus Toxin  
Table: 
 
Table 30 : Animals epilepsy induced with tetanus toxin 
Study 
Author 
Region  of 
Brain species no 1 st Seizure onset Last seizure 
Carrea and Lanaria, 
1962 Cerebral cortex Dog 63 Two to seven days 2 months 
Brooks and 
Asanuma, 1962 Motor cortex Cat  
Two to six hours 
 
 
Glaser and Yu,1997 Dorsal hippocampus Cat  Two hours 26 hours 
Mellanby and 
George, 
1977 
Hippocampus Rat  3 days 
 
5 weeks 
McGeer et al., 
1980 
 
Substantia nigra 
thalamus Rat >8 Immediately 
five 
days 
(death) 
McGeer 1980 
 
 
Caudate Rat 4 3 to5days 10 days 
Louce et al., 1990 Motor cortex Cat 5 2-18 days 
Seizures persistent 
even after 38 days  
seizure types were 
focal motor seizures 
of variable 
complexity, focal 
motor seizures with 
secondary 
generalization, and 
epilepsia partialis 
continua 
Barkmeier, Loeb,  
2009 
Somato 
sensory cortex rat  
Interictal spikes 
appeared between 
4-2 days 
In 6 weeks highly 
spiking animals 
developed 
generalized seizures 
 
 
From the results of the studies above three conclusions emerged that: 
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 The model matches pathological dysfunction in brain in terms of chronicity.  
 The seizures in rats and cats, dogs (see above) occur spontaneously over a time. 
 Convenience of using single or few intracortical injections in an animal. 
 
Action of Tetanus Toxin  
 
1) Tetanus toxin acts as a protease, blocking the protein Synaptobrevin which plays an 
essential role in synaptic transmission. It has preference for inhibitory neurons. So the 
blockage of GABA release is more pronounced. After a single low dose, into the 
hippocampus or other cortical regions, it selectively blocks GABA release and associated 
IPSPs for a week or two. 
 
2) After this period the inhibitory transmission recovers but this inhibition is much more 
weaker making the circuit more ‘epileptogenic‘ 
Mossy fiber sprouting (axons of dentate granule cells) producing altered connectivity is well 
established in many chronic models of temporal lobe epilepsy and in human cases. The 
Tetanus Toxin model also shows mossy fiber sprouting (Mitchell et al., 1996).  
 
Methods 
 
1. One primate (macaque fascicularis) male, was used for this study three intracortical 
injcetions of tetanus toxin were made into motor cortex using the already implanted canula. 
Using Hamilton Syringe the Tetanus Toxin was injected intracortically at a rate of 1 microL/ 
min. The needle tip was kept in situ and withdrawn after 5 min. Post injection, monkey was 
analysed for behavioural and elctrophysiological seizures over several days. 
2. Toxin Preparation Tetanus Toxin (Sigma Aldrich: 25micro G/r 250microL) diluted to 
produce 2nG/ microL. 
 
Table 31 : Dose of tetanus toxin 
Experiments Dose of tetanus toxin Time period between injections 
1 5 microL (10nG) 0 
2 5 microL (10nG) 8 weeks (between inj 1 and 2)  
3 10 microL (20nG) 6 weeks (between inj 2 and 32) 
 
Results 
 
The animal tolerated the injection well and there were no side effects related to intracortical 
ionjection.The spikes and polyspikes and small seizures were observed. Three patterns could 
be noted: one with predominant spikes other with predominantly polyspikes and the third 
spikes followed by small duration clonic seizures noted in contralateral forelimb (figure 30, 
31, 32 and 33).  
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Figure 30 : Tetanus toxin model: Predominant Spikes 
Recorded in Spike 2® CED UK format using BIOMEA V2.3 ®CEA, LETI, France interface) 
 
Figure 31 : Tetanus toxin model: Predominantly polyspikes. 
Recorded in Spike 2® CED UK format using BIOMEA V2.3 ®CEA, LETI, France interface) 
 
 
 
Figure 32 : Tetanus toxin model: Spikes followed by seizures. 
Recorded in Spike 2® CED UK format using BIOMEA V2.3 ®CEA, LETI, France interface) 
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Figure 33 : Tetanus toxin model: A seizure. 
Recorded in Spike 2® CED UK format using BIOMEA V2.3 ®CEA, LETI, France interface) 
 
 
 
Evolution of these electrographic abnormalities is summerised below: 
 
Table 32 : Results of tetanos toxin experiments 
Experiments Spikes Poly spikes Seizures Caesation of 
abnormality 
1 3 rd post injection day 
4 th post injection 
day None After 11 days 
2 36 hours post injection 36 hours None 
Few spikes noted 
till two weeks 
3 About 2 days 2 th day 
Since the 2nd day 
Few small 
duration  clonic 
motor seizures 
Seizures stopped 
after one day, 
ECOg 
abnormality 
remained even 
after l three weeks 
 
 
Discussion 
 
Though the three experiments demonstrated that intracortical injection of tetanus toxin in 
primate motor cortex is able to generate focal seizures, it might not be a suitable model to test 
effect of DBS. The evolution of seizures were unpredictable in terms of time it took for 
developing a seizure after the injection, the seizures were of small duration and stopped in one 
day after the third experiment. The dose increase carried out in the third experiment did 
produce EcoG abnormality that lasted more than three weeks. These shortcomings of model 
led to abandonment of further experiments till dose optimization and characterization of the 
model could be worked out and we decided to continue with the penicillin injection model. 
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CHAPTER VI  
EXPERIMENTAL RESULTS 
 
6.1 INTRODUCTION 
 
Rationale for choosing STN and Putamen as targets 
 
The extensive reviews of basal ganglia involvement in seizures (chapter 4) and evidence from 
animal studies as well as human case reports of DBS in epilepsy (chapter 3) indicate 
possibility of using STN and Putamen as targets. This decision was more justified by findings 
of dynamic changes in neural activity of these structures during focal motor seizures in 
primates. Few important findings from the work performed earlier by our group in Grenoble 
on the penicillin induced model of focal motor epilepsy in primates (Devergnas et al., 2012) 
are referred here. 
 
Summary of previous work by Devergnas 
Methods 
 
In two monkeys, surgical access to basal ganglia structures was created by a trephine hole 
positioned appropriately. A recording chamber over this craniotomy, two cannuli positioned 
over motor cortex to facilitate injections of penicillin and five epidural screws for ECoG 
constituted assembly over the cranium. Micro electrode recordings performed in each basal 
ganglia structures during 65 seizures were used for analysis. Single unit activity and local 
field potentials were characterized.  
 
Findings  
 
Following figures summarizes the dynamic changes occurring in STN and Putamen during 
focal motor seizures from interictal state, to seizure onset, during the seizure and at the seizure 
offset. 
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Figure 34 : Changes in mean firing rate during motor seizure 
X axis: stage of seizure evolution 
Y axis: mean firing rate (Hz). 
(figure based on data by Devergnas, 2012) 
 
 
 
 
 
 
 
Figure 35 : Changes oscillatory pattern during motor seizure 
X axis: stage of seizure evolution  
Y axis: mean firing rate (Hz). 
(figure based on data by Devergnas, 2012) 
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Figure 36 : Firing activity of one STN neuron. 
Example of the typical evolution of spike firing activity of one STN neuron during interictal and ictal periods.  
Example of complete seizure with EEG, unit activity and instantaneous frequency of the firing rate and autocorrelogram 
(Devergnas et al., 2012) 
 
Figure 37: Firing activity of one Putamen neuron 
Example of the typical evolution of spike firing activity of one Putamen neuron during interictal and ictal periods.  
Example of complete seizure with EEG, unit activity and instantaneous frequency of the firing rate and autocorrelogram 
(Devergnas et al., 2012) 
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The findings of this investigation can be summarized as: 
 
• STN (figure 35) and GPe (data not shown): The mean firing rate increased 
significantly at the seizure onset and decreased at the seizure offset as compared to 
inter ictal state. The percentage of oscillatory neurons increased from inters ictal state 
and remained high mainly in the seizure offset period. 
 
• In Putamen the firing rate and percentage of oscillatory neurons increased during 
seizure. But the oscillator pattern was changing along the seizure and oscillatory 
frequency was twice high than cortical oscillation during seizure. This phase 
decoupling was more significant at the end of the seizure. 
 
 
• There were no significant modification in firing rate of GPi and SNr neurons and 
oscillatory frequency was stable through the seizure. 
 
Conclusion  
 
From above findings it was concluded that the direct cortico- STN pathway is involved in 
motor seizure propagation and can be seen as a facilitating structure allowing the reoccurrence 
and spread of seizure. A reciprocating circuit between STN and GPe may participate in motor 
seizure. Putamen oscillatory bursts were almost twice as compared to cortical bursts. Thus for 
an excitatory cortical input received Putamen was transmitting twice the inhibitory signal 
downstream to basal ganglia output structures. Thus Putamen could be a physiological 
controller of the motor seizure propagation in this model. 
 
There are many mechanisms postulated for explaining clinical effects of deep brain 
stimulation. But generally functional inhibition of structure being stimulated during high 
frequency stimulation and functional activation of structure during low frequency stimulation 
is more accepted views. Based on the dynamic changes of neuronal activity in STN and 
Putamen found during focal motor seizure reported above (Devergnas et al., 2012), we 
decided to test high frequency STN stimulation and low frequency putamen stimulation for 
control of seizures. 
 
6.2 MATERIALS AND METHODS 
 
Protocol was approved by a local Ethics Committee and experiments followed the European 
Communities Council Directives of November 24, 1986 (86/609/EEC) for care of laboratory 
animals. 
 
6.2.1 ANIMALS 
 
Study was performed on four Macaca fascicularis (CRP, Port Louis, Mauritius) 
 Specimen 1 (male, 7 years old weighing 11.4 kg)  
 Specimen 2 (female, 10years old weighing 5 kg)  
 Specimen 3 (male 7.5 years old weighing 7.8 kg)  
 Specimen 4 (male 9 years old weighing  5.8 kg) 
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6.2.2 SURGERY 
 
The following text describes the implantation surgery for DBS of STN in details. The animals 
were kept fasting 10 hours before surgery. 
 
The surgery was performed under general anesthesia with intra muscular injection of 
Ketamine (Imalgene, Merial laboratory, France) 0.4 mg at induction followed by 0.2 mg per 
hour/kg and Xylasine (Rompun 2%) 0.2 ml at induction followed by 0.1ml per hour. 
Additional local scalp anesthesia was provided with subcutaneous injection of Lidocaine with 
1% Adrenalin. Prophylactic antibiotics, analgesics and anti-inflamatory therapy were given 
during perioperative period. Surgery was performed with a stereotactic frame (David Kopf 
Instruments, Tujunga California USA) under intraoperative radiographic control.  
 
A midline scalp incision was made to expose skull, after obtaining hemostasis a craniotomy 
was performed prior to ventriculography. 
 
Targeting the STN: The presumptive coordinates of the right Subthalamic nucleus were 
determined on pre operative MR images and refined by collating them with atlas of macaque 
fascicularis brain (Szabo Cowan, 1984) and actual orthogonal Xrays obtained during surgery. 
For these Xrays ventriculography was performed injecting  2ml water soluble iodine contrast 
medium (Iopamiron 200mg/ml Brac, Italy). Using outline of ventricles as landmark, anterior 
and posterior commisures and thalamic outlines were determined. The Guiot’s method of 
determining the coordinates of STN based on outlines of ventricles in humans (Guiot et al 
1976) was adapted to the primates and possible location of STN was determined. This 
targeting was refined according also to the position of the STN as seen in the pre op MRI. 
 
After this the intraoperative mapping of STN in vertical plane was undertaken. A single sterile 
microrelectrode (Tungsten microelectrode, impedance: 2 - 3 mega Ohm, FHC Inc, Bowdoin, 
USA) was used with specific software (lead point3, Medtronics USA) to map cortex, white 
matter, thalamus, subthalamic nucleus, substantia nigra in progressive descending plains in 
the vertical axis. The height, beginning and end of STN nucleus were determined. 
Considering anatomic information derived from atlas, pre-op MR and ventriculography and 
neurophysiological information obtained during microelectrode recordings together, the final 
implantation of STN was undertaken. On the atlas and AC- PC landmarks the coordinates of 
the STN were X (lateral): 5 mm, Y (anterio posterior): AC -6 mm, usually midpoint of AC-
PC distance and Z (azimuth): 1/8 th of the hight of thalamus below the AC- PC plane.  
 
Following figure explains the targeting STN based on atlas and AC- PC landmarks outlined 
on ventriculography. 
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Figure 38 : Targeting STN 
On right side shows atlas image of coronal section of Monkey brain at Ac -6mm showing the STN. Left side shows a AP 
projection Xray obtained by ventriculography during surgery outlining ventricles and target. 
 
 
Figure 39 : Targeting STN. 
Two images superimposed on each other. 
 
Following figure displays the neuronal firing patterns recorded during intra operative 
electrophysiology.  
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Figure 40 : Neuronal firing patterns during targeting STN 
On right side shows the neuronal firing patterns as recorded during the intra op electrophysiology. On left side a T2W image 
in coronal section of monkey brain indicates the structures sampled. White interrupted line represents the tract of the 
recording electrode. 
 
Implantation of the depth electrode: The electrode (quadripolar, lead length 20 cm, electrode 
length 0.5mm,outer diameter of electrode 0.029" spaced 0.5mm apart,Numed USA) was 
implanted so that all the four contact points were in the STN. It was anchored extra cranially 
to a screw and fixed with dental cement.  
 
Two canulae were then screwed in the skull above the hand area of the right motor cortex to 
enable further injections of penicillin. Four stainless steel screws (radius of the head 2.25 mm 
length 20 mm, Safix France) were implanted after small craniotomies. The screws were 
secured taking care that the face of the screws was in contact with the dura. Finally a Head 
Holder (Crist Instrument Company, Hagerstown USA) was positioned, and secured with 
dental cement. 
 
Then the back of animal was prepared. A skin incision was made to create a subcute space 
which accommodated the neurostimulator (Soletra 7426, Medtronic, Mineapolis, USA). Lead 
extensions(lead extension 37086,length 40 cm,Medtronic, Mineapolis, USA) were tunneled 
through the subcutaneous space in the back and neck and connected with the implanted DBS 
electrode and the stimulator to complete the circuit. Skin incision was closed in two layers. 
 
Animals were allowed to recover and monitored in the post operative period. Food and water 
was provided ad libitum. Experimental induction of seizures was performed after 10 days of 
recovery period.   
 
The following images show the surgical steps: 
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Figure 41: Serial steps followed in implantation surgery 
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6.2.3 PUTAMINAL IMPLANTATION   
The surgical implantation procedure (except the target location) was same as described for 
STN implantation. On the atlas and AC- PC landmarks the coordinates of the Putamen were 
X (lateral) 11- 12 mm, Y (anterio posterior) AC +1 mm, and Z (azimuth) 4 mm above the line 
drawn from outer canthus of orbit to tragus of the ear on X ray; so as to correspond to lateral 
and superior portion of the putamen mainly consisting of motor division (Nambu et al 2002). 
 
 
 
Figure 42: Targeting Putamen. 
Part A shows a lateral Xray (ventriculogram) and putamen target. 
Part B shows Anterio Posterior Xray (ventriculogram) and putamen target.  
 
 
 
 
Figure 43: Targeting Putamen. 
Part A shows a lateral Xray with depth electrode in the putamen target. 
Part B shows Anterio Posterior Xray with depth electrode in the putamen target. 
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6.2.4 STN + PUTAMINAL IMPLANTATION 
 
The surgical implantation procedure (except introduction of two electrodes one in STN and 
other in putamen), induction of seizures, recording and statistical analysis were same as 
described in details earlier.  
 
 
 
Figure 44 : Targeting STN and Putamen. 
Part A shows a lateral Xray with depth electrodes in the STN and Putamen targets 
Part B shows Anterio Posterior Xray with depth electrodes in the STN and Putamen targets 
 
6.2.5 STIMULATION PROTOCOL 
 
Continues unilateral STN HFS experiments were conducted in three monkeys with each 
monkey being its own control. The schedule of control and stimulation situation was in 
random order. The threshold of voltage at which motor side effects (dystonia on the contra 
lateral side of the stimulation) was determined for both primates. Then subthreshold high 
frequency Stimulation was delivered to STN by turning the stimulator ‘on’ as soon as the 
penicillin was introduced intracortically. It was turned off after 66 % of total time of 
recording in each session in specimen 1 and specimen 2 and 75 % of total time in Specimen 3. 
This allowed us to note if there was a ‘rebound ‘phenomenon in seizure activity after the 
acute stimulation was turned off. Subthreshold for stimulation was 80 % below the strength 
when motor side effects apparent in each experiment seizures were recorded paying attention 
to containment and comfort of animal in a restrained position. For the Specimen 1 and 2 
duration of each experiment was 6 hours for Specimen 3 this duration was 4 hours. 
 
The best contact electrode contacts were determined in each monkey. This was determined by 
selecting different contact points and programming the neurostimulator accordingly. After 
switching on the stimulator, a step wise increase in the voltage was performed from the lowest 
setting till the appearance of side effects. This was noted for each contact point. The contact 
points which showed side effects at the minimal current strength, and where the appearance of 
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side effects was consistent after several trials were considered as best contact points. The 
voltage setting was then set at 80 % of the threshold value during stimulation. 
 
 
Table 33 : Stimulation parameters 
For STN HFS (pulse width 60 µs, frequency 130 Hz) 
 Best contact point Threshold voltage  
Specimen1 Monopolar (case +); contact 2 - 2.4 V 
Bipolar contact  0+, contact 2 - 3 V 
Specimen 2 Monopolar (case +)contact 3 - 2V 
Bipolar contact 2+, contact 3 - 2V 
Specimen 3 Monopolar (case +) contact 3 - 2.8V 
Bipolar contact 0+ve, contactnt 3 - 3.3V 
 
For Putamen LFS (pulse width 200 µs, frequency 5 Hz, 20 Hz) 
 Best contact point Threshold voltage  
Specimen1 Monopolar (case +) contact 1 - 3 V 
Bipolar contact 0+, point 3 - 3.2 V 
Specimen 4 Monopolar (case +) contact 3 - 3.4V 
Bipolar contact 2+, contact 3 - 3.8V 
 
For STN HFS + Putamen LFS  
 Best contact point Threshold voltage  
Specimen2 STN Monopolar (case +) contact 3 - 
Putamen (case +), 
 contact 2-ve, contact3 - 
2 V 
 
3 V 
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Following figure illustrates the stimulation protocols 
 
 
Figure 45 : Stimulation protocols 
Preventive HFS STN stimulation  
 
In one specimen we tested the effect of preventive STN Stimulation. The stimulator was 
turned on 36 hours before the induction of seizures by intra cortical injection of Penicilin. 
After the seizures were induced stimulation was continued for 4hours and then it was turned 
off. Recording was continued for 6 hours from the time of induction of seizures. 
Continues LFS Putamen Stimulation 
The stimulation protocol was same as described for continues HFS STN.  
Combined HFS STN and LFS Putamen stimulation  
 
The stimulation protocol was same as described for continues HFS STN.  
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6.2.6 ANALYSIS  
 
Images below show an example of the actual tracings of ECoG recorded during the 
experiments. 
 
Figure 46 : ECoG records during STN stimulation (control experiment) 
Tracings during control experiments when there was no stimulation.  
 
 
Figure 47 : records during STN stimulation (stimulation experiment) 
Tracings contaminated by stimulation related electric artifacts. 
 
In some experiments the stimulation related artifacts were severe and prevented easy counting 
of seizures. 
 
 111 
 
We overcame this difficulty by marking the seizure onset and offset in real time, online 
during the conduct of experiment, observing the behavioral changes like contralateral motor 
activity evident in the real time video which was synchronized with the ECoG. 
 
Further off-line analysis of the seizures was carried out for entire duration of the recording. At 
this time the video was replayed at reduced speed so as to precisely note the beginning and 
end of a seizure. Similarly the number of interictal spikes was also determined by observing 
and documenting myoclonic jerks that were time locked and matched with the ECoG spikes. 
 
This off- line analysis was carried out by two persons independently, one of which was not 
involved in actual experiments. The data was compared between two observers. The 
difference between the values obtained (e.g. duration of seizures, number of interictal spikes) 
by two observers was not statistically significant. If on rare occasion the difference was found 
large then, the values were corrected by observing the seizure and video record again 
together.  
 
Statistical tests were performed using software GraphPad InStat3 (GraphPad Software Inc., 
California, USA).  "Mann Whitney test, two-tailed and nonparametric, to compare two groups 
of values, nonparametric ANOVA for each group of data. A difference was considered 
significant for a p-value < 0.05. 
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6.2.7 CONFIRMATION OF IMPLANTED ELECTRODES  
 
The animals were sacrificed after completion of protocol. Post mortem MRI were obtained. 
These were compared with the final radiographs obtained during surgery which showed the 
intracerebral depth electrodes.  
6.3 RESULTS 
 
6.3.1 IMPLANTATION 
 
 The site of electrodes implanted was found to be correct that is in the STN in all specimens.  
 
 
Figure 48 : Confirmation of implanted depth electrodes 
Fig A: Lateral Xray projection shows the target (STN) based on the Anterior Commissure –posteriro Commusure landmarks 
obtained by a ventriculography. 
Fig B: Sagital T2W post mortem MRI in same specimen showing the tract and placement of depth electrode. 
 
 
 
Figure 49 : Confirmation of implanted depth electrodes 
Fig A:  A lateral Xray projection obtained after completion of surgery shows the location of the depth electrode in STN.   
Fig B:  Sagital T2W post mortem MRI in same specimen showing the tract and placement of depth electrode. 
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Figure 50 : Confirmation of implanted depth electrodes 
Fig A: Anterio Posterior Xray obtained after completion of surgery shows the location of the depth electrode in STN.   
Fig B: Coronal T2W post mortem MRI in same specimen showing the tract and placement of depth electrode. 
 
6.3.2 EFFECT OF STN STIMULATION  
 
In three monkeys a total of 1572 seizures were induced in 30 sessions.  
 
Following table summarizes this. 
 
Table 34 : Summary of seizures in STN experiments 
 
6.3.3 BEHAVIORAL EFFECT OF STN STIMULATION 
 
The threshold for stimulation was determined by progressively increasing the current 
(voltage) and documenting the motor side effects. The frequent motor contractions and 
hypertonia in flexors in contralateral limbs indicated the threshold. All stimulation 
experiments were conducted with voltage set at 80 % below the threshold (see table above). 
Periodic assessment of threshold level was carried out in between experiments to check 
whether undesired effects like coagulation of the tissue or break in the integrity had occurred 
that would prevent effective current delivery to the target. During experiments a contralateral 
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motor seizure with tonic and clonic components was noted. The interictal period marked by 
brisk flexor contraction, representing interictal spike but no other motor abnormalities. The 
stimulation was well tolerated as no behavioral side effects like dyskinesia, agitation, 
restlessness or strange vocalization was noted during stimulation.  
 
6.3.4 EFFECT OF HFS STN DBS ON NUMBER OF SEIZURES  
 
Following table summarizes the effect of HFS STN on number of seizures. The data is 
presented separately as each monkey acted as it’s own control, and the natural biological 
variability could possibly make the reponses different among the specimen. However the 
effect was consistent  and similar in all specimens. 
 
Table 35 : Reduction in number of seizures during STN stimulation 
(the numbers represent percentage) 
 
The same results are graphically presented below:  
Specimen 1 
 
Figure 51 : Effect of DBS STN on number of seizures in specimen 1 
X axis: hours after injection  
Y axis: number of seizures 
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Specimen 2 
 
Figure 52 : Effect of DBS STN on number of seizures in specimen 2 
X axis: hours after injection  
Y axis: number of seizures 
 
 
Specimen 3 
 
 
Figure 53 : Effect of DBS STN on number of seizures specimen 3 
X axis: hours after injection  
Y axis: number of seizures 
 
  
 116 
 
6.3.5 EFFECT OF HFS STN DBS ON TOTAL DURATION OF SEIZURES 
 
Following table summarizes the effect of HFS STN on total duration of seizures. The data is 
presented separately as each monkey acted as it’s own control, and the natural biological 
variability could possibly make the responses different among the specimen. However the 
effect was consistent  and similar in all specimens. 
 
Table 36 : Reduction in total duration of seizures during STN stimulation 
(the numbers represent percentage) 
 
 
 
The same results are graphically presented below  
Specimen 1 
 
Figure 54 : Effect of DBS STN on total duration of seizures in specimen 1 
X axis: hours after injection   
Y axis: total duration in seconds   
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Specimen 2 
 
Figure 55: Effect of DBS STN on total duration of seizures in specimen 2. 
X axis: hours after injection   
Y axis: total duration in seconds   
 
 
Specimen 3 
Figure 56: Effect of DBS STN on total duration of seizures in specimen 3. 
X axis: hours after injection   
Y axis: total duration in seconds   
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6.3.6 EFFECT OF HFS STN DBS ON AVERAGE DURATION OF SEIZURES 
 
Following table summarizes the effect of HFS STN on average duration of seizures. The data 
is presented seperately as each monkey acted as it’s own control, and the natural biological 
variability could possibly make the reponses different among the specimen. The effect was cd 
similar in specimens 1 and 3.However there was an increase in the average duration during 
stimulation between second and fourth hour in specimen 2. 
 
Table 37 : Reduction in average duration of seizures during STN stimulation 
(the numbers represent percentage) 
 
The same results are graphically presented below: 
 
 
Specimen1  
 
Figure 57 : Effect of DBS STN on average duration of seizures in specimen 1. 
X axis: hours after injection   
Y axis: total duration in seconds   
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Specimen2 
 
Figure 58 : Effect of DBS STN on average duration of seizures in specimen 2 
X axis: hours after injection   
Y axis: total duration in seconds   
Specimen3 
 
Figure 59 : Effect of DBS STN on average duration of seizures in specimen 3 
X axis: hours after injection   
Y axis: total duration in seconds   
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6.3.7 EFFECT OF HFS STN DBS ON NUMBER OF INTERICTAL SPIKES  
 
In specimen 1 and 2 there was a trend of increasing in number of spikes during stimulation .In 
specimen 3 there was a decrease in number of spikes during stimulation but in all specimens 
the trend was not statistically significant. 
 
Figure 60 : Effect of DBS STN on number of interictal spikes in specimen 1 
X axis: hours after injection   
Y axis: number of spikess   
 
 
 
Figure 61 : Effect of DBS STN on number of interictal spikes in specimen 2 
X axis: hours after injection   
Y axis: number of spikess   
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Figure 62 : Effect of DBS STN on number of interictal spikes in specimen 3 
X axis: hours after injection   
Y axis: number of spikess   
 
6.3.8 Effect of preventive HFS STN  
 
This effect was tested in one monkey during 10 experiments (5 control and 5 stimulation) in 
454 seizures. Though there was an effect especially during the first hours during stimulation 
and last hours (5th and 6th hours) after stimulation on number and total time spent in seizures, 
it was not statistically significant. 
 
Figure 63 : Effect on number of seizures in preventive STN 
Stimulation in one monkey (5 control experiments and 5 stimulation experiments). 
X axis: hours after injection  
Y axis: time in seconds 
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Figure 63 : Effect of preventive STN DBS on total duration of seizures 
Stimulation in one monkey (5 control experiments and 5 stimulation experiments). 
X axis: hours after injection  
Y axis: time in seconds 
 
 
 
Figure 64: Effect of preventive STN DBS on average duration of seizures  
Stimulation in one monkey (5 control experiments and 5 stimulation experiments). 
X axis: hours after injection  
Y axis: time in seconds 
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6.4 RESULT OF PUTAMINAL STIMULATION  
 
6.4.1 LOW FREQUENCY PUTAMEN STIMULATION  
 
This effect was tested in two monkeys during 14 experiments (7 control and 7 stimulation) in 
289 seizures. In specimen 4, the number of experiments were few (2 control, 2 stimulation) as 
the animal had to be sacrificed early due to its deteriorating health. Though there was an 
effect it was not statistically significant. 
 
Table 38 : Summary of seizures in Putamen stimulation 
 
6.4.2 BEHAVIORAL EFFECT OF LFS PUTAMINAL STIMULATION 
 
The threshold for stimulation was determined by progressively increasing the current 
(voltage) at two frequencies ie at 5Hz and 20 Hz and documenting the motor side effects. The 
frequent dystonia and facial muscle twitching indicated the threshold. All stimulation 
experiments were conducted with voltage set at 80 % below the threshold. Periodic assesment 
of threshold level was carried out in between experiments to check whether undesired effects 
like coagulation of the tissue or break in the integrity had occurred that would prevent 
effective current delivery to the target. During experiments a contralateral motor seizure with 
tonic and clonic components was noted. The interictal period was marked by brisk flexor 
contraction representing interictal spike but no other motor abnormalities.  No other side 
effects like agitation, hyperactivity were noted indicating that the stimulation was well 
tolerated.  
6.4.3 EFFECT OF LFS PUTAMEN DBS ON NUMBER OF SEIZURES 
 
In the first specimen there was significant reduction in number of seizures during the first two 
hours of stimulation. Other specimen showed significant reduction only in second hour. 
Results are graphically represented below.  
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Specimen 1 
 
Figure 65: Effect on number of seizures LFS Putamen stimulation in specimen 1. 
(5 control experiments and 5 stimulation experiments).  
X axis: hours after injection  
Y axis: time in seconds 
 
 
Specimen 4 
 
Figure 66: Effect on number of seizures LFS Putamen stimulation in specimen 4. 
(2 control experiments and 2 stimulation experiments).  
X axis: hours after injection  
Y axis: time in seconds 
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6.4.4 EFFECT OF LFS PUTAMEN DBS ON TOTAL DURATION OF SEIZURES 
 
Following table summarizes the effect on total duration  
 
Table 39: Reduction in total duration of seizures during Putamen stimulation. 
(the number represents percentage) 
Hours 1 2 3 4 5 6 
Specimen 1 100 88.94 53.37 12.53 11.40 Almost 100% increase 
Specimen 4 61.90 100 24.90 0 53.10 25 
 
Specimen 1  
 
Figure 67: Effect on total duration of seizures LFS Putamen stimulation in specimen 1. 
(5 control experiments and 5 stimulation experiments).  
X axis: hours after injection  
Y axis: time in seconds 
 126 
 
Specimen 4 
 
Figure 68: Effect on total duration of seizures LFS Putamen stimulation in specimen 4 
(2 control experiments and 2 stimulation experiments).  
X axis: hours after injection  
Y axis: time in seconds 
6.4.5 EFFECT OF LFS PUTAMEN DBS ON AVERAGE DURATION OF SEIZURES 
 
The average duration was reduced in first two hours of stimulation in both specimens. 
Specimen 1   
 
Figure 69: Effect on average duration of seizures LFS Putamen stimulation in specimen 1 
(5 control experiments and 5 stimulation experiments).  
X axis: hours after injection  
Y axis: time in seconds 
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Specimen 4 
 
Figure 70: Effect on average duration of seizures LFS Putamen stimulation in specimen 4. 
(2 control experiments and 2 stimulation experiments).  
X axis: hours after injection  
Y axis: time in seconds 
 
6.5 RESULT OF HFS STN and LFS PUTAMEN STIMULATION 
 
This effect was tested in one monkey during 10 experiments (5 controls and 5 stimulations) in 
477 seizures analyzed. Results indicate that numbers of seizures seem to decrease 
significantly but the reduction in time spent in seizures seems to be more pronounced in the 
late hours of recording. 
6.5.1 EFFECT OF STN AND PUTAMEN DBS ON NUMBER OF SEIZURES 
 
A modest reduction of about 20 % was noted during first two hours of the stimulation. This 
effect was noted throughout the six hours of recording. 
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Figure 71 : Effect on number of seizures in simultaneous STN + Putamen stimulation 
In one monkey (5 control experiments and 5 stimulation experiments) 
X axis: hours after injection  
Y axis: number of seizures 
6.5.2 EFFECT OF STN AND PUTAMEN DBS ON TOTAL DURATION OF SEIZURES 
 
A statistically insignificant reduction was noted throughout the six hours of recording. The 
effect was miniscule in second, third and fourth hour. 
 
Figure 72 : Effect on total duration of seizures in simultaneous STN +Putamen stimulation 
In one monkey (5 control experiments and 5 stimulation experiments)  
X axis: hours after injection  
Y axis: time in seconds 
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6.5.3 EFFECT OF STN AND PUTAMEN DBS ON AVERAGE DURATION OF SEIZURES 
 
A statistically insignificant increase was noted during the 3 hours of stimulation. During the 
subsequent three hours there was a statistically insignificant reduction in the average duration 
of seizures. 
 
Figure 73 : Effect on average duration of seizures in simultaneous STN +Putamen stimulation 
In one monkey (5 controls experiments and 5 stimulations experiments).  
X axis: hours after injection  
Y axis: time in seconds 
6.6 Discussion 
 
6.6.1 INTRODUCTION 
 
Summary of results 
  
We developed and characterized a stable reproducible model of focal motor seizures in 
primates and established its pharmaco resistance. We then performed DBS in Subthalamic 
nucleus 3 specimens) Putamen (2 specimens) and combined HFS STN and LFS Putamen (1 
specimen). The main findings were: 
 
 Acute HFS STN was most effective in controlling number of seizures and the total 
time spent in seizures. Preventive HFS STN (in one specimen) was not found to be 
superior to acute stimulation.  
 LFS Putamen alone was effective  but mainly in first two hours of stimulation  
 In a combined HFS STN and LFS Putamen stimulation tested in one monkey the 
effect of stimulation in terms of seizure control was modest and poor compared to 
HFS STN alone or LFS Putamen alone.  
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Thus we can conclude, within the constraints of the experiments conducted in our model that 
the best results in terms of seizure control were obtained by acute HFS STN DBS. 
 
Though HFS DBS in STN is found effective for disorders like Parkinson’s disease and is an 
already established clinical therapy for these movement disorders, the exact mechanism 
through which DBS produces results is open for debate. There are various explanations of the 
effect and DBS may act through one or several of the proposed mechanisms. We now explain 
our results in light of all these speculative mechanisms proposed for DBS. It is worth noting 
that the insight about these mechanisms was gained mainly from HFS DBS in animal 
experiments and Parkinson’s patients. This is because HFS DBS in Parkinson’s disease has a 
long history and newer indications for conditions like Epilepsy, OCD, depression are 
emerging just recently. Whether findings from Parkinson’s disease could be extrapolated to 
epileptic disorders is a question. But we assume that though the clinical manifestations of the 
diseases are quite different, the HFS DBS of STN might operate through an identical way in 
both conditions. This assumption is strengthened by a study in which the results indicated that 
there is no statistically significant difference in the resting STN neuronal discharge rates or 
regularity in the discharge pattern between PD and epilepsy patients (Montgomery, 2008). In 
this study data was obtained from 9 PD patients with DBS electrodes implanted in STN and 4 
patients of pharmaco- resistant epilepsy with implanted DBS electrodes in STN. 
 
6.6.2 OUR RESULTS COMPARED TO PAST HUMAN CASE REPORTS 
 
First we discuss our results in light of human case studies in the past  About 20 patients have 
received HFS DBS of STN for intractable epilepsies so far (see chapter 3). This is a very 
small number to be used in comparison. Also the STN DBS surgery was undertaken in many 
cases after drug trials failed and patients were subjected to surgeries for control of epilepsy or 
had a VNS. For example, a report of 5 patients (Chabardes et al 2002) includes one patient 
with Rt premotor resection and one with VNS. Of 5 patients reported by Willi (Willi et al., 
2011) one had received VNS. Both cases reported by Shon (Shon et al., 2005) had respective 
surgery and both cases reported by Capecci (Capecci, 2012) had anterior callosotomy. 
When the seizure control is considered the best responder (about 80% reduction in frequency) 
was noted in one case of cortical dysplasia in primary motor area reported by Benabid 
(Benabid et al., 2002). The best responders in Chabardes’series were patients who had 
epileptic abnormality originating in sensory motor area. The best responders in Willi’s series 
of myoclonic patients (almost 100% benefit in myoclonic seizures) had an EEG with 
intermittent slow, spike and wave activity but no MRI abnormality. In Capecci’s report the 
patient who responded best (65% control over partial motor seizures and 100% control over 
generalized seizures) suffered from motor seizures. The patient who did not respond had 
absence seizures. In a case reported by Hammer (Hammer et al 2003) a bilateral STN 
stimulation in a refractory seizure patient did not produce satisfactory results .This patient had 
left fronto- central epilepsy due to cortical dysplasia in this region. He already had undergone 
multiple subpial resections of the face and motor area and focal cortical excision anterior to 
eloquent cortex. Also he had Vagus nerve stimulation. In contrast to this result a cortical 
dysplasia patient responded substantially (Benabid et al., 2002). This variation could be 
related to location of dysplasia and possible different networks involved in epilepsy. Other 
reported human case studies demonstrate good benefit in partial onset seizures (Handsforth, 
2006). Our results also match the results of STN HFS carried out in patients who already had 
undergone surgery for epilepsy or had Vagus nerve stimulation. Based on this data in limited 
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number of patients, HFS STN is found effective in patients with epileptic zone located in 
motor cortex or sensori motor cortex. 
 
It seems that when comparing our results of the present study and those of the literature in 
humans, there a great convergence to think that seizures originating from the central region 
are the best candidates for STN-DBS. Of course, not all types of epilepsies were treated so far 
and we cannot come up with a final conclusion .But it is important to note that in a pilot study 
conducted at the University of Grenoble, patients treated by STN-DBS and who experienced 
atypical absences were not improved at all by STN-HFS (Chabardès et al., in preparation) 
6.6.3 ACUTE STN STIMULATION 
 
We now attempt to explain our results of HFS STN based on dynamic neuronal changes 
during motor seizure in the same model discussed in the introduction and the cortico - basal 
ganglia circuitry. 
 
 
Figure 74 : The cortico basal ganglionic circuits implicated during focal motor seizures in primate (Modified from 
Nambu et al 2002) 
The normal circuit. Filled black arrows show inhibitory pathway while hollow arrows indicate excitatory pathways. 
Part B) Modification in focal motor seizures The STN and Gpi get display oscillatory synchrony with the Cortex during the 
seizure. The putamen comes into synchrony in the second half of a seizure.   
Part C) Possible effect of HFS DBS of STN in controlling seizures. The reciprocating circuit between STN and GPi might be 
influenced by the functional inhibition of STN during the HFS allowing a control over seizures. 
 
STN subthalamic nucleus GPe Globus Pallidus externa GPi Globus Pallidus interna Th Thalamus STR Striatum PUT 
Putamen SNr Substantia Nigra glu Glutamate.  
 
Oscillatory synchrony is indicated by  
 
 
While disruption of this synchrony is indicated by  
 
 
 
 
The STN occupies an important place in the basal Ganglia circuitry. From cortex it receives 
significant afferents. In turn it projects to both parts of the pallidum (GPe and GPi) Thus STN 
can be considered as a major input structure to basal ganglia along with Striatum. The cortico-
STN-/pallidal pathway has been shown to exert powerful excitatory effects on the output 
nuclei of the basal ganglia, and is faster in signal conduction. Hence it is called hyperdirect 
pathway (Nambu et al., 2002). Striatum, the other input structure also is connected to output 
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of Basal ganglia through a ‘direct’ inhibitory connection to GPi and SNr and an indirect 
inhibitory path going through the GPe. 
 
This is the normal stationary model of basal ganglia functioning. The STN is excitatory to 
GPe while GPe sends inhibitory connections to STN. This could be possible seizure 
sustaining pathway. Motor seizures induced by intracortical injection of Penicillin modify 
STN intrinsic properties due to powerful hyperdirect pathway. This in turn leads to changes in 
the STN - GPe reciprocal circuit. 
 
In fact the MER studies performed on basal ganglia structures during focal motor seizures in 
primate earlier in the lab (Devergnas et al., 2012) indicate the presence of such mechanism. In 
this study it was found that 71% of STN neurons and 77% of GPe neurons show oscillatory 
synchrony wit h the cortical ictal spikes seen on EEG. This synchrony is evident from the 
beginning till the end of a focal motor seizure. Putamen shows a tendency to synchronize 
towards the second half of total duration of a seizure. 
 
The local functional inhibition in the STN during HFS DBS might reduce the excitatory 
influence over GPe and disrupt the pathological oscillatory synchrony during the motor 
seizures in our model. Similarly the activation or inhibition of the downstream pathways may 
modulate influence of output structures over thalamic nuclei and restore disturbed 
thalamocortical network. The influence of HFS STN on cortical activity could be mediated by 
two pathways: 
 
Orthodromic activation  
 
It can be postulated that the reciprocal circuit between STN and GPe sustains seizures induced 
in the motor cortex. HFS DBS interferes with this circuit and controls the seizure.  
 
The pallidothalamic pathway may influence intrinsic properties of thalamic nuclei during HFS 
STN stimulation. It is proposed that during low frequency stimulation of STN the ventral and 
intra laminar nuclei of the thalamus hyperpolarize producing rebound bursts in thalamo 
cortical relay (MacKinnon et al., 2005). This in turn activates the cortical neurons. HFS DBS 
of STN may act in opposite way and control the rebound bursts. This would result in net 
suppression of activity of cortical neurons. 
 
It has been documented that the stimulation also activates axons in a radial fashion beyond the 
actual electrodes (Mcintyre, 2004). Zona Inserta (ZI) which is in close relation to STN might 
get stimulated during HFS STN. Zona Inserta is an important structure in the sensory motor 
integration with connectivity to frontal cortex, cingulate cortex, brain stem and thalamus. The 
GABAgeric output from ZI to Ventral anterior nucleus of thalamus (Barth et al., 2002) might 
inhibit the thalamocortical neurons affecting the cortical activation. 
 
The tracts in vicinity of STN are also likely to be activated during the stimulation. Medial 
fibers of the internal capsule, Forel field containing many fibers from brain stem to Striatum 
are two such systems likely to get modulated during the HFS DBS. 
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Antidromic conduction 
 
In a recent study on MPTP primates (Devergnas and Wichmann, 2011) it was found that 10 
Hz stimulation of STN produced short latency evoked potential in the motor cortex noted on 
EEG. This indicates an antidromic activation pathway that could be involved in the HFS DBS 
too.  
 
Just as the presence of a monosynaptic pathway between cortex and STN is implicated in 
changes in neuronal activity of STN during focal motor seizures; a reverse pathway between 
STN and Cortex might be presumed to be involved in effects of HFS STN. However the 
presence of such a pathway has been demonstrated in rats (Degos et al., 2008) and not in 
primates. 
 
Disruption of oscillatory synchrony and cortical excitability  
  
As discussed earlier in our model an oscillatory synchrony was evident between cortex and 
STN during the focal motor seizures. We postulated that HFS DBS of STN may interrupt this 
synchrony and control seizures. Indirect evidence indicating this mechanism (though in 
Parkinson’s patient) was found in a study by Whitmer (Whitmer et al., 2012). He found a  
spatially- specific suppression of beta synchrony in the motor cortex during STN HFS DBS 
supporting  the hypothesis that DBS may treat Parkinsonism by reducing excessive synchrony 
in the functionally connected sensorimotor network. 
 
A TMS study in Parkinson’s patient with HFS DBS showed that cortical silent period 
increased during HFS DBS of STN. This indicated a possibility of modification of functions 
of cortical interneurons during STN stimulation and restoring of balance between excitability 
and inhibition (Fraix et al., 2008). Similar findings were also found by Dauper (Dauper et al., 
2002). 
 
Metabolic imaging and effect of HFS DBS of STN  
 
The cortical excitability could be decreased by the HFS STN. PET, SPECT and fMRI are 
neuroimaging techniques that can indirectly inform about neuronal activity by recording 
alterations in associated factors such as blood flow, blood oxygenation and glucose 
consumption. However fMRI studies are rare in patients with implanted depth electrodes due 
to concern with the magnetic effect on electrodes, stimulator and potential tissue damage .We 
review here few PET studies in Parkinson’s patients with HFS DBS of STN.  
 
In a report involving 12 Parkinson’s patients, a H,I5O PET study showed that effective STN 
stimulation significantly deactivated sensorimotor and lateral premotor cortex ipsilateral to 
stimulation compared with ineffective STN stimulation(Limousin et al 1997). Another PET 
study in 12 patients found that STN stimulation reduced blood flow bilaterally in frontal, 
parietal, and temporal cortex (Hershey et al., 2003). Payoux et al found in a H,I5O PET study  
that the main effect of high-frequency stimulation of left  STN was to reduce regional cerebral 
blood flow in the left primary sensorimotor cortex and concluded that abnormal over activity  
of cortex is reduced during HFS DBS of STN in Parkinson’s patient(Payoux et al., 2004). 
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Anasuma et al (Anasuma et al., 2006) studied PET in 9 patients of Parkinson’s during HFS 
STN. A significant metabolic reduction in the putamen, globus pallidus, sensorimotor cortex 
and cerebellar vermis was found.  In a study involving 48 PD patients bilateral STN DBS 
showed increased regional cerebral blood flow (rCBF)in the bilateral thalami, right midbrain, 
and decreased rCBF in the right premotor cortex,suggest ing a network modulatory effect of 
STN stimulation (Karimi et al., 2008). 
 
Other studies in recent years also have supported the findings above .In a study by Cilio et al 
(Cilio et al 2009)SPECT scan were obtained in  40 Parkinson’s  patients with STN DBS on 
and off and compared .These were also were compared with 20 matched PD patients who had 
no BDS. rCBF decrements were found in motor cortical areas and prefrontal cortex bilaterally 
during stimulation .They concluded that effective STN DBS (one that produces clinical 
benefit )might be associated with stimulation-induced normalization of the abnormal over 
activity within the cortico-basal ganglia-thalamo-cortical motor loop in advanced PD. 
 
A study by Geday et al indicated that HFS STN leads to subsequent deactivation of the 
thalamic anteroventral and ventrolateral nuclei and the supplementary motor area. (Geday et 
al 2009) supporting the hypothesis that STN stimulation would influence thalamo cortical 
system, a major component also implicated in seizure propagation. 
 
Wang and his collogues (Wang et al., 2010) studied FDG PET in 5 Parkinson’s patients 
undergoing STN DBS in on and off condition. They found that HFS DBS decreased glucose 
metabolism in the right lentiform nucleus, cerebellum, the bilateral ventral thalamus and 
precuneus. The thalamic decreased metabolism might reflect a decreased thalamic activity, 
which ultimately influences the thalamo-cortical relay implicated in seizures. The spatial 
covariance pattern comparison between on and off stimulation condition led to a conclusion 
that there is likelihood of suppression of hyperactive motor circuitry following STN 
stimulation in these patients. The same mechanism might be operative in epileptic condition. 
 
A combined SPECT + PET study in Parkinson’s revealed significantly decreased glucose 
metabolism of the two superior frontal gyri without any attendant perfusion changes 
following STN DBS (Haegelen et al., 2010). Similarly another FDG PET study in 10 patients 
undergoing STN DBS in obsessive compulsive disorder found decreased metabolism in 
prefrontal cortex during stimulation (Le Jeune et al., 2010). These evidences of decreased 
cortical metabolism in HFS DBS of STN could be extrapolated to epilepsy and sustain our 
hypothesis that seizure control in our model during HFS STN could be due to decreased 
cortical metabolism and modulation of basal ganglionic- thalamo- cortical network . 
Information processing in Computational models  
 
The information processing models of various basal ganglia disorder indicate misinformation 
conduction (pathological oscillations) in the various parts of circuits as the basis of diseases. 
HFS is postulated to correct this situation .In a computational model of Gpi and thalamic 
activity during HFS DBS of Parkinson’s monkeys it was shown that the thalamo cortical relay 
fidelity improves during STN stimulation restoring the ‘normal’ information process (Guo et 
al., 2008). The same mechanism could be hypothesized to work for epileptic 
hypersynchronization. In another computational model of M1 motor cortex excitability in 
normal and Parkinsonian monkeys the results suggested that therapeutic HFS DBS would 
restore the information processing capacity of the cortex by masking the misinformation 
coming from the BG-thalamic loop with more regular patterns (Santaniellio et al., 2012). 
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Other animal models; the nigral control of epilepsy 
 
The role of substantia nigra in control of seizures has been demonstrated earlier in rats. Gale 
and Iadorla in the 1980s showed that increase in GABA by inhibiting GABA transaminase in 
SNr augments anti convulsant effect (Idarola and Gale, 1982) 
 
Thus the nigral control of seizures was postulated (Depaulis, 1994). The SNr is involved in 
the control of seizures by its GABAgeric output that inhibits the Dorsal Midbrain Anti 
Epileptic Zone (DMAZ). The DMAZ is formed by deep and intermediate layers of the 
superior colliculi, the intercollicular nucleus and the midbrain reticular formation. Blockage 
of GABA receptors in SNr disinhibits the DMAZ and consequently triggers a strong 
anticonvulsant effect in case of focal, tonic- clonic and absence seizure in rats (Redgrave, 
1992). In GAERS, an animal model of absence epilepsy, (Deransart, 1996) beneficial effects 
of SN stimulation are also documented.  
 
However in our focal motor seizure model induced by intracortical penicillin injection no 
modification of SNR neuronal activity during seizures was noted (Devergnas et al., 2012). 
Still it can be argued that output structures like SNR might be affected by HFS STN 
stimulation. Hence it can be conceptualized that HFS DBS of STN may influence the output 
structures and control focal motor seizures. 
 
This is proposed based on secondary evidences of role of superior colliculus in movement 
disorders. Dystonic postures are often noted in temporal epilepsy and partial complex 
seizures. In fact dystonic events during temporal seizures can be considered as an expression 
of endogenous anti convulsant mechanism. In one such study occurrence of bilateral tonic or 
clonic behaviors and dystonia were negatively correlated (Cleto Dal-Cól et al., 2008). 
 
In a primate model infusion of GABA agonist muscimol produced cervical dystonia. Infusion 
of muscimol in superior colliculus of these primates (the equivalent of DMAZ in rats) 
inhibited the structure and prevented cervical dystonia (Holmes et al., 2012). As an argument 
a disinhibition of superior colliculus would increase occurrence of dystonia during seizure, 
considered a marker of anticonvulsant action. This is similar to role of DMAZ proposed in 
rats. Thus proposed disinhibition of superior colliculus by SNr as a seizure controlling 
mechanism might be possible in primates too.  
Mechanism of DBS and our model   
 
Putative mechanisms of DBS are many. DBS is likely to either inhibit or stimulate activity in 
the target brain structure (Beurrier et al., 2001) The conventional view based on Parkinsonian 
models about HFS STN was that it acts like a functional lesion and inhibits the structure 
(Benabid et al., 2001). In Parkinson’s patients, HFS DBS is found to inhibit local neuronal 
activity (Filali et al., 2004, Dostrovsky et al., 2000). But the different neural elements in the 
STN could be differentially activated. Somatic firing is known to get suppressed throughout 
the STN, whereas the myelinated axons of projection neurons will be activated. Animal 
studies inform us that mechanism of HFS DBS is not a simple effect. It may inhibit (Ma, 
2007) or activate (Xu et al., 2008; Moran et al., 2012) the output structures of basal ganglia. 
The notion that  during  HFS STN output to the basal ganglia output nuclei may be increased  
is  supported by different studies using microdialysis (Windels et al.,  2005) imaging studies  
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like fMRI and PET, (Stefurak et al., 2003; Perlmutter et al., 2002; Hershey et al., 2003). If we 
assume that HFS DBS of STN activates Snr and GPi then increased inhibition of thalamus by 
Gabageric output from GPi and SNr can be conceptualized to influence thalamus and thalamo 
cortical relay and influence seizures. 
 
6.6.4 Preventive STN stimulation, chronic and responsive stimulation 
 
In one monkey 174 seizures from 5 experiments of preventive stimulations were compared 
with 291 seizures obtained in 5 control experiments. Though the number of seizures and total 
duration of time spent in seizures was affected especially in the first hour and last hour of 
recording the difference was not statistically significant. 
 
We tested the STN stimulation for control of focal motor seizures in a continueus, chronic 
mode .The other stimulation strategy currently attracting attention is acute responsive 
stimulation. Some consider responsive stimulation as a better for DBS in epilepsy .It appears 
as more physiological since epileptic seizures are episodic in nature, it also improves 
stimulator life .In our model there were characteristic changes in neuronal activity in STN 
during focal motor seizures (Devergnas et al 2012), so responsive stimulation by a specific 
electrode designed to sense these changes in STN and simultaneously deliver stimulation 
could be a possibility. However we choose the chronic mode considering that the long term 
neuromodulatory effects of chronic HFS STN stimulation,as noted in Parkinson’s patients and 
neuropsychiatric patients could also contribute to seizure control .The observation that after 
withdrawing stimulation after 4 hours (specimen 1, 2) and after 2 hours (specimen 3) there 
was no increase either in the number of seizures or total duration of seizures in subsequent 
hours of recording and the beneficial effect of control over seizures persisted points out to 
possible superiorirty of chronic stimulation over responsive mode .It is also interesting to 
mention other study of cortical stimulation using the same primate model used here .In this 
study of focal motor seizures induced by Penicillin acute stimulation of the epileptic cortical 
focus failed to achieve control over siezures.A responsive stimulation of epileptic cortex, 
based on automatic seizure detection also failed in achievieng seizure control (Blauwblomme 
et al 2011).Perhaps as mentioned above  seizure generation in our model involves a powerful 
monosynaptic Cortico – STN pathway and seizure sustaining occurs through a STN GPe 
network .Both combined together might be too powerful mechanisms to be controlled by an  
acute  responsive stimulation. 
6.6.5 Putaminal Stimulation  
 
As described at the beginning of the chapter in our model, the putamen showed phase 
decoupling with the cortex especially at the end of motor seizure. Hence the possible 
beneficial effect of Putaminal activation by low frequency stimulation was tested. During 
stimulation a trend towards decrease in number of seizures, and total duration of seizures was 
noted. The number of seizures seems to increase after the stimulation was stopped after fourth 
hour. The effect however seems statistically insignificant possibly due to large amount of 
variation (as reflected in standard deviation) in values of number of seizures and total duration 
of seizures during the control experiments (see Figure 66 to 71). 
 
The role of dopaminergic system in epilepsy has been previously postulated .The 
anticonvulsant action of dopamine was attributed to D2 receptor stimulation in the forebrain, 
Commentaire [G2]:  
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while D1 receptors were implicated in proconvulsant action as discovered by the 
proconvulsant properties of the selective D1 agonist drugs (Starr, 1996). Altered D2, D3 
receptor binding in putamen of the patients of juvenile myoclonic epilepsy (Landvogt et al 
2010) and patients of temporal lobe epilepsy (Werhahn et al., 2006) has been documented. 
Hence putaminal participation in modulating seizures especially motor seizures seems 
plausible. Despite the correct placement of stimulating electrodes in the motor part of the 
putamen, the results seem statistically disappointing. Putamen has different types of neurons 
(ref chapter 4) and it is possible that the effects depend upon the types of neurons being 
stimulated. In our model putamen came into synchrony with the cortex only in the second half 
of the total duration of motor seizures. Perhaps the effect might be weaker than the effect of 
STN HFS stimulation because of the powerful monosynaptic excitatory connection between 
cortex and STN that is implicated during the motor seizures in our model. Similarly the trend 
of rising number of seizures in the fifth hour and total duration of seizures in the sixth hour 
(after withdrawing stimulation in the fourth hour) of recording may be attributed to different 
properties ie D1 receptors with anticonvulsant action and D2 /D3 with pro convulsant action. 
 
6.6.6 Combined stimulation  
 
There was a trend of decrease in number and total duration of seizures during combined high 
frequency STN and low frequency Putamen stimulation however the difference is not 
statistically significant. One of the possible explanations is that the effect was studied in one 
monkey during few experiments (5 control and 5 stimulation experiments). 
 
6.6.7 Effect on interictal spikes  
 
There seems to be a contrasting trend when the number of interictal spikes is compared 
between control experiments and stimulation experiments. It seems that apparently the 
number of spikes increased (though not statistically significant) during STN stimulation in 
two monkeys and apparently decreased during stimulation in third monkey. 
 
It was noted that in our model the number of interictal spikes are maximum during first hour 
and then though declined, remain steady for next few hours. The interictal spikes with a 
contralateral myoclonic jerk were still observed after the recordings ended at sixth hour. 
 
The interictal spikes had a reciprocal relationship with the number and total duration of 
seizures. That is the number of interictal spikes was less when total duration of seizures in a 
particular time was prolonged and vice a versa. This could be the reason behind apparent 
increase in their number during stimulation experiments as the total duration of seizure got 
decreased in stimulation experiments. The interictal spikes represent the activity in the 
epileptic zone (the cortical area of penicillin injection in our model) and it seems logical that 
DBS in the basal ganglia modifies the ‘expression’ of the disease process (that is seizure 
duration,number of seizures etc…) and does not influence ‘ pathology ‘ behind it . 
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6. 7 LIMITATIONS OF STUDY  
 
6.7.1 IS REDUCING SEIZURE NUMBER ENOUGH? 
 
Our results indicate that acute HFS STN controls seizures by reducing the numbers of 
seizures during stimulation .We know that controlling seizures is not controlling epilepsy. 
Still seizures are the obvious manifestations of epileptic process .Especially motor seizures 
can have potential of producing falls, accidents. In a clinical setting, frequent motor seizures 
also mean a restricted motor activity, loss of independence in some cases and need for 
supervision and monitoring by care takers for a patient .This may reflect negatively on quality 
of life (see chapter 1). So a good control, around 70% reported in our model is a promising 
option. There might be other long term cortical modulatory effects of chronic HFS DBS of 
STN which might become evident after months and years; that might improve seizure control. 
A study designed with these aims might be interesting. 
6.7.2 UNILATERAL STIMULATION  
 
Our model used a unilateral HFS STN to study seizure control .It seems rational because the 
epileptic zone was in  unilateral primary motor cortex specific to location of canula for 
penicillin injection. We also noted strictly contralateral focal tonic clonic activity during 
seizures (see chapter 5). Bilateral implantation though possible is difficult in primates as it 
requires two large stimulators to be embedded in the back of the primate. All these 
considerations led to unilateral HFS DBS study in our model. 
 
However in clinical settings when HFS DBS of STN is used generally bilateral stimulations 
are performed for its presumed overall larger modulatory effect over neuronal 
networks.Bilateral HFS STN is also found to be more effective than unilateral stimulation 
(Bastian et al., 2003, Ferrarin et al., 2007). We maintain that bilateral HFS STN is possible for 
motor epilepsy in human patients as bilateral implantations are standardized, routinely 
performed and have excellent safety profile .Curiously even unilateral stimulation is found to 
have bilateral effects. In a study of 37 Parkinson’s patients with unilateral STN DBS, an 
improvement was found in the ipsilateral UPDRS subscores (P < 0.001, 54.6% at 1 year) too 
(Walker et al., 2009). 
 
6.7.3 PRECISION OF IMPLANTATION  
 
The exact location of the DBS electrodes within the STN after implantation would have 
provided a better clue to which region of STN was stimulated during the stimulation. 
However a post operative MRI was not possible due to presence of metallic screws on the 
scalp. But we believe that final placement of electrodes was indeed in the STN as indicated by 
composite study of pre op MRI, intra op ventriculography, final radiogram after completion of 
surgery showing the placement in AP and Lat direction and the post mortem MRI of head 
obtained after removal of the metal implants that showed the site of intracerebral electrodes. 
 
Commentaire [sC3]: You mean ipisi 
lateral? 
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In our study the preventive HFS STN stimulation was found to confer no additional benefit 
over acute continuous STN stimulation. However this study was conducted in one monkey 
and effect tested in few experiments as opposed to acute HFS STN which was studied in 3 
experimental animals. A differently designed protocol of duration of preventive stimulation of 
STN might also be useful. 
 
6.8 CONCLUSION AND GLOBAL PERSPECTIVES 
 
Application to human disease condition  
 
Summarizing the key findings in experiments, it can be stated that HFS STN is quite useful in 
controlling focal motor seizures in a primate model. The putaminal stimulation seems less 
effective, combined stimulation of STN and Putamen, and preventive STN stimulation might 
require more experiments and alternative stimulation protocol to arrive at a definitive 
conclusion. 
 
The model used in this condition shares closely the clinical characteristics of Kojenikov’s 
syndrome. Though it does not reproduce the pathophysiology of epilepsy implicated in human 
disease. As the seizures in this model reflect ictal semiology, the HFS DBS of STN might be 
useful in seizures arising due to cortical dysplasia, Rasmussen’s encephalitis, and possibly 
those seen in refractory myoclonic epilepsy as well as seizures of frontal cortical origin. STN 
HFS DBS would be possibly beneficial when other surgical or stimulation strategies have 
failed. In conditions like Dravet’s syndrome or autosomal dominant frontal lobe epilepsy the 
STN stimulation alone might not achieve optimum control over seizures (Chabardes et al., 
2002) possibly due to the fact that, progressive nature of disorder and complex pathways of 
seizure progression might be present in these conditions. 
STN is an important ‘node’ in many circuits .It has a motor component,as well as limbic and 
associative components .Information processing in  basal ganglia is now considered not 
restricted to strictly segregated loops  (see chapter 4). Thus we hypothesize that HFS DBS of 
STN with modification of target location in specific part of STN might be beneficial in 
seizures arising from other cortical areas besides motor cortex. It might have a potential in 
other epileptic disorders like limbic epilepsy. This of course is a hypothesis. 
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ANNEXES I  
CLASSIFICATION OF SEIZURES AND 
EPILEPSIES 
 
 
Introduction: 
 
First systematic attempt to classify the seizures began in 1960 and the ILAE (International 
league against Epilepsy) published a comprehensive classification for seizures in 1981 and for 
epilepsies in 1989. Some attempts have been made to incorporate information gained from 
developments in modern neuroimaging, genomic technologies and concepts in molecular 
biology in classification. This might reflect more accurately the epilepsy type in its basic 
pathology as well as clinical aspects, but the official classification of the 1980s is still valid 
and no new system with universal consensus has been proposed yet. 
 
 
The ILAE classification of seizures  
 
 
The international League against Epilepsy has classified seizures in different categories: 
 
I.  Partial (focal, local) seizure  
      A) Simple partial seizure (consciousness not impaired)  
1. With motor symptoms  
2. With somatosensory or special sensory symptoms  
3. With autonomic symptoms  
4. With psychic symptoms  
 
 
B) Complex partial seizure (with impairment of consciousness) 
 
 
1. Beginning as simple partial sz & progressing to impairment of consciousness  
a. With no other features  
b. With features as in A 1-4  
c. With automatisms  
2. With impairment of consciousness at onset  
a. With no other features  
b. With features as in A 1-4  
c. With automatisms  
 
     C)  Partial seizure evolving to secondarily generalized  
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II. Generalized seizure  
A) Absence seizures  
 
1. Typical absence seizures   
2. Atypical absence seizures  
 B) Myoclonic seizures  
 
C) Clonic seizures  
 
D) Tonic seizures  
 
E) Tonic-clonic seizures  
 
F) Atonic (astatic) seizures 
 
III. Unclassified  
 
A) Inadequate data  
 
B) Neonatal seizure   
 
Rhythmic eye movements  
Chewing movements  
Swimming movements  
 
C) Special epileptic syndromes 
  
Myoclonus and myoclonic seizure  
Reflex epilepsy  
Landau-Kleffner syndrome  
Febrile seizures  
Hysterical seizures  
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ILAE classification of epilepsy syndromes  (Engel, 2006a)  
 
 
 
 
 
 
 
 
 
1- Self-limited 
seizure types 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Generalized seizures 
 
Tonic-clonic seizures (includes variations beginning 
with a clonic or myoclonic phase) 
Clonic seizures 
Without tonic features 
With tonic features 
Typical absence seizures 
Atypical absence seizures 
Myoclonic absence seizures 
Tonic seizures 
Spasms 
Myoclonic seizures 
Eyelid myoclonia 
Without absences 
With absences 
Myoclonic atonic seizures 
Negative myoclonus 
Atonic seizures 
 
Focal seizures 
 
 
 
 
 
Gelastic seizures 
Hemiclonic seizures 
Secondarily generalized 
seizures 
Focal sensory seizures 
With elementary sensory symptoms (e.g., occipital 
and parietal lobe seizures) 
With experiential sensory symptoms (e.g., temporo 
parieto occipital junction seizures) 
Focal motor seizures 
 
With elementary clonic motor signs 
With asymmetrical tonic motor seizures (e.g., 
supplementary motor seizures) 
With typical (temporal lobe) automatisms (e.g., mesial 
temporal lobe seizures) 
With hyperkinetic automatisms 
With focal negative myoclonus 
With inhibitory motor seizures 
2 Continuous 
seizure types 
 
 
Generalized status 
epilepticus 
 
 
Generalized tonic-clonic status epilepticus 
Clonic status epilepticus 
Absence status epilepticus 
Tonic status epilepticus 
Myoclonic status epilepticus 
 
Focal status epilepticus 
 
 
Aura continua 
Limbic status epilepticus (psychomotor status) 
Hemiconvulsive status 
 
 
 
 
 
 
3 Reflex seizures 
 
Precipitating stimuli for 
reflex seizures 
 
Visual stimuli 
Flickering light: color to be specified when possible 
Patterns 
Other visual stimuli 
Thinking 
Music 
Eating 
Praxis 
Somatosensory 
Proprioceptive 
Reading 
Hot water 
Startle 
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Modifications to this classification system have been suggested but no new system is 
proposed to replace the former widely accepted and widely used classification system (Engel, 
2006b) 
 
Multitier classification of epilepsy  
There is a subtle difference between ‘epileptic seizures ‘and ‘Epileptic Syndrome ‘. The 
epileptic seizure is the paroxysmal ictal event with characteristic EEG changes .While the 
Epileptic syndrome includes specific signs and symptoms (various seizures) a certain pattern 
in age of onset, evolution and seizure frequency along with certain neurodeficits and 
prediction about prognosis. 
In order to have a complete understanding of a patient clinical picture a rather extensive 
description of his epilepsy is necessary. Luders has proposed a five tier system of 
classification which cover both epilepsy and epileptic seizures (Luders, 2008). 
 
 
Tier 1: Epilepsy 
 
This tier describes the location of epileptogenic zone. This zone is defined by diagnostic tests 
like interictal and ictal EEG, and imaging like MRI PET SPECT, or more invasive EEG 
studies with subdural grids or depth electrodes etc…).  
The following subdivisions can be defined: 
 
1. Focal: epileptogenic zone  
a- Frontal 
b- Perirolandic 
c- Temporal 
i. Neocortical temporal 
ii. Mesial temporal 
d- Parietal 
e- Occipital 
f- Other 
 
2. Multilobar: 
a- Bilobar homotopic 
b- Other 
 
3. Generalized 
 
Tier 2 : Semiological seizure classification 
  
This tier explains the clinical overt expression of the epilepsy, usually in the form of a seizure 
or abrupt change in the physiology  
 
1. Auras 
a- Somatosensory auras 
b- Visual auras  
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c- Auditory auras 
d- Gustatory auras  
e- Olfactory auras 
f- Autonomic auras  
g- Abdominal auras  
h- Psychic aura 
 
2. Autonomic seizures 
These refer to objectively documented autonomic changes during seizures 
  
3. Dialeptic seizures  
  Dialeptic seizures refere to change in the consciousness level during seizure  
 
4. Motor seizures 
a- Simple MPotor Seizures 
i. Myoclonic Seizures 
ii. Clonic Seizures 
iii. Tonic Seizures 
iv. Versive Seizures 
v. Tonic-Clonic Seizures  
vi. Epileptic Spasms 
 
b- Complex Motor Seizures 
i. Automotor Seizures 
ii. Hypermotore Seizures 
iii. Gelastic Seizures 
 
5. Special Seizures 
a- Atonic seizures  
b- Akinetic seizures  
c- Astatic seizures  
d- Negative myoclonic seizures  
e- Hypamotor seizures  
f- Aphasic seizures 
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Tier 3 : Etiology 
 
Etiology can play a direct role in some epilepsy (for example epilepsy and a cerebral tumor) 
Tier 3 provides etiological description platform. 
 
1.  Hippocampal sclerosis 
 
2. Tumor 
a- Glioma 
b- Dysembrioplastic neuroepithelial tumor  
c- Ganglioglioma 
d- Other 
 
3. Malformations of cortical development (MCD) 
a- Focal MCD 
b- Hemimegalencephaly 
c- MCD with epidermal nevi 
d- Heterotopic grey matter 
e- Hypothalamic hamartoma 
f- Hypomelonosis of Ito 
g- Other 
 
4.  Malformations of vascular development 
a- Cavernous angioma 
b- Arteriovenous malformation 
c- Sturge_Weber syndrome 
d- Other 
 
5. Central nervous system infections  
a- Meningitis 
b- Encephalitis 
c- Abscess 
d- Other 
 
6. Central nervous system inflammation 
a- Rasmussen encephalitis 
b- Vasculitis 
c- Other 
 
7. Hypoxic ischemic brain injury 
a- Focal ischemic infarction 
b- Diffuse hypoxic-ischemic injury 
c- Periventricular leukomalacia  
d- Hemorrhagic infarction 
e- Venous sinus thrombosis 
f- Other  
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8. Head trauma 
a- Head trauma with intracranial hemorrhage  
b- Penetrating head injury  
c- Closed head injury 
d- Other 
 
9. Inheritable conditions 
a- Presumed genetic cause 
b- Tuberous sclerosis  
c- Progressive myoclonic epilepsy  
d- Metabolic syndrome  
e- Channelopathy 
f- Mitochondrial disorder 
g- Chromosomal aberration 
h- Other 
 
10. Structural, brain abnormality of unknown cause 
 
11. Other  
 
12. Unknown etiology 
 
Tier 4 : Seizure frequency  
 
The major goal of therapy for epilepsy is t o reduce frequency and severity of seizure. Tier 4 
classifies seizure based on frequency  
 
1. Daily seizures  
Seizure every day  
2.   Persistent seizures 
      At least one seizure per month  
2. Rare or no seizures  
Fewer tha none seizure every six month  
3. Undefined 
Seizure frequency can nbot be defined. 
 
 
 
 
 
 
Tier 5 : Realted medical condition   
 
Additional information about existing medical condition is put in this tier. 
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PUBLICATIONS 
List of Publication 2009-2012 
 
Book Chapter: 
Surgery for temporal lobe epilepsy: pros, cons and comparison between different 
procedures 
Stephan Chabardès, Shivadatta Prabhu, Taner Tanriverdi in Mesial Temporal Lobe Epilepsies 
(Ed. Hans Luders, Rosenov) p 245-262, 2011 John Libby Eurotext 
 
Papers: 
The subcortical hidden side of focal motor seizures: evidence from micro-recordings and 
local field potentials 
Annaelle Devergnas,1,2 Brigitte Piallat,1,3 Shivadatta Prabhu,1 Napoleon Torres,4 Alim 
Louis Benabid,1,4 Olivier David1 and Stephan Chabardès1,3,5 
Published in ‘Brain’ Brain jJune2012: 135; 2263–2276 | 
 
Posters: 
1.Continuous high frequency Subthalamic nucleus DBS controls ongoing focal motor 
seizures in a primate model 
S. Prabhu, B. Piallat, S.Michallat, O David and S. Chabardès 
10 th Colloque, Société des Neurosciences Marseille ,24-27 May 2011(p 3.114) 
2.Differential involvement of basal ganglia structures during motor seizures in a primate 
model 
B. Piallat, A.Devergnas, S.Prabhu, S.Michallat, O.David and S.Chabardès 
10th Colloque, Société des Neurosciences Marseille ,24-27 May 2011(p 3.110) 
3.Could basal ganglia input structures control ongoing focal motor seizures? Results of 
Subthalamic nucleus DBS and further plan in a primate model 
S. Prabhu, B. Piallat, S.Michallat, A.Sherdil, O David and S. Chabardès 
8 th world congress of International Brain research Organization Florence, Italy July 14 18 
2011 (p B 440) 
4.The prefix ‘Neuro’ in terms like neuromarketing, neuroeconomics :Truly 
transdisciplinary approaches or just catchy hyped up syllables ? 
S.Prabhu, H.Misra, B.Augier, A.Sherdil 
8 th world congress of International Brain research Organization Florence, Italy July 14 -18, 
2011(p T20) 
5.Electric modulation of ongoing pharmacoresistent focal motor seizures by 
Subthalamic nucleus in a primate model 
Prabhu S, Piallat B, Michallat S, David O, Chabardes S 
29th International Epilepsy Congress of International league against Epilepsy Rome, Italy 28 
August 1 st September2011 (p 867) 
6.Treating Pharmacoresistant Focal Motor Seizures with HFS DBS of Subthalamic 
Nucleus: Rationale and Results in a Primate Model 
S. Prabhu, B. Piallat, A. Devergnas, S.Michallat, O David and S. Chabardès 
65th Anuual Conference of American Epilepsy Society, Baltimore USA, December 2- 6, 
2011( poster 3.070) 
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